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ABSTRACT 
Cytolethal distending toxin (CDT) is a genotoxin, which belongs to a group of bacterial protein 
toxins called cyclomodulins. These are characterized by their interference with the eukaryotic 
cell cycle. CDT causes DNA damage, which induces cell cycle arrest and apoptosis. The active 
holotoxin consists of three subunits CdtA, CdtB and CdtC, where CdtB is the active subunit and 
has structural and functional similarities with DNase I. 
 
We demonstrated that CDT uses the same internalization pathway as several other bacterial 
toxins do, such as cholera toxin and Shiga toxin. The binding on the plasma membrane is 
dependent on cholesterol. The toxin is internalized via the Golgi complex, and retrogradely 
transported to the endoplasmic reticulum (ER) and found in the nucleoplasmic reticulum. The 
translocation from the ER to the nucleus does not require either the ER-associated (ERAD) 
pathway or the Derlin-1 protein. Additionally, we showed that CDT is not farnesylated, a 
modification known to occur in the cytosol. In contrast, to other AB toxins, CdtB was 
demonstrated to have heat-stable properties and is not degraded by the 20S proteasome. All these 
evidence suggest that the toxin is translocated directly from the ER to the nucleus. 
 
In adherent cells the cellular response to the CDT-induced DNA damage involved activation of 
the RhoA GTPase. We showed that the RhoA-specific Guanine nucleotide exchange factor 
(GEF) Net1 is dephosphorylated and translocated from the nucleus to the cytosol upon DNA 
damage. Knock down of Net1 by RNAi prevents RhoA activation, inhibits the formation of 
stress fibers, and enhances cell death. This indicates that Net1 activation is required for RhoA-
mediated response to genotoxic stress. The Net1 and the RhoA dependent signals converge the 
activation of mitogen-activated protein kinase p38 (p38 MAPK) and its downstream target 
MAPK-activated protein kinase 2 (MK2). To further investigate this novel cell survival pathway 
in response to CDT we screened a yeast deletion library for CdtB-sensitive strains. 
Approximately 4500 yeast deletion strains were transformed with a plasmid containing CdtB. 
The screen shows that 78 mutated strains were hypersensitive to CdtB. Twenty of the human 
ortholog genes were found to interact with the actin cytoskeleton regulation network. Our 
analysis focused on TSG101, FEN1 and Vinculin (VCL). We demonstrated that they are all 
required to induce actin stress fiber formation in response to DNA damage.  FEN1 and VCL also 
regulate the RhoA GTPase and p38 MAPK activation, and delay cell death in response to CDT 
intoxication. 
  
In response to DNA damage, Ataxia-telangiectasia mutated (ATM) and ATM and Rad-3-related 
kinases (ATR) are activated and orchestrate DNA damage response. The transcription factor 
Myc has multi-functions such as inducing apoptosis in response to DNA damage. The Myc-
regulated effectors acting upstream of the mitochorial apoptotic pathway are still unknown. We 
demonstrated that Myc is required for activation of the ATM-dependent DNA damage 
checkpoint response in cells exposed to ionizing radiation or CDT. Activation of ATM effectors, 
such as histone H2AX and the nuclear foci formation of the Nijmegen Berakage Syndrome 
(Nbs)1 protein, were abolished in the absence of Myc. The cellular response to UV irradiation, 
known to activate an ATR-dependent checkpoint, was not delayed in the absent of the Myc 
expression. This data demonstrate that Myc is required for activation of the ATM-dependent 
pathway. 
 
Our studies highlight the importance of understanding the CDT biology and its mode of action. 
This knowledge could provide new tools to elucidate the putative involvement of bacteria in 
carcinogenesis. 
 
SAMMANFATTNING PÅ SVENSKA 
 
Bakterietoxinet cytolethal distending toxin (CDT) är ett genotoxin, det vill säga ett toxin som 
skadar arvsmassan. CDT tillhör en grupp bakterietoxiner som kallas cyclomoduliner. Dessa 
karaktäriseras av att de påverkar livscykeln hos celler. När CDT orsakar skador på arvsmassan i 
cellerna, leder det till stopp i cellens livscykel och så småningom till cellens död. CDT består av 
tre delar; CdtA, CdtB och CdtC, där CdtB är den verksamma delen.  
 
Vi har visat att CDT tar sig in i värdcellen på samma sätt som många andra bakterietoxiner, 
exempelvis koleratoxin. Toxinets bindning till cellytan är kolesterolberoende. Väl inne i cellen 
transporteras toxinet till Golgiapparaten och vidare till det endoplasmatiska nätverket. 
Transporten från nätverket till cellkärnan är inte beroende av ERAD signalvägen eller av proteinet 
Derlin-1, vilket är viktigt för andra toxiner. Vi har även visat att CDT inte farnesyleras, vilket 
endast sker i cytoplasman. CDT kan istället lokaliseras i det nukleärplastiska nätverket nära 
cellkärnan. Till skillnad från andra toxiner, visade sig CdtB vara värmestabilt och bryts inte ner av 
destruktionsmekanismen 20S proteasomen. CDT tar sig direkt från nätverket till cellkärnan utan 
att först passera cytoplasman. 
 
CDT-framkallade skador på arvsmassan leder till aktivering av RhoA GTPase. Vi påvisade att 
GEF (RhoA-specifika Guanine nucleotide exchange factor), Net1, defosforyleras och 
transporteras från cellkärnan till cytoplasman när arvsmassan skadas. Nedreglering av Net1 
stoppar bildningen av stressfibrer och ökar celldödligheten. Detta visar att aktivering av Net1 är 
nödvändig för hur cellen skall reagera när arvsmassan skadas. Net1 och RhoA behövs för vidare 
signalering till molekylerna p38 MAPK och MK2. För att ytterligare undersöka denna nya 
signalväg som är viktig för cellens överlevnad, tog vi hjälp av ett genetiskt jästbibliotek. En 
plasmid med CdtB placerades in i cirka 4500 jäststammar. Resultatet visar att 78 av dessa 
jäststammar är känsliga för CdtB. Hos dessa är 20 stycken mutanter inblandade i kontrollen av 
cytoskelettet i mänskliga celler. Ytterligare experiment visar att molekylerna TSG101, FEN, och 
Vinculin (VCL) är viktiga för bildning av stressfibrer när arvsmassan skadats. FEN1 och VCL 
reglerar även aktiveringen av RhoA GTPase och p38 MAPK och är viktiga för cellens överlevnad 
när arvsmassan skadats. 
 
ATM (Ataxia-Telangiectasia Mutated) och ATR (ATM and Rad-3-related kinases) är molekyler 
som aktiveras vid skador på arvsmassan. Myc är ett protein med flera funktioner bland annat vid 
celldöd. Vi undersökte Mycs roll efter att arvsmassan skadats i cellen. ATM visade sig inte 
aktiveras lika snabbt i celler utan Myc jämfört med celler med Myc. Celler utan Myc överlevde 
längre med skador i arvsmassan och vissa molekyler som är inblandade i reparationen av 
arvmassan aktiverades inte. Detta betyder att Myc är nödvändig för ATMs aktivering efter att 
arvsmassan skadats med antingen strålning eller CDT. ATR-signalvägen som aktiveras av UV 
strålning är inte beroende av Myc.  
 
Dessa resultat understrycke vikten av att förstå biologin om CDT och dess mekanismer. Dessa 
kunskaper om CDT kan bli viktiga för att kunna förstå sambandet mellan bakterieinfektioner och 
uppkomsten av cancer. 
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1. OBJECTIVES 
The objective of this study: to understand the internalization and the cellular response in 
mammalian cells upon DNA damage induced by the bacterial genotoxin CDT. 
 
The specific aims were to: 
 
-  Characterize the internalization pathway of CDT from binding on the cell membrane to its    
entry into the nucleus where it causes DNA damage.  
 
-  Identify key effectors of the RhoA-dependent survival signals in response to DNA damage.  
 
-  Investigate the role of the transcription factor Myc in response to radiation- and CDT induced 
DNA damage.  
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2. INTRODUCTION 
 
 
2.1 Background 
 
Cytolethal distending toxin (CDT) is a bacterial toxin affecting many cellular processes, such 
as cell cycle, actin stress fiber formation and inflammation. To entirely understand the complex 
biology of CDT and its mode of action, it is necessary to review several of these cellular key 
pathways. 
 
2.1.1 Cell cycle 
 
The eukaryotic cell cycle consists of four coordinated activities, cell growth, deoxyribonucleic 
acid (DNA) replication, distribution of the duplicated chromosomes to daughter cells, and cell 
division. There are four phases: Gap 1 phase (G1), synthesis (S), Gap 2 phase (G2), and mitosis 
(M) (Figure 1) [143, 173].  During the G1 phase, there is cellular growth and preparation of the 
chromosomes for replication. Chromosome duplication takes place during the S phase. During 
the G2 phase, the cell continues to grow, synthesizes protein, and prepares for mitosis. During 
the M phase, the chromosomes condense, the nuclear envelope breaks down, the cytoskeleton 
rearranges to form the mitotic spindle, and the chromosomes separate and move to opposite 
poles. The cell is pinched into two parts, each with a complete set of chromosomes. The 
chromosomes are enveloped by a nuclear membrane to form a nucleus and cell division takes 
place. The new daughter cells eventually enter the G1 phase to continue the cycle [98]. If the 
conditions that signal the transition to the next phase are not present, the cell exits the cell cycle 
and enters a quiescent stage called G0 [172, 173]. 
 
2.1.1.1 Checkpoints 
 
There are several systems, called checkpoints. These systems ensure the proper execution of 
the cell division, by checking that the essential events of a cell cycle step are completed before 
progression to the next step. In case of detection of DNA damage, the checkpoints prolong the 
length of a stage to allow repair [40]. The cell cycle checkpoints, activated by DNA damage, 
occur at the G1/S transition (G1 checkpoint), S phase progression (S checkpoint), G2/M 
boundary (G2 checkpoint), and M phase (M checkpoint) (Figure 1) [40, 133]. 
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Figure 1. The cell cycle. The cycle is divided into four phases with a checkpoint in each, which is preventing the 
cell from proceeding in the cycle if any errors occur. Different cyclins and Cdks are regulating the transition from 
one phase to another. 
 
2.1.1.2 Cyclins and Cdks 
 
The cell cycle of eukaryotes is controlled by a conserved set of protein kinases, which 
promotes the transition to the next stage of the cycle. Regulatory protein subunits, referred to as 
cyclins, are associated with these kinases. Distinct pairs of cyclins and cyclin-dependent 
kinases (Cdks) are the primary regulators of the cell cycle. The levels of cyclins rise and fall 
through the stages of the cell cycle through periodic synthesis and degradation, but the Cdk 
levels remain relatively stable. Association with specific cyclins regulates the kinase activity of 
the Cdks by phosphorylation and dephosphorylation, by the binding of Cdk inhibitors, and by 
degradation of the attached cyclin. The role of Cdks is to phosphorylate a number of protein 
substrates that control cell cycle procession [40, 141, 173]. Upstream regulators, such as tumor 
suppressor genes, like Ataxia-telangiectasia mutated protein kinase (ATM), Rb and p53 control 
the Cdks. 
 
 
  6 
2.1.2 DNA Damage and checkpoint responses 
 
The genomic integrity of organisms is maintained, generation after generation through a 
number of mechanisms, like replication, cell cycle checkpoints, and DNA repair. Genomes are 
subjected to a number of exogenous DNA damaging agents (e.g. ionizing radiation (IR), 
radiomimetic chemicals and bacterial toxins), or endogenous DNA damaging agents (e.g. 
reactive radicals, stalled replication forks, meiotic recombination, and immune system 
maturation) that cause DNA double-strand breaks (DSBs) or single- strand breaks (SSBs) 
(Figure 2).  The DSBs can cause chromosomal rearrangements, senescence, carcinogenesis or 
cell death [72, 171]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.  DNA damaging agents and cellular response to DNA damage. Many agents can cause DNA damage 
and this may have different outcomes. ATM and ATR are the main sensor kinases, activated by different kinds of 
DNA damage. IR or genotoxins activate preferentially ATM, while ATR is activated by ultraviolet (UV) exposure 
or stalled replication fork. ATM and ATR activate cascades of signaling pathways, leading to either cell death or 
attempt to rescue the cell. 
 
The DNA repair is dependent on the family of phosphatidylinositol 3-OH-kinase like kinases 
(PIKKs), such as ATM and the ataxia-telangiectasia and Rad-3-related kinases (ATR), and 
DNA protein kinase catalytic subunit (DNA PKcs). The kinases phosphosphorylate a diversity 
of proteins that transduce DNA damage signals. The signal leads to cell cycle arrest, alternate 
transcription, start DNA repair or, if the DNA damage cannot be repaired, apoptosis [2, 152].  
A recent proteomic analysis of the components in the DNA repair machinery reveals an 
extensive network of more than 700 proteins [100]. The substrate proteins of ATM and ATR 
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kinases are involved in nucleic acid and protein metabolism, cell cycle regulation, signal 
transduction, cell structure and proliferation, oncogenesis, and immunity. In mammalian cells, 
the activation of ATM is induced by DSBs. The ATM phosphorylation is followed by 
dissociation of the inactive complex to form the active ATM [6]. Upon treatment of cells with 
IR, proteins such as the Mre11-Rad50-Nbs1 complex involved in repairing DNA DSBs are 
moved to the site of the damaged DNA and are required for proper ATM activation [88]. ATM 
phosphorylates histone H2AX that localizes to the break site along with the Mre11-Rad50-
Nbs1 complex [99, 104, 110, 122]. Detection of phosphorylated H2AX is a well-established 
way to detect and quantify DNA damage in cells [93]. Another known ATM substrate is 
checkpoint kinase 2 (Chk2), which inactivates CDC25C phosphatase leading to accumulation 
of hyperphosphorylated (inactive) Cdk1 [133]. ATM also activates p53, which increases the 
production of the cyclin-dependent kinase inhibiting p21 (Figure 6) [151]. p21 inhibits 
dephosphorylation of cyclin E/Cdk2, thereby blocking transition from G1 into S of the cell 
cycle.  
 
2.1.3 Cell death and apoptosis 
 
Apoptosis or programmed cell death is an important mechanism to balance cell proliferation 
and remove unwanted cells during the development and homeostasis of multicellular organisms 
[43]. Apoptosis is characterized by shrinkage of the cell, membrane blebbing, chromatin 
condensation, followed by DNA fragmentation and the appearance of apoptotic bodies, which 
are then engulfed by the surrounding cells [176]. The apoptotic process can be divided into 
three main phases: the initiation phase, the effector phase and the execution phase. The two 
major pathways for apoptosis induction are the death receptor-dependent pathway and the 
mitochondria-dependent pathway. Activation of either of these pathways ultimately target a 
family of cystein-dependent aspartate directed proteases, called caspases [174], the main 
executioners of cell death. The receptor-dependent pathway includes ligation of a death ligand 
to its transmembrane receptor belonging to the tumor necrosis factor (TNF) receptors super 
family. The receptor forms a death complex, followed by recruitment and activation of 
caspases in the death-inducing signalling complex. The mitochondria-dependent pathway is 
mainly activated by intracellular signals such as DNA damage. Activation of the mitochondria, 
results in release of caspase-activating proteins into the cytosol, thereby forming the 
apoptosome where caspases will bind and become activated [172, 174].  
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2.1.4 The Rho GTPases family  
 
The Rho guanosine triphosphatases (GTPases) are molecular switches that regulate many 
essential cellular processes, including actin dynamics, gene transcription, cell cycle progression 
and cell adhesion. Rho GTPases are inactive when bound to GDP, and kept in this form by 
binding to guanine nucleotide dissociation inhibitors (GDI).  They are activated by GDP/GTP 
exchange, induced by guanine nucleotide exchange factors (GEFs) and are inactivated by 
hydrolysis of the bound GTP, a process that is mainly facilitated by GTPases-activating 
proteins (GAPs (Figure 3). The active Rho GTPases interact with a large spectrum of effector 
proteins to mediate downstream signalling [12, 67, 129]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. The Rho-GTPase molecular switch. The small GTPases cycle between an inactive GDP-bound state 
and an active GTP-bound state. GEFs activate the Rho-GTPases by accelerating their GDP/GTP exchange rate and 
GAPs inactivate the Rho-GTPases. 
 
Members of the Rho family of small GTPases (RhoA, Rac, Cdc42) have shown to be key 
regulators of the actin cytoskeleton, and furthermore, through their interaction with multiple 
target proteins, they ensure a coordinated control of other cellular activities like gene 
transcription and adhesion. The cytoskeleton is a dynamic structure that maintains cell shape, 
protects the cell, enables cellular motion, and plays an important role in both intracellular 
transport and cellular division. Eukaryotic cells contain three main types of cytoskeletal 
filaments; microfilaments, intermediate filaments, and microtubules [145].  
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Each of the three GTPases regulate distinct processes; RhoA is involved in the formation of 
stress fibers and focal adhesions, by activating the Rho-associated, coiled-coil containing 
protein kinase 1 (ROCK1) which stimulates LIM kinase, then stimulates Cofilin that re-
organises the actin cytoskeleton. Rac stimulates the polymerisation of actin underneath the 
plasma membrane leading to membrane ruffles. Cdc42 induces polymerization of actin to 
produce filopodia [16, 71].  
 
 
2.2 Bacterial toxins 
 
Bacterial toxins are the most powerful human poisons known and retain high activity at very 
low concentrations. For example the lethal dose of botulinum toxin in mouse is in the range of 
1–5ng/kg [106]. In contrast, the lethal dose of strychnine, a very toxic pesticide, is 2mg/kg 
[135].  
 
There are two main types of bacterial toxins, lipopolysaccharides (LPS), which are associated 
with the cell wall of Gram-negative bacteria (endotoxins), and proteins, which are released 
from the bacterial cells and can act at tissue sites removed from the site of bacterial growth 
(exotoxins) [91]. Since the attention of my work is to characterize the cellular responses to 
cytolethal distending toxin (CDT) which regulate the cell cycle, the primarily discussion will 
be on bacterial toxins that interfere with this process; the bacterial cyclomodulins. 
 
2.2.1 Cyclomodulins 
 
Pathogenic bacteria have developed a complicated arsenal of virulence factors that take over 
eukaryotic host functions to their own benefits. One of the pathways targeted by several 
bacterial toxins is the eukaryotic cell cycle. These toxins, termed cyclomodulins, can promote 
cell proliferation, or in opposition inhibit cell growth and modulate differentation by blocking 
cell cycle progression (Table 1) [115, 117].  
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Table 1. Bacterial cyclomodulins. Adapted from [115]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.2.1.1 Inhibiting cyclomodulins 
 
CDT and Colibactin induce DNA damage in the host cells, resulting in activation of the DNA 
damage checkpoints [114, 167, 181]. 
 
Cif produced by enteropathogenic and enterohemorrhagic Escherichia coli (EPEC and EHEC) 
is injected into the host cell by the bacterial type II secretion system, and inhibits the G2/M 
transition via constant inhibition of Cdk1, [20, 97]. Cif also induces reorganization of the actin 
cytoskeleton, although the effect is cell type-dependent, and cell cycle arrest is not a result of 
the cytoskeleton alterations [114, 162]. Cif is composed of a C-terminal effector domain and an 
exchangeable N-terminal translocation signal [20]. In contrast to CDT and Colibactin, Cif-
induced Cdk1 phosphorylation is not a consequence of DNA damage response and does not 
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cause phosphorylation of histone H2AX [162]. Cif-induced block of the cell proliferation 
correlates with induction of cyclin-dependent kinase inhibitor (CKI) p21 and p27 ubiqutination. 
Fusobacterial immunosuppressive protein (FIP) is produced by Fusobacterium nucleatum, a 
Gram-negative anaerobe involved in various diseases, including periodontitis. FIP suppresses 
human B- and T-cell responses to antigen and mitogens in vitro by arresting the cell cycle in 
the G1 phase. The G1 arrest is associated with the failure in these cells to express the 
proliferating cell nuclear antigen (PCNA), an important factor in DNA replication and repair 
[149].  
 
Mycobacterium ulcerans is a causative agent of Buruli ulcer, a debilitating skin disease found 
in Australia and West Africa. The disease is characterised by persistent severe necrotic lesions 
of the skin and underlying fat, and lack of an acute inflammatory response. M. ulcerans 
secretes a polyketide-derived macrolide, named mycolactone, which induces cell rounding, 
inhibits protein synthesis and causes cell cycle arrest in G0/G1 and eventually cell death [55]. 
 
2.2.1.2 Promoting cyclomodulins 
 
Several bacterial products are known to stimulate the proliferation of eukaryotic cells. 
Cytotoxic necrotizing factor (CNF) from E. coli and Yersinia pseudotuberculosis and the 
dermonecrotic toxin (DNT) from Bordetella species are transglutaminases. These toxins 
catalyze deamination or polyamination at Gln63 of RhoA and the corresponding Gln residues 
of the other members of the GTPase family, Rac and Cdc42. This blocks the essential GAP-
stimulated GTP hydrolysis, thereby constitutively activating the GTPases [65]. CNF and DNT 
trigger the G1/S transition and induce DNA replication in different mammalian cells, such as 
fibroblasts and osteoblasts [66, 118]. Another toxin acting in these cell types is the Pasteurella 
multocida toxin (PMT), which is a highly potent mitogen for various cell types [109, 134]. 
 
2.2.1.3 Helicobacter pylori 
 
Helicobacter pylori is the only bacterium so far classified as a human carcinogen by the 
International Agency for Research on Cancer (IARC), since it is associated with an increased 
risk of gastric adenocarcinoma and mucosa-associated lymphoid tissue (MALT) [87]. H. pylori   
produces cyclomodulins that have both inhibitory and promoting properties. They can both 
induce cell proliferation ans cause cell cycle arrest. Cytotoxin-associated antigen A (CagA), 
which is encoded by cagA in the cag-pathogenicity island of H. pylori is an important virulence 
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factor [19]. It has been shown that CagA promotes a rapid progression from G1 into G2/M and 
p53-independent apoptosis within 72 hours in a gastric cell line [123]. Once CagA is localized 
in the plasma membrane it is phosphorylated and activates the oncogene tyrosine phosphatase 
SHP2. CagA activation of SHP2 leads to cellular morphological changes that are reminiscent 
of unrestrained stimulation by growth factors, and CagA appears to induce cell proliferation by 
activation of the MAPK pathway via both Ras-dependent and -independent signalling [62, 63]. 
 
The virulence factor vacuolating cytotoxin (VacA) is expressed as a precursor protein. VacA 
action on cells is associated with rapid formation of acidic vacuoles enriched for late 
endosomal and lysosomal markers [34]. In gastric epithelial cells, VacA has been shown to 
inhibit cell proliferation through p53-dependent cell cycle arrest in the G1 phase and induce 
cell death via activation of the mitochondrial-dependent apoptosis pathway [21, 30]. 
 
2.2.2 Cellular internalization of bacterial protein toxins 
 
Many protein toxins consist of two parts, one compartment (subunit A) is responsible for the 
enzymatic activity of the toxin; the other compartment (subunit B) binds to a specific receptor 
on the target cell membrane and transferres the enzyme across the membrane. The enzymatic 
component is not active until it is released from the native AB toxin. Isolated A subunits may 
bind to target cells but lack the ability to enter. On the other hand, isolated B subunits may bind 
to target cells and enter cells, but are not toxic. The best known mechanism of toxin uptake into 
target cells is receptor-mediated endocytosis where the native AB toxin is within the 
endosomal compartments [59, 116]. The specific receptors for the B subunit of toxins on target 
cells or tissues are usually glycoproteins [82, 90]. 
 
Several bacterial protein toxins are internalized rapidly and efficiently by binding to 
transmembrane proteins entering by clathrin-dependent endocytosis. Diphtheria toxin, cholera 
toxin (CT) and Pseudomonas aeruginosa exotoxin A (ETA) are toxins, which take advantage 
of the clathrin-dependent pathway [75, 112, 153, 169]. Transmembrane receptors that become 
concentrated in clathrin-coated pits have an internalization signal in their cytoplasmic domain, 
which interacts with the adaptor protein 2 (AP2). AP2 binds to clathrin and many other adaptor 
proteins and the internalization of the coated vesicle takes place [73, 163]. Another molecule 
important for toxin internalization is the GTP-binding dynamin, which controls the formation 
of coated pits and is involved in a late step of clathrin-dependent endocytosis [146]. Also 
cholesterol is important for clathrin-dependent endocytosis [130, 158]. Several protein toxins 
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can be internalized by an endocytic mechanism that functions independently of clathrin and 
caveolae. For example the plant toxin ricin as well as CNF is internalized by clathrin- and 
caveolae- independent endocytosis [24, 138].  
 
A number of bacterial toxins, such as diphtheria toxin and anthrax toxin are translocated 
directly from the endosome to the cytosol. The trigger for the translocation is the endosomal 
pH, which induces a conformational change in the B subunit of the toxin, allowing 
translocation of the A compoment [23, 24, 44]. A number of toxins such as ricin, Shiga toxin 
and CT are transported to the Golgi apparatus after being endocytosed [70, 136, 138].  Such a 
toxin can be present in an organelle in concentrations too low to be visualized by microscopy. 
Biochemical approaches have been developed to quantify the transport and presence of a toxin 
in the Golgi complex or the ER. Addition of a sulfation sites to the toxin allows it to be sulfated 
in the Golgi complex. Similarly, addition of glycosylation sites allows one to use glycosylation 
in the ER to monitor retrograde transport [136]. Cholesterol is important not only in regulating 
endocytosis, it is also crucial for endosome to Golgi transport of toxins. When reducing the 
cholesterol levels with methyl-β-cyclodextrin (mβCD) the transport to the Golgi complex is 
decreased [140].  
 
Toxins that are retrogradely transported to the ER and act on cytosolic targets, such as the 
ETA, ricin, and CT, are known to enter the cytosol from the ER. The proposed mechanism for 
their transmembrane translocation involves the ER associated protein degradation (ERAD) 
pathway [154, 165], known to translocate misfolded secretory and ER membrane proteins into 
the cytosol for proteolytic degradation [57].  
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3. CYTOLETHAL DISTENDING TOXINS 
 
 
3.1 Introduction 
 
CDT is a bacterial genotoxin with the unique ability to induce DNA damage and cell cycle 
arrest, thereby inhibiting cell proliferation. These cellular responses are identical to those 
induced by IR, a well-characterized DNA damaging agent. CDT causes cell cycle arrest and 
progressive cellular distension leading to enlargement of both the cell and nucleus followed by 
chromatin fragmentation and cell death [27, 50]. It is possible that CDT acts as a cytotoxic 
agent in the pathogenesis of infection. Because of its genotoxic activity CDT may be a 
potentially carcinogenic agent.  
 
CDT was first reported by Johnson and Lior in 1987. It was described as a novel type of toxic 
activity produced by pathogenic strains of E. coli. The cytotoxic effect was observed as an 
extraordinary cell distension, obvious 3-5 days after addition of bacterial culture supernatants 
to cells growing in vitro, and resulting after a few more days in cell death [69]. They named the 
toxin “cytolethal distending toxin” (CDT) based on the morphological effect on mammalian 
cells. It has been showed that CDT has an effect on a variety of cells, even yeast cells [58, 168]. 
 
CDTs are produced by several Gram-negative bacterial pathogens, including E. coli, 
Salmonella typhi, Shigella dysenteriae, Aggregatibacter actinomycetemcomitans, Haemophilus 
ducreyi, Helicobacter sp and Campylobacter spp (Table 2) [168]. The toxin consists of three 
subunits CdtA, CdtB and CdtC. Only a cdtB gene has been demonstrated in S. typhi and is not 
present in other S. enterica reservoirs. There are no homologues of the cdtA or cdtC genes. The 
cdtB from S. typhi forms a complex with S. typhi PltA (persussis-like toxin A) and PltB 
(persussis-like toxin B) [56, 156].  
 
The subunits of CDT appear to be constitutively synthesized, assembled into CDT complex 
and translocated into the periplasm in bacterial cells. The CDT complex is then secreted into 
the extracellular medium, probably via CdtA that undergoes post-translational cleavage at its 
N-terminal signal sequence [61, 170]. A recent study has demonstrated that CDT is released in 
association with outer membrane vesicles (OMVs) in E. coli, suggesting that OMVs could 
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represent the natural vesicle through which CDT is delivered to the target cells from the 
bacteria [10]. 
              
Table 2. Summary of CDT occurrence in bacteria. Adapted from [168]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
a. Probably presence of cdtB sequences 
 
In our studies we have used CDT derived from Haemophilus ducreyi, named HdCDT. H. 
ducreyi is a fastidious Gram-negative rod-shaped bacterium, that is the causative agent of the 
sexually transmitted disease, chancroid [155]. It has been demonstrated that HdCDT is virtually 
identical with the CDT produced from A. actinomycetemcomitans; the amino acid sequence 
identities were 91%, 97%, and 94% for CdtA, CdtB, and CdtC, respectively [159]. HdCDT 
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induces cell distension and cell cycle arrest in HeLa cells [25]. The toxin also has cytotoxic 
effects on epithelial cells [28], keratinocytes, fibroblasts [157], antigen presenting cells  [177] 
and endothelial cells [161].  
 
HdCDT is not necessary for initiation of the early stages of an infection. It is possible that the 
cytotoxic effect of CDT on certain cells may be responsible for the slow healing seen in 
untreated chancroid [161]. The apoptosis induced in B- and T-cells by HdCDT indicates that 
the consequential immunosuppression would delay or decrease immune function and allow 
bacterial growth and enhance tissue damage [28, 54, 160]. 
 
 
3.2 The structure of CDT 
 
The CDT holotoxin is composed of the subunits CdtA, CdtB and CdtC with the predicted 
molecular masses of approximately 26, 30 and 20 kDa [27]. All three components are 
necessary for cytotoxicity of CDT [51]. The cdt gene cluster are generally located on the 
chromosome of CDT-producing bacteria [53]. 
 
3.2.1 Structure and function 
 
HdCDT is a ternary complex with three extensive globular protein-protein interfaces between 
CdtA-CdtB, CdtA-CdtC and CdtB-CdtC. CdtA and CdtC are both lectin-type structures, 
homologous to the B-chain repeats of ricin. CdtA and CdtC bind at one end of CdtB, and 
contact each other by the repeats in the ricin B-chain [107]. HdCdtB is the most conserved of 
the three holotoxin components and shows sequence similarity to proteins of the 
deoxyribonuclease I (DNase I) family (approximately 12% identity based on a structural 
alignment) [64] Mammalian DNase I is a Mg2+-dependent endonuclease which functions as a 
digestive enzyme [80].  
 
Structure and mutagenesis analysis indicate that two primary features of the combined CdtA 
and CdtC subunits are responsible for the surface binding ability of CDT, namely a patch of 
aromatic residues found in CdtA and a deep grove formed by the combined structure of CdtA 
and CdtC.  This deep groove, which likely plays an important role in the cellular receptor, may 
explain the previous observations that combined CdtA and CdtC bind to cell surfaces much 
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better than either subunit by itself. This would also explain why the toxicity is higher when 
both CdtA and CdtC are present together (Figure 4) [111]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.  Crystal structure of HdCDT. Adapted from [111]. 
 
CDT from other bacteria have also shown DNase I similarities in structure and activity. A 
significant position-specific amino acid similarity was demonstrated between CdtB-II from E. 
coli and DNase I. Co-incubation of supercoiled plasmid DNA and culture supernatants from 
CDT-II producing E. coli indicated that within 2h, the supercoiled DNA was transformed into 
linear DNA and by 12h, there was no intact DNA present [42]. Culture supernatants of 
bacterial strains containing amino acid substitutions in the CdtB protein, corresponding to 
active sites in DNase I, lacked DNase activity, and did not induce distension or cell cycle arrest 
in HeLa cells [41, 42]. DNase assays were perfomed with a supercoiled pTRE2 plasmid that 
was incubated with purified HdCDT in a dose-dependent manner. It demonstrated that indeed a 
clevage of the supercoiled plasmid into the relaxed and linear form was observed, indicating 
induction of DNA SSBs and DSBs respectively [92]. Kinetic analysis has shown that also CdtB 
from A. actinomycetemcomitans exhibit DNAse activity in vitro.  
 
However, CdtB requires a ten fold higher concentration than DNase I to optimally convert 
supercoiled to relaxed form of DNA, CdtB is more heat-stable than DNase I and it is not 
inactivated by actin [38]. These differences are not unexpected since the cdtB gene has 
developed as part of a prokaryotic cytotoxin and would not be expected to be identical to a 
typical mammalian endonuclease. 
  18 
3.2.2 The subunits 
 
CdtA is able to bind to target cells, but alone it lacks cytotoxic activity, and the combination of 
only CdtA and CdtB is without cytotoxicity on HeLa cells [84, 89, 96].  CdtB is the active 
subunit of the holotoxin and shows DNase I activity in vitro and in vivo. CdtB is cytotoxic after 
microinjection or electroporation-facilitated entry into the host cells [41, 83, 96, 178]. In 
contrast, extracellulary added CdtB is not able to bind to most target cells and therefore is not 
cytotoxic by itself [53].  
 
It has been demonstrated that the purified recombinant His-tagged A. actinomycetemcomitans 
CdtC alone, delivered to the cytosol, was able to induce cell distension and eventually cell 
death in Chinese hamster ovary cells (CHO) [96]. However, the effect was not reproduced for 
CdtC derived from other bacteria. The CdtAC complex is the cell surface binding component 
and mechanism for the delivery of CdtB of the eukaryotic cells [84, 111]. CdtC has been 
reported to change the holotoxin environment. The isoelectric point (pI) of the HdCdtC subunit 
was 1.5 pH units higher in recombinant strains expressing all three subunits than in 
recombinant strains expressing the CdtC subunit alone [51]. A similar change of pI occurred 
after mixing the three individual recombinant subunits in vitro. Therefore, it was suggested that 
HdCdtA/CdtB might apply some kind of processing activity on HdCdtC, to make it active [36, 
51]. 
 
 
3.3 Cellular internalization of CDT 
 
Different CDTs have the ability to intoxicate cells even after exposure times as short as two to 
fifteen minutes. It indirectly suggests that CDT binds to cells rapidly and irreversibly, although 
no specific receptor has been demonstrated [5, 25]. It has been shown that the toxic action of 
CdtB is dependent on its internalization of the toxin into the target cell [56]. 
 
CDT belongs to the AB-type of bacterial protein toxins. The two binding subunits attach to the 
target regions on the cell membranes; the active subunit enters though the membrane and 
possesses enzymatic functions [85]. All the subunits are required for its binding to the surface 
of the target cell and for maximal cytotoxic activity [125, 126, 180]. Studies suggest that the 
CDT binds to either a fucose-containing glycoprotein [103] or gangliosides [105] on the cell 
surface.  
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Cortes-Bratti and colleagues showed that HdCDT enters HeLa cells by endocytosis via 
clathrin-coated pits. Additionally, the cellular intoxication was completely inhibited under 
conditions that block the fusion of the endosomal compartment with downstream 
compartments or after treatment with Brefeldin A (BFA) [26]. Like many AB toxins HdCDT 
must travel from the plasma membrane to the ER before its active moiety can escape the 
endomembrane system to reach its target.  
 
Since chromosomal DNA is the target of the CDT action, nuclear translocation of CdtB is 
necessary to induce DNA damage. Nuclear translocation requires the presence of nuclear 
localization signal (NLS) sequences. CdtB contains no known conventional NLS. However, it 
has been demonstrated that CdtB-II from E. coli does localize in the nucleus of HeLa cells. 
Putative bipartite NLS sequences have been located at the C-terminus of the CdtB-II protein. 
Mutations were introduced into the wild type cdtB gene, which affected the NLS sequence 
without affecting DNase activity. When CdtB-II protein with a NLS mutation was 
electroporated into HeLa cells, the proteins did not localize in the nucleus and there was no 
induction of cell cycle arrest [102]. Microinjection experiments in HeLa cells showed that a 76 
amino acid stretch in the amino-terminal region in the CdtB from A. actinomycetemcomitans 
forms an unusual NLS. Cells exposed to a holotoxin containing a mutant CdtB did not get 
intoxicated [113].  
 
 
3.4 Cellular responses upon CDT intoxication 
 
CDT induces DNA DSBs similar to IR. The DNA damage activates a cascade of pathways 
including the DNA repair pathway and RhoA activation. The most distinct morphological 
effect of CDT is the slowly developing cell distension, along with the strongly promoted, actin 
stress fibers in cells of epithelial origin (Figure 5). The stress fiber promotion has been reported 
in many different cell types, including CHO cells, HeLa cells and fibroblasts [168]. After 
several days of toxin exposure, adherent cells begin to round up, show membrane blebbing in 
some cases, and then diffuse completely. Upon treatment with HdCDT, HEp, HeLa, Don 
(Chinese hamster lung fibroblasts), and HaCaT (human immortalized keratinocyte) cells 
undergo irreversible damage resulting in cell enlargement without proliferation and cell cycle 
arrest followed by cell death [25]. Treating HEp2 cells with CDT caused enlarged cell nuclei 
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without mitotic spindles, which indicated that cell cycle arrest is at G2 rather than at the M 
phase [25].  
 
 
 
 
 
 
 
 
 
 
 
Figure 5. CDT intoxication induces cell distension and promotion of actin stress fibers.  Cells intoxicated with 
CDT for 24h and stained with fluorescein isothiocyanate (FITC)-phalloidin to visualize the actin stress fibers. 
 
3.4.1 CDT causes DNA damage and activates DNA repair pathways 
 
Phosphorylation of two well-known ATM substrates; p53 and Chk2 was demonstrated in 
intoxicated primary fibroblasts and in HEp2 cells respectively, indicating that the response to 
CDT is ATM-dependent [28]. The role of ATM in CDT intoxicated cells was further 
confirmed the delayed p53 phosphorylation and cell cycle arrest in ATM-deficient cells, 
compared to cells expressing a wild type ATM.  
 
CDT intoxication activates proteins and protein complexes known to coordinate the activation 
of DNA repair responses such as ATM-dependent phosphorylation of histone H2AX, which 
localize in nuclear foci, and the relocalization of the Mre11-Rad50-Nbs1 complex at the site of 
DNA damage (Figure 6) [28, 92]. Therefore, HdCDT similarly to IR induces DNA damage, 
DNA repair proteins, and cell cycle arrest. 
 
3.4.2 CDT induces cell cycle arrest and cell distension 
 
The effects of HdCDT are cell-specific; B-cells undergo apoptosis, caused by phosphorylation 
and stabilization of p53 [25]. Normal fibroblasts undergo cell cycle arrest in both G1 and G2 
phases of the cell cycle when intoxicated with CDT, thereby hyperphosphorylate Cdk1 and 
phosphorylate p53, and p21 [11, 25, 28]. p21 inhibits Cdk2 which induces G1 cell cycle arrest. 
Epithelial cells and normal keratinocytes undergo cell cycle arrest exclusively in the G2 phase. 
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This was confirmed by the activation of hyperphsophorylation of Cdk1 and prevention of 
cyclin B translocation into the nucleus (Figure 6) [11, 25, 35]. CDT does not directly inhibit 
Cdk1 since it can be fully reactivated in vitro by CDC25 [35]. 
 
The destiny of CDT-intoxicated mammalian cells likely depends on cell types as well on the 
cell receptor binding specificity of different CdtA/CdtC. In both epithelial cells and fibroblasts 
the morphological effect of CDT is cell-distending leading within 72h to a 3-to 5-fold increase 
of the cell size [167]. This is regulated by activation of phosphoinositide 3-kinases (PI3K) and 
its downstream target mammalian target of rapamycin (mTOR) (Figure 7) [49].  
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Outline for the mechanisms of cytopathic effects in the nucleus for CDT. DNA damage activates 
ATM, which activates the DNA repair, and the G1/G2 cell cycle arrest pathway. ATM activation may as well lead 
to apoptosis. 
 
3.4.3 CDT induces RhoA activation 
 
HdCDT has been found to induce F-actin rearrangement, including pronounced stress fibers 
development and promotion of membrane ruffling in HEp2 and Don cells [49]. Induction of 
actin stress fibers is not exclusively a CDT-related effect but was also demonstrated in HEp2 
cells and in fibroblasts exposed to IR. This demonstrates that the formation of actin stress fibers 
is not a strictly toxin induced response, rather a DNA damage response. Promotion of actin 
stress fibers is dependent on the small GTPase RhoA, since expression of a dominant-negative 
RhoA prevented the CDT-induced phenotype. Furthermore, biochemical assays demonstrated 
that RhoA, but not Rac or Cdc42 was activated in a time-dependent manner in intoxicated 
primary fibroblasts and HeLa cells. RhoA activation in CDT intoxicated cells was dependent 
on the DNA damage sensor kinase ATM (Figure 7) [49]. 
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Figure 7. Outline for the mechanisms of cytopathic effects in the cytosol for CDT. CDT intoxication leads to 
PI3K activation and cell distension. ATM promotes the activation of the RhoA pathway, which induces actin stress 
fiber formation and enhanced cell survival. 
 
The activation of RhoA was associated with prolonged cell survival. Therefore, it may 
represent an attempt of intoxicated cells to maintain cell adherence in order to stay alive while 
some time is given for DNA repair. The ATM-dependent activation of RhoA constitutes a 
previously unknown type of cell survival response to induction of DNA DSBs. 
 
3.4.4 Cellular responses to CdtB in yeast 
 
In contrast to mammalian cells, yeast cells can not receive CDT from the peripheral medium 
because of the structure and thickness of the cell wall [74]. Therefore, Hassane and co-workers 
constructed a plasmid containing each CDT subunit from Campylobacter jejuni in 
Saccharomyces cerevisiae under a galactose (GAL) promoter. It was demonstrated that the C. 
jejuni CdtB subunit expressed in S. cerevisiae induced irreversible G2/M cell cycle arrest, 
extensive degradation of chromosomal DNA, and loss of viability. Yeast expressing CdtA or 
CdtC did not show any damage. The similar effect of the toxin in yeast cells compared to 
mammalian cells shows that yeast systems can be used to analyze cellular responses to CDT 
[58].  
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3.5 CDT in inflammation and cancer 
 
The concept that bacterial infections could lead to cancer was first proposed in the late 
nineteenth and early twentieth centuries [86]. Several bacteria have been linked to increased 
risk of cancer, but so far it is only H. pylori which has been classified as a human carcinogen 
by IARC [1]. However, toxins as PMT, CNF and Cif have all been reported to have 
carcinogenic potential [86]. Since CDT induces DNA DSBs and activates checkpoint 
responses, it has the potential to function as a biological carcinogen contributing to the 
initiation, promotion and progression of cancer.  
 
Cancer starts when a cell acquires sufficient mutations to promote cell growth, escape of 
senescence and inhibition of apoptosis. The cell breakout from its normal status is regulated by 
extracellular factors and interactions with its surroundings. The carcinogenic processes that 
arise by accumulation of mutations in crucial genes such as p53, Ras, Rb follow a stepwise 
sequence. Tumor initiation occurs when mutations free the cells from growth restraints, and the 
build-up of a small colony of cells takes place. Tumor promotion leads to cells, which are more 
dysfunctional and have lost more growth controls. As the colony of cells grows it has to obtain 
its own blood supply by organizing growth of blood vessels into the tumor (angiogenesis). The 
colony becomes invasive when it acquires the ability to break down local structures. The worst 
outcome is when cells marsch off from the tumor mass and travel around the body to establish 
cell colonies (metastases) [86, 101]. 
 
 Many evidence suggest that chronic inflammation is associated with the initiation of cancer 
development [45]. Inflammation begins with the production of pro-inflammatory cytokines, 
such as interleukin-1 (IL-1), IL-8 and TNFα. This attracts infiltration of the tissue mainly by 
neutrophils, which produce and secrete a number of toxic compounds, which can potentially 
favour tumor initiation and progression. These include the production of nitric oxide (NO) and 
reactive oxygen species (ROS), and elevation of levels of cyclooxygenase-2 (COX2). 
Consecutively, these products result in a complex mixture of effects including direct DNA 
damage, inhibition of apoptosis, and stimulation of proliferation or inhibition of cell cycle 
progression, increased angiogenesis and immunosuppression. Each of these outcomes is likely 
to contribute to the carcinogenic process [29, 86].  
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3.5.1 CDT and inflammation 
 
Several studies have demonstrated that CDT from different bacteria are involved in 
inflammation. 
 
The fact that C. jejuni enteritis presents with transient watery diarrhoea that progresses to 
bloody diarrhoea is consistent with the idea that bacterial toxins play a role in this disease. [32]. 
Sequencing the complete genome of C. jejuni has shown that the only toxin genes present in 
Campylobacter are those encoding CDT, no pilus structures are encoded by the chromosome 
[119]. This made it clear that C. jejuni, in contrast to other diarrhoea-causing bacteria, does not 
express a large number of classical virulence factors. The role of CDT in C. jejuni pathogenesis 
has not been determined yet. However, it might play a role in invasiveness and modulation of 
the immune response [127]. The CDT-producing bacterium C. jejuni has been shown to induce 
pro-inflammatory activity in NF-κB deficient (3x) mice [47] and promote secretion of IL-8, 
from human embryo intestinal epithelial (INT407) cells [61, 182]. Therefore, C. jejuni CDT 
might cause intestinal inflammation via its ability to elicit IL-8 secretion from intestinal 
epithelial cells.  
 
Also the individual CDT subunits from A. actinomycetemcomitans have to induce the 
production of IL-1β, IL-6 and IL-8, but not TNFα, IL-12, or granulocyte-macrophages colony 
stimulating factor in human peripheral blood mononuclear cells [3]. CDT produced from A. 
actinomycetemcomitans and H. ducreyi induce the expression of receptor activator of NF-κB 
ligand (RANKL) mRNA and RANKL protein [9]. A study performed with IL-10-/- and 
C57BL/6J (B6) mice, demonstrated that H. cinaedi could colonize and cause inflammation of 
the cecum and colon in the Th1-prediposed IL-10-/- strain, similar to other models using IL-10-/- 
mice infected with enterohepatic helicobacters [46, 78, 79]. CDT expressed in H. cinaedi was 
not necessary for colonization of the mice, but rather it increases the persistence of the disease, 
as reported for C. jejuni and H. hepaticus [147]. 
 
3.5.2 CDT and senescence 
 
It has recently been demonstrated that human cells (IMR-90, HeLa) that have been exposed to 
CDT and survive the acute intoxication phase undergo “premature cellular senescence” [13]. 
Senescence is a naturally irreversible cell cycle arrest that is known to be induced by DNA 
damage responses [31]. It is also observed in response to oncogenes and diverse stresses 
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including genotoxic chemicals [17]. CDT-intoxicated cells demonstrate all the classical 
senescence criteria, including long-term cell cycle arrest, large flat cellular morphology, 
positivity for acidic beta-galactosidase, activation of the major suppressor pathways; the 
p16/RB and p53/p21 cascades, persistent DNA damage signalling, enhanced promyelocytic 
leukaemia (PML) cellular compartments and induced expression of proinflammatory 
cytokines, such as IL-6 and IL-8 [13].  
  
3.5.3 CDT as a potentially carcinogenic agent 
 
Genotoxic activity of cyclomodulins, such as that caused by CDT could participate in genetic 
alterations and act as a promoting factor for the development of cancer. For instance, H. 
hepaticus, which produces CDT, colonizes the liver and causes chronic active hepatitis, which 
leads to hepatocarcinoma in mice [175]. A recent study of mouse liver carcinogenesis showed 
that the CDT produced by H. hepaticus was not required for induction of chronic hepatitis per 
se, but it was necessary for the promotion of further development into cancer [52]. 
 
It has been shown that survivals of typhoid outbreaks and those who become carriers of S. 
typhi, have 200 fold excess risk of developing hepatobiliary carcinoma compared with people 
who had acute typhoid and have cleared the infection [18]. Three to five percent of infected 
individuals who survive become carriers; therefore typhoid carriage could represent a 
significant cause of this cancer. Since CDT is only found in S. typhi and not in other 
Salmonella species, it probably has a specific role in typhoid, and it is appealing to hypothesize 
that it might be involved in the carcinogenic aspect of S. typhi carriage [86]. 
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4. RESULTS AND DISCUSSION 
 
The aim of my PhD thesis was to study several aspects of the CDT biology from the toxin 
internalization to the characterization of cell survival responses in intoxicated cells.  
 
 
4.1 CDT internalization through the Golgi apparatus and the 
endoplasmic reticulum to the nucleus 
 
Little was known about the cellular internalization pathway of CDT. Only one study had been 
published analyzing the internalization of CDT, and it demonstrated that HdCDT is 
internalized via clathrin-coated pits and is transported to the Golgi complex [26]. 
 
In paper I we demonstrate that the binding of the HdCDT on the plasma membrane of 
sensitive cells is cholesterol dependent, since it was abolished by cholesterol extraction with 
mβCD. This chemical is a well-known agent, which extracts cholesterol from the plasma 
membrane and disrupts lipid rafts, which are domains enriched in cholesterol, sphingolipids 
and glycosylphophatidylinositol (GPI)-anchored proteins [15]. This suggests that CDT may 
bind to lipid rafts on the cell membrane as many other bacterial toxins do, such as CT and H. 
pylori VacA [139]. Shenker and co-workers found indications that the CdtC subunit contains a 
cholesterol recognition/interaction amino acid consensus region, called CRAC. Mutation of the 
CRAC site resulted in decreased binding of the holotoxin to cholesterol containing model 
membranes as well as to the surface of Jurkat cells. The mutation also inhibited the 
internalization of CdtB and its toxicity. They suggest that cholesterol can work as a 
ligand/receptor for CDT [14]. However, there is no convincing evidence of what the receptor 
for CDT is. Nevertheless, we could for the first time visualize the binding of CDT in CDT-
sensitive HeLa cells as compared with CDT-insensitive BalbC3T3 cells by fluorescence 
microscopy. It indicates that BalbC3T3 cells are resistant to CDT, because they lack the surface 
receptor.  
 
Is the internalization of CDT necessary to induce cytotoxic effects? Or is it enough to induce 
DNA damage by transmembrane signalling from the plasma membrane, as suggested by 
Shenker and colleagues [148]? Indeed, the genotoxic activity of HdCDT was dependent on its 
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internalization and its DNase activity, since induction of DNA DSBs was prevented in BFA-
treated cells and in cells exposed to a catalytically inactive holotoxin.  
 
How is CDT internalized through the cell from the plasma membrane to the nucleus? By 
constructing a CdtB subunit with a C-terminal-containing sulphation site we could confirm that 
the toxin is internalized via the Golgi complex. A CdtB-containing sulphation site and three 
partially overlapping N-linked glycosylation sites, was used to determine that the active subunit 
is localized in the ER (Figure 8). Data have shown that also CdtC is localized in the Golgi 
complex (Frisan, unpublished data). This suggests that CdtC may help CdtB to the nuclear 
compartment. Additional studies have to be perfomed to assess whether CdtC is also 
retrogradely transported to the ER and if CdtA is following the same pathway.  
 
Further translocation from the ER did not require the ERAD pathway. This is based on that 
CHO cell clones, which showed an impaired ER to cytosol translocation, were still sensitive to 
HdCDT. These cell lines have been selected for their resistance to ricin, ETA and CT, which 
use the ERAD pathway for translocation from the ER to the cytosol. The toxin could also 
intoxicate a CHO cell line clone that has an enhanced cytosolic degradation. [166].  We could 
also exclude that HdCDT exits the ER via the Derlin1-ER-cytosol translocation pathway [94, 
179], since HeLa cells expressing Derlin-1GFP dominant-negative mutant were still arrested in 
G2 upon intoxication. 
 
Our results suggest that HdCDT either does not need to transit to the cytosol before entering 
the nucleus to exert its genotoxic activity, or alternatively its translocation to the cytosol occurs 
via a different pathway (Figure 8). We hypothesize that the CdtB nuclear translocation requires 
an uncommon mechanism, which has still not been identified, such as a direct translocation 
from the ER to the nucleus. In paper II we further studied this mechanism. We investigated the 
biophysical properties of CDT because thermal instability of the toxin active subunit is a 
common property of toxins that exit the ER by exploiting the mechanism of ERAD. Since 
HdCDT does not utilize ERAD to exit the ER, we predicted that the biophysical properties of 
its catalytic subunit would differ from those of ER-translocating toxins. 
 
Fluorescence spectroscopy and far-UV CD were used to examine the thermal stability of 
HdCdtB. The readings demonstrated that substantial disordering of the HdCdtB tertiary 
structure did not occur at 37°C. In fact, sample heating to 60°C was required to observe a 
disordering of the HdCdtB tertiary structure. Analysis of the ellipticity at 220 nm demonstrated 
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that substantial denaturation of the HdCdtB secondary structure only occurred at temperatures 
above 50°C. Thus, significant unfolding of HdCdtB did not occur at physiological temperature. 
To further examine the thermal stability of HdCdtB a protease sensitivity assay was performed. 
HdCdtB exhibited considerable resistance to proteolysis with thermolysin when incubated at 
temperatures up to 45°C. Thermolysin is a calcium-dependent metalloprotease that hydrolyzes 
peptide bonds on the amino side of bulky hydrophobic residues [8]. 
 
Figure 8. Internalization of HdCDT. CDT binds to the cell as a trimeric holotoxin, CdtB enters the cell through 
early and late endosomes, is transported to the Golgi, and further retrogradely transported to the ER. From the ER, 
the toxin is directly transported through the nucleoplasmic reticulum, and enters the nucleus, where it causes DNA 
damage. 
 
Our data indicate that HdCdtB exhibits remarkable heat stability and thermolysin resistance 
compared to the active chains of other ER-translocating toxins, such as CT. When testing the 
sensitivity to degradation by the 20S proteasome, little or no degradation was observed during 
the 20h time frame of the experiment. Chemical chaperones such as glycerol prevent protein 
unfolding [131] and block intoxication of ER-translocating toxins, such as ricin and exotoxin A 
[137]. We showed that the CDT genotoxic activity was not inhibited by glycerol treatment. 
This result suggests that HdCdtB does not require unfolding before exiting the ER and possibly 
does not exit the ER at all. 
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To further examine whether HdCdtB can bypass the cytosol and move directly from the ER to 
nucleus, we generated a recombinant HdCDT that contains a CVIM-tagged HdCdtB subunit. 
The C-terminal CVIM farnesylation motif can work as an indicator of protein localization to 
the cytosol because farnesylation takes place only in the cytosol [22]. The CVIM-tagged 
HdCdtB could not be found in the cytosolic fraction, suggesting CdtB is not farnesylated in the 
cytosol. Confocal microscopy detected HdCdtB in a fine, branching intranuclear network that 
is continuous with the nuclear envelope and the ER, named the nucleoplasmic reticulum [39, 
48, 81].  
 
Our results indicate that HdCdtB differs from all other bacterial toxins known to day, and 
support the hypothesis that CDT might not enter the cytosol before translocation to the nucleus. 
We could for the first time visualize CdtB in the nucleoplasmic reticulum. This data contribute 
to a better understanding of the CDT biology and its mode of action, as it demonstrated for the 
first time how a member of the CDT family is internalized via an intact Golgi, and that it is 
further retrogradely transported to the ER and probably directly to the nucleus. Furthermore, 
we showed that DNA damaging activity could only be exerted upon internalization, thereby 
rejecting previous hypotheses regarding activation of transmembrane signalling pathways.  
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4.2 Net1 and FEN1 are key proteins in the RhoA-dependent survival 
pathway 
 
Exposure of adherent cells to DNA damaging agents, such as CDT or IR, activates the small 
GTPase RhoA, which promotes the formation of actin stress fibers and delays cell death [49] 
[12, 67]. The signalling intermediates that regulate RhoA activation and promote cell survival 
were unknown.  
 
GEFs are key activators of small GTPases that regulate the switch between the active GDP-
bound and the active GTP-bound form of the GTPase. The majority of the known RhoA-
specific GEFs have a cytoplasmic localization. One of the few exceptions is the RhoA-specific 
GEF encoded by the neuroepithelioma transforming gene 1 (Net1) which is normally found in 
the nucleus of mammalian cells [132]. The regulation of Net1 activity is poorly understood. 
PAK1 dependent phosphorylation of Net1 inhibits its GEF activity and abolishes Net1-
dependent RhoA activation. Activation of RhoA requires translocation of Net1 from the 
nucleus to the cytoplasm [4, 144]. These data suggested that the activation of Net1 requires 
both changes in the phosphorylation pattern and shuttling between the nucleus and the 
cytoplasm. The signals that trigger these events were still unknown. We identified DNA 
damage as the trigger for Net1 activation.  
 
In paper III we demonstrate that DNA damage caused by either CDT or IR induces 
dephosphorylation of Net1 on its negative regulatory site. Moreover, knock down of 
endogenous Net1, inhibited the activation of RhoA in response to IR or CDT treatment. We 
could show that this was not due to a general destruction of the RhoA-dependent response 
since Net1 knock down did not prevent RhoA activation or the formation of actin stress fibers 
in cells treated with CNF that constitutively activates RhoA. We further examined whether 
inhibition of Net1 affected the RhoA-dependent formation of actin stress fibers in cells 
intoxicated with CDT. Without a doubt, there was a significant decrease in the intensity of 
fluorescence induced by intoxication in the Net1 ribonucleic acid interference (RNAi) treated 
cells as compared to controls.  
 
Activation of RhoA also promotes the survival of cells exposed to CDT [49]. In order to 
investigate whether Net1 is required for this RhoA mediated response, Net1 expression was 
inhibited by RNAi prior to intoxication, and cell death was observed. Down regulation of Net1 
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resulted in a 4-5-fold increase in the number of cells presenting chromatin condensation 48h 
after intoxication. The induction of cell death was also confirmed by cleavage of Poly (ADP-
ribose) polymerase (PARP) and activation of the pro-apoptotic protein Bax. These results 
indicate that Net1 is an essential component in the survival response to DNA damage. 
 
DNA damage has been shown to induce activation of mitogen-activated protein kinase p38 
(p38 MAPK) [37]. Therefore, we tested whether exposure to IR or CDT stimulates p38 MAPK 
activity, and whether this is necessary for protection of cell death. Both CDT and IR induced 
the activation of p38 MAPK within 3h. Inhibition of p38 MAPK with specific p38 MAPK 
inhibitors increased by 2-4 folds the number of chromatin condensations 48h after treatment. 
These results indicate that activation of p38 MAPK protects the cells from death induced by 
DNA damage. Inhibition of either Net1 or RhoA by RNAi resulted in a potent inhibition of the 
p38 MAPK activation in treated cells, demonstrating that Net1 and RhoA are upstream signals 
in the p38 MAPK activation cascade in response to DNA damage. Moreover, the 
phosphorylation of MAPK activated protein kinase2 (MK2), a direct substrate of p38 MAPK, 
following irradiation was abolished by knock down of either Net1 or RhoA, indicating that 
these proteins are required for MK2 activation. Inhibition of ROCKI/ROCKII did not impair 
the activation of p38 MAPK, demonstrating that ROCKI/ROCKII were not essential for 
signalling to this MAPK. 
 
These results demonstrate for the first time that genotoxic stress is a trigger for Net1 activation 
and they contribute to the characterization of a novel survival pathway in response to DNA 
damage, which involves Net1 and its downstream targets RhoA and p38 MAPK (Figure 10). 
Our finding that CDT-induced DNA damage is accompanied by activation of survival signals 
suggests that chronic infection with CDT-producing bacteria may promote genomic instability 
and favour malignant transformation. The association between bacterial infections and cancer 
is poorly understood. The only bacterium classified as human carcinogen is H. pylori, but a 
possible involvement in oncogenesis has been suggested for other bacteria, such as for example 
the Gram-negative, CDT-producing bacterium S. typhi [86]. The role of CDT in cancer could 
be its stimulation of prolonged survival in target cells, instead of inducing apoptosis when 
DNA is damaged. The prolonged cell survival in potential tumor cells may help the cells to 
accumulate mutations in crucial genes and progress toward a malignant phenotype.  
 
In paper IV we identified more players of the RhoA-dependent survival pathway by screening 
a yeast deletion library for genes that encode proteins, which promote survival of CdtB- 
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expressing yeast cells. A total of 4492 yeast strains harboring deletions in nonessential genes 
were transformed with a CdtB-expression plasmid under a galactose promoter and 
subsequently screened for delayed growth, which is indicative of defective survival signals. 
The screen was performed by using S. cerevisiae direct transfomation in a 96-well format 
[142]. All transformed yeast strains where spotted out on selective 2% glucose (CDT off) or on 
2% galactose (CDT on) plates for 48h. The strains that showed any signs of CdtB-sensitivity 
were subjected to dilution series (1:5) on plates containing 2% galactose for CdtB expression or 
on 2% glucose for control (Figure 9). Mutants that did not grow after the third dilution step out 
of six were classified as CdtB-hypersensitive strains. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Schematic outline of the yeast screen in a 96-well format using a 48-pin replicator. Wild type  
deletion strains were transfected in 96-well plates and transferred to selevtive -leucine/glucose (-leu/glu) plates. All 
transformants were suspended in water and moved to -leucine/galactose (-leu/gal) (CdtB on) or on -leu/glu (CdtB 
off) plates. All strains that show any indication of CdtB-sensitivity were transferred to 96-well plates for dilution 
series of 1:5 and replated on -leu/gal (CdtB on) or on -leu/glu ( CdtB off) plates.  
 
 
The screening identified 78 deletion mutants that are CdtB-hypersensitive and further system 
biology studies demonstrated that 20 of the human orthologs are involved in the actin 
cytoskeleton regulation. Based on protein-protein interaction networks three genes (the tumor 
susceptibility gene 101 (TSG101), flap endonuclease 1 (FEN1) and vinculin (VCL)) were 
selected for further studies in mammalian cells. Knock down assay with specific RNAi 
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demonstrated that all three genes significatlly reduced actin stress fiber formation in DNA 
damage cells compared with control cells.  
 
Are these genes involved in the novel RhoA cell survival pathway? Indeed, knock down of 
FEN1 and VCL completely prevented RhoA activation upon CDT intoxication, whereas 
TSG101 did not. Cell death was assessed 72h after intoxication by common detection methods, 
such as monitoring chromatin condensation and detection of the activated Bax. Approximately 
a 11-fold increase in apoptotic cells was detected in intoxicated cells where FEN1 or VCL have 
been knocked down, compared with a 3-fold increase of apoptotic cells in control cells. Since 
both FEN1 and VCL were essential for the RhoA activation, it is conceivable that these genes 
are also important for p38 MAPK phosphorylation. Downregulation of either FEN1 or VCL 
showed indeed decrease of p38 MAPK phosphorylation. 
 
In summary; TSG101, FEN1 and VCL are important to induce actin stress fibers. FEN1 and 
VCL also regulate the activation of RhoA GTPase and its downstream molecule p38 MAPK, 
resulting in prolonged cell survival (Figure 10). 
 
The finding that FEN1 is one of the key molecules in the RhoA survival pathway is novel and 
has not previosly been reported. FEN1 has multifunctional endonuclease acitivity. It is 
involved in RNA primer removal and long-patch base excision repair [7, 93, 95], but also has a 
5’-3’ exonuclease (EXO), as well as a gap endonulease (GEN) activity [95, 120]. How FEN1 
activates the RhoA GTPase remains unknown. It is possible that FEN1 regulates the RhoA 
specific GEF Net1, which is located in the nucleus, via activation of a specfic phosphatase or 
inhibition of a kinase. VCL is not present in yeast, but was selected because it has been 
reported to interact with FEN1 and for its role in focal adhesion complexes and integrin 
signaling to the actin cytoskeleton proteins [33]. It is not understood whether FEN1 and VCL 
act consecutively or if they activate different signaling pathways that act on RhoA. 
 
Inhibition of TSG101, did not have any effect on the cell survival nor on the activation of 
RhoA GTPase or p38 MAPK. TSG101 had a major effect on the formation of stress fibers, 
demonstrating that TSG101 is important in the regulation of stress fiber formation. TSG101 
belongs to one of the four endosomal sorting complex required for transport (ESCRT), the 
ESCRT I, which controls formation of multivesicular bodies [164]. Several components of the 
ESCRT complexes or ESCRT-binding proteins were found in the yeast gene screen that 
promote cell survival in response to CdtB. It has been reported that other members of the 
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ESCRT proteins induce regulation of the actin cytoskeleton. Our novel data suggest that a 
number of proteins, which regulate protein and vesicular trafficking may play a role in the 
regulation of cell adhesion and cell survival in normal or stress conditions, such as DNA 
damage. The ESCRT protein may function as a scaffold for the compartmentalization of 
specific signalling complexes. One of these proteins is TSG101,which has already been shown 
to interact with ROCKI [108, 164]. This suggest that TSG101 activates a part of the RhoA 
signaling pathway that leads to stress fiber formation, but is not involved the activation of the 
MAPK pathway or the cell survival pathway. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. Chart of the Net1/FEN1/VCL regulated cell survival signals upon exposure to DNA damaging 
agents. Upon DNA damage Net1 is dephosphorylated and transported out from the nucleus to the cytosol. There it 
activates RhoA, promotes actin stress fibers and increases cell survival. FEN1, located in the nucleus and VCL 
located in the cytosol are also involved in the regulation of RhoA activation. TSG101 is involved in the induction 
of actin stress fibers. 
 
This study identified three novel actors FEN1, VCL and TSG101 as important effectors 
regulating RhoA activation, actin stress fibers, p38 phosphorylation, and ultimately cell 
survival. This highlights a complex and still poorly characterized cross-talk between DNA 
damage and the actin cytoskeleton. The cytoskeleton, focal adhesions and integrin activation 
are important for the cells to maintain the connection with the extracellular matrix (ECM) and 
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enhanced resistance to IR and cytotoxic drugs [60]. The connection is crucial for the cell 
survival. If the cell looses the connection to the matrix, it can undergo anoikis, a form of 
apoptosis induced by detachment from the ECM.  
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4.3 Myc: an important player in the DNA damage induced ATM 
activation 
 
In paper V we investigate the role of Myc in the DNA damage response. The Myc protein is 
known to control cellular functions such as differentiation, proliferation, and apoptosis. In 
response to genotoxic agents, cells expressing Myc undergo apoptosis [124]. However, the 
Myc-regulated effectors acting upstream of the mitochondrial apoptotic pathway were still 
unknown. In this study, we demonstrate that expression of Myc is essential to activate the 
ATM-dependent DNA damage checkpoint responses in cells exposed to IR or CDT and plays 
an important role in the regulation of the cellular response to genotoxic stress. 
 
Myc positive TGR-1 cells showed G2 cell cycle arrest after 12h compared to 24h to 48h in myc 
null rat cell line HO15.19. Phosphorylation of ATM occurs after 30 minutes in Myc positive 
cells, whereas it was not detectable in HO15.19 cells. By using an antibody specific for 
phosphorylated ATM/ATR substrates, we detect two unknown phospho-proteins in the TGR-1 
cell but not in the myc null rat cells. Phosphorylation of the ATM and its downstream effectors, 
such as histone H2AX, were delayed in the HO15.19, compared to the Myc positive TGR-1 
and HOmyc3 cells. Nuclear foci formation of the Nijmegen breakage syndrome (Nbs)1 protein, 
essential for efficient ATM activation, was also inhibited in absence of Myc. The data indicate 
that Myc exerts an additional level of control, apart from gene regulation in the DNA damage-
induced activation of up-regulation of Nbs1.  
 
Phosphorylation of the ATR substrate Chk1 was not affected in the HO15.19 cells in response 
to irradiation. Accordingly, the cellular response to UV irradiation, known to activate an ATR-
dependent checkpoint, was similar in all the cell lines, independently of the Myc status (Figure 
11). Therefore, our results suggest that Myc regulates the activation of ATM but not the ATR-
dependent checkpoint pathway induced by radiation. The DNA damage response and delayed 
cell death in the myc null rat cell line HO15.19 in response to CDT intoxiation may promote or 
enhance genomic instability and favor carcinogenesis. 
 
Over-expression of Myc can induce DNA damage; thereby contribute to genome instability 
and chromosomal aberrations. In contrast, expression of physiological levels of Myc is 
important for the proper activation of DNA damage checkpoint responses. This suggests that 
Myc may have a tumor-suppressor-like function, by contributing to the DNA repair pathway. 
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These data demonstrate that Myc is required for the rapid activation and nuclear formation of 
Nbs1. This activates the ATM and consequent phosphorylation of downstream effectors. If the 
DNA damage cannot be repaired, the activation of ATM will probably result in mitochondria-
dependent apoptosis. Myc may play an important role for maintaining genome stability when 
expressed at levels observed in non-malignant cells. Myc is a very complex molecule which is 
involved in many processes in the cell. This study has helped to clarify one more aspect of the 
complicated regulation in the cell that Myc is controlling. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. Sketch of the MYC-dependent response to IR or CDT intoxication. Upon DNA damage Myc is 
activated and regulates the activation of ATM and Nbs1, which leads cell cycle arrest apoptosis. The ATR 
pathway is not dependent on the activation of Myc. 
 
As discussed in previously in this thesis, chronic infection with CDT-producing bacteria may 
be associated with increased risk of cancer. How the bacterial infection can contribute to 
carcinogenesis is still not fully characterized. The loss of Myc and the delayed cell death in 
chronic infection with CDT-producing bacteria may promote or enhance genomic instability, 
and favor tumor initiation and/or promotion. This suggests that CDT does not alone cause 
carcinogenesis but it may require additional factors, such as a mutated or dysfunctional tumor-
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suppressor gene. If cells with a non proper functional MYC gene are infected with CDT-
producing bacteria, the action of CDT may contribute to carcinogenesis. Cell survival is 
important for a cell to have the possibility to repair DNA damage, but this may as well lead to 
accumulation of mutations, which will increased the risk of cancer.  
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5. CONCLUDING REMARKS  
 
The work described in this thesis has provided new insight on the mechanisms of bacterial 
genotoxins and their possible role in carcinogenesis. This knowledge has set the platform for 
further explorations of the biology of CDT and the cellular responses to CDT. Furthermore, it 
has highlighted many new aspects of CDT and DNA damaging cellular response.   
 
CDT is following the same internalization pathways as many other bacterial toxins for example 
CT and ETA. In contrast to these other protein toxins, CDT is so far the only toxin that does 
not exit to the cytosol. It is suggested that the toxin is directly translocated to the nucleus, 
through a tightly connected ER-nucleus network (paper I and II). CDT is heat-stable and not 
degraded in physiological temperatures by the proteasome (paper II). This raises several 
questions about the complexity of the nuclear translocation of CDTs, emphasizing once more 
the importance of bacterial toxins as tools for characterization of cellular processes. 
 
The first molecular characterization of a RhoA-dependent survival pathway triggered by DNA 
damage induced by CDT intoxication or IR was described. The RhoA specific GEF Net1 was 
identified as the key regulator of RhoA activation upon DNA damage. p38 MAPK was 
characterized as an important player for cell survival downstream of RhoA (paper III). 
Additional studies of the novel survival pathway were performed with help of a wide genome 
screen in yeast. The study revealed that both FEN1 and VCL are regulators of RhoA activation 
and important for cell survival, while TSG101 regulates actin stress fiber formation (paper 
IV). Moreover, we have indications that FEN1 regulates the activation of Net1 since it is 
demonstrated that downregulation of FEN1 expression by RNAi inhibited dephosphorylation 
of Net1. Further dissections of this pathway will provide new tools to elucidate the mechanisms 
of bacterial-induced carcinogenesis, and may also help to design specific inhibitors that can act 
synergistically with conventional chemotherapy. 
 
A more upstream key player in CDT-induced DNA damage response is Myc, since it regulates 
the ATM-dependent checkpoint responses to damage (paper V). Myc is a complex molecule 
involved in many different pathways [124]. Further analysis of this phenomenon would be to 
characterize the two unknown ATM substrates, which are phosphorylated only in the presences 
of Myc and upon IR treatment (paper V, Figure 3). 
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Studies have shown that CDT beyond any uncertainties acts on the DNA, and has similarities 
with DNase I [111] Remarkably, DNase I has a significantly more potent DNase activity than 
CdtB. In contrast, CdtB can enter cells and translocate to the nucleus. How the translocation to 
the nucleus is carried out is still unclear. It is clear that CDT just like many other bacterial 
toxins, such a CT uses the endosomal compartments and the retrograde transport to bring itself 
across the cell to its target destination. 
 
Shenker and colleagues have questioned whether the relevant activity of the CDT family is a 
DNase-like activity. They suggest that the cytotoxic effect might be triggered upon toxin-
induced transmembrane signalling from the cell surface [148, 168]. Shenker and co-workers 
recently demonstrated that the CdtB subunit has phosphatidylinositol (PI)-3,4,5-triphosphate 
phosphatase (PI-3,4,5-P) activity in Jurkat cells. Analysis indicated that CdtB hydrolyzes PI-
3,4,5-P to PI-3,4-P2 and therefore functions similar to phsophatidylinositol 5-phosphatases such 
as the tumor suppressor phosphatase, PTEN and SHIP1. Mutations analysis showed that CDT 
toxicity correlates with phosphatase activity, and additionally, lymphocytes treated with toxin 
showed reduced PI-3,4,5-P levels [150].  However, several studies including those presented in 
this thesis demonstrate beyond any doubt that at least the active CdtB subunit has to be 
endocytosed and undergo intracellular transport to the nucleus before it can damage the cells 
and the cell damage is caused by its DNase activity. 
 
The new data presented in this thesis concerning the responses to DNA damage induced by two 
known DNA damaging agents (CDT and IR) contribute to disclose the complex cellular 
response to DNA damage. The identification of the novel cell survival pathway, which allows 
cells to survive in the presence of agents that cause genomic instability, is crucial in the 
development of more selective therapeutic inhibitors to treat cancer. 
 
Senescence in cells has proven to have a tumor-suppressive fuction and may be the outcome of 
particularly severe DNA damage. The cells can also undergo apoptosis. It is still unclear what 
decides the choice between apoptosis and senescence, but the decision may include cell type, 
intensity, duration and type of damage [31]. The senescence induced by CDT-intoxicated cells 
may be a dose-dependent response. If cells are intoxicated with higher amount of CDT it 
causes rapidly DNA damage, resulting in senescence or cell death. If the cells are intoxicated 
with a lower dose of CDT it may not cause a large extent of DNA damage but instead induce 
genomic instability. The mutations may force the cell through the cell cycle, and eventually 
progress into a more malignant phenotype can occur. 
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The inhibition of cell proliferation and the cell cycle arrest caused by CDTs indicate that CDTs 
may be virulence factors in vivo. While not clearly demonstrated, it is probable that the CDTs 
produced by A. actinomycetemcomitans and H. ducreyi are disease determinants since these 
CDTs induce cell destruction in a number of different cell types and induce apoptosis in 
immune cells. The antiproliferative and immunosuppressive activities of these CDTs may be 
responsible for the slow healing and chronic nature of untreated aggressive periodontitis and 
chancroid diseases.  
 
Is CDT a carcinogenic agent? It has not been established yet that CDT itself can cause cancer, 
but given that CDT has the abilities to cause DNA damage, mutations and genetic instability 
resulting in cell cycle arrest, apoptosis and slow healing of ulcers, it could very well be a 
carcinogen [13]. CDT-producing bacteria have been demonstrated to induce inflammation. It is 
known that chronic inflammations can initiate tumor progression. Moreover, data have shown 
that long time low-dose intoxication with HdCDT causes chromosomal aberrations, which are 
indications for genomic instability, and associated with different types of cancers (Guerra, 
unpublished data) [13, 128]. As incorrectly repaired DNA can ultimately result in 
carcinogenesis, insight into how CDT intoxicated cells can survive, may help in designing 
strategies to prevent tumor development in people that are chronically infected with CDT-
producing bacteria. 
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6. FUTURE PERSPECTIVES 
 
This thesis has contributed to many major findings concerning CDT and its mode of action. 
However, many questions still need to be answered. Still the receptor is not identified and how 
CDT translocates from the ER to the nucleus also remains unknown. Even though the cell 
survival pathways have been to some extent characterized in this thesis, there are still plenty 
that remain to be clarified.  
 
The toxin is produced by a number of enteric bacteria, however the role of CDT as enteric 
disease inducer remains unclear. It does not appear that CDT plays a direct role in the induction 
of diarrhoea; this family of toxins may be responsible for some of the prolonged symptoms 
seen in diarrhoeal diseases.  
 
Whether the in vitro finding of CDTs obtained in cultured cells are possible to be translated in 
vivo still need to be fully assessed. For this purpose a good animal model should to the 
established, particularly for the human specific CDT-producing bacteria.  
 
Evidence suggests that CDT is a virulence factor that benefits bacterial survival and enhances 
microbial pathogenicity. CDT is essential for persistent colonization of the host, for example by 
CDT-producing H. hepaticus or C. jejuni in mice. It could be of interest to determine whether 
anti-CDT vaccines generated with catalytic or receptor binding sites-mutated CDT can prevent 
or clear infection of a human pathogen such as H. ducreyi. 
 
Another aspect of the DNA damage and cell killing abilities of CDT is the use of CDT as an 
immunotoxin. Some bacterial toxins, such as Diphtheria toxin and ETA are in phase I/II in 
clinical trials for use as immunotoxins. Immunotoxins are bacterial toxins, which are connected 
with a specific cell binding ligand. The immunotoxin is designed bind to specific cells such as 
tumor cells, and destroy them [68, 76, 77, 121]. In particular, it has been suggested that CDT 
could represent a novel immunotoxin for lymphocytes, since these cells are five fold more 
sensitive to CDT than other cells [150]. Some initial attempts have already been made with 
CDT, but unfortunately none of these have been particularly successful. It is an assignment for 
the future.  
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Further in vitro and in vivo studies regarding CDT will not only increase the understanding of 
the virulence properties of CDT but could also provide prophylactic and therapeutic strategies 
to combat infectious diseases such as diarrhoea, inflammatory bowel disease, fever and 
chancroid. The characterization of the mode of action of bacterial toxins has led to many 
developments in the basic and applied medical science. To further investigate the relationship 
between the DNA damage and the actin cytoskeleton is of great importance since it is a 
survival pathway, and may be important for bacterial-induced carcinogenesis.  
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Summary
The cytolethal distending toxins (CDTs) are unique in
their ability to induce DNA damage, activate check-
point responses and cause cell cycle arrest or apop-
tosis in intoxicated cells. However, little is known
about their cellular internalization pathway. We dem-
onstrate that binding of the 
 
Haemophilus ducreyi
 
 CDT
(HdCDT) on the plasma membrane of sensitive cells
was abolished by cholesterol extraction with methyl-
 
b
 
-cyclodextrin. The toxin was internalized via the
Golgi complex, and retrogradely transported to the
endoplasmic reticulum (ER), as assessed by N-linked
glycosylation. Further translocation from the ER did
not require the ER-associated degradation (ERAD)
pathway, and was Derlin-1 independent. The geno-
toxic activity of HdCDT was dependent on its internal-
ization and its DNase activity, as induction of DNA
double-stranded breaks was prevented in Brefeldin A-
treated cells and in cells exposed to a catalytically
inactive toxin. Our data contribute to a better under-
standing of the CDT mode of action and highlight two
important aspects of the biology of this bacterial toxin
family: (i) HdCDT translocation from the ER to the
nucleus does not involve the classical pathways fol-
lowed by other retrogradely transported toxins and (ii)
toxin internalization is crucial for execution of its
genotoxic activity.
Introduction
 
Cytolethal distending toxins (CDTs) are produced by sev-
eral Gram-negative bacteria, including 
 
Escherichia coli
 
,
 
Campylobacter
 
 spp., 
 
Shigella
 
 spp., 
 
Haemophilus ducreyi
 
and 
 
Actinobacillus actinomycetemcomitans
 
 (reviewed in
Thelestam and Frisan, 2004a). In the producing bacte-
rium, three linked genes, named as 
 
cdtA
 
, 
 
cdtB
 
 and 
 
cdtC
 
,
encode three polypeptides, with the predicted molecular
masses of 26, 30 and 20 kDa respectively (reviewed in
Dreyfus, 2003). The CdtA, CdtB and CdtC proteins form
a biologically active tripartite complex (Lara-Tejero and
Galan, 2001), which is able to bind to the cell surface of
the target cells (Lee 
 
et al
 
., 2003).
The classical effects of CDT intoxication are cell disten-
sion and block of cellular proliferation, which occurs at
different stages of the cell cycle, in a cell type-dependent
manner. Human fibroblasts are arrested in the G1 and G2
phases of the cell cycle, while other cell types, such as
HeLa cells, are exclusively arrested in G2 (reviewed in
Thelestam and Frisan, 2004a). The molecular pathways
leading to the CDT-induced cell cycle arrest are identical
to the checkpoint responses induced by ionizing radiation,
a well-known DNA-damaging agent, including phosphory-
lation of histone H2AX and hyperphosphorylation of the
cyclin-dependent kinase (cdc) 2 (Cortes-Bratti 
 
et al
 
.,
2001; Li 
 
et al
 
., 2002; Hassane 
 
et al
 
., 2003). Activation of
the DNA damage checkpoint responses in CDT-treated
cells is consistent with the demonstration that the CdtB
subunit shares functional and structural homology with the
mammalian DNase I (Elwell and Dreyfus, 2000; Lara-
Tejero and Galan, 2000). The crystal structure of the 
 
H.
ducreyi
 
 CDT (HdCDT) has been recently solved, and it
reveals that the toxin consists of an enzyme belonging to
the DNase I family (CdtB), bound to two lectin-like
domains (CdtA and CdtC) with homologies to the cell
binding component of the plant toxin ricin (Nesic 
 
et al
 
.,
2004). Furthermore, the CdtB subunit from 
 
E. coli
 
 causes
DNA degradation in an 
 
in vitro
 
 system (Elwell and Drey-
fus, 2000), CdtB from 
 
Campylobacter jejuni
 
 (CjCdtB)
induces nuclear collapse when microinjected or ectopi-
cally transfected in eukaryotic cells (Lara-Tejero and
Galan, 2000), and DNA double-stranded breaks (DSBs)
 922
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were induced by CjCdtB expressed in yeast (Hassane
 
et al
 
., 2001) and by HdCDT intoxication in mammalian
cells (Frisan 
 
et al
 
., 2003). Point mutations in residues
important for catalysis, Mg
 
2
 
+
 
 or DNA binding completely
prevent cellular intoxication by CDTs (Elwell and Dreyfus,
2000; Lara-Tejero and Galan, 2000). However, some con-
troversy still exists regarding the mechanism of action of
CDTs, as it has been recently suggested that cellular
intoxication could be mediated by CDT-induced signals
from the cell membrane (Shenker 
 
et al
 
., 2004).
Internalization of several cytosolic acting toxins, such
as ricin, cholera toxin and 
 
Pseudomonas aeruginosa
 
 exo-
toxin A (ETA), requires translocation via the endosomal
compartment, transit through the Golgi complex and
transport to the endoplasmic reticulum (ER) (reviewed in
Sandvig and van Deurs, 2002). It is noteworthy that
among the bacterial toxins discovered so far, CDT is the
only one acting as a DNase, and therefore needs to gain
access to the nuclear compartment.
Few studies have addressed the issue of CDT internal-
ization and its requirement for nuclear translocation. It has
been shown that HdCDT enters HEp-2/HeLa cells by
endocytosis via clathrin-coated pits. Furthermore, the cel-
lular intoxication was completely inhibited under condi-
tions that block the fusion of the endosomal compartment
with downstream compartments or after treatment of cells
with Brefeldin A (BFA) (Cortes-Bratti 
 
et al
 
., 2000).
Nishikubo 
 
et al
 
. (2003) recently identified an atypical
nuclear localization signal (NLS) within the N-terminal
region of the A. 
 
actinomycetemcomitans
 
 CdtB (AaCdtB),
which was essential for nuclear translocation of the recom-
binant His-tagged CdtB-GFP. Cells exposed to a holotoxin
containing a mutant CdtB, with 11-amino-acid deletion, did
not present any sign of intoxication. On the other hand,
two NLS sequences, designated as NLS1 and NLS2, have
been identified in the C-terminal region of the 
 
E. coli
 
 CdtB-
II (EcCdtB-II). Deletion of these two regions prevented
induction of cell cycle arrest and nuclear localization of
the holotoxin, without affecting its DNase activity, as tested
in 
 
in vitro
 
 assays (McSweeney and Dreyfus, 2004).
The knowledge concerning the mechanism of action of
CDTs has increased exponentially over the past 4 years.
However, some relevant questions still need to be
answered regarding this unusual family of bacterial toxins,
such as the nature of the toxin receptor and the complete
characterization of its internalization pathway. In this
study, we have addressed some of these questions.
 
Results
 
Binding of HdCDT on sensitive cells is cholesterol 
dependent
 
To establish a reliable method to detect surface binding of
HdCDT, HeLa cells were exposed for 20 min on ice to: (i)
CdtA
 
+
 
CdtC
 
+
 
GST-CdtB, (ii) CdtA
 
+
 
CdtC and (iii) GST-CdtB
alone. After extensive washing, bound toxin was detected
by fluorescence microscopy via a fluorescein-conjugated
anti-GST antibody. A distinct membrane staining was
observed in HeLa cells exposed to CdtA
 
+
 
CdtC
 
+
 
GST-
CdtB, while we could not detect any signal in cells incu-
bated with CdtA
 
+
 
CdtC, or the GST-CdtB subunit alone,
which were used as negative control (Fig. 1A). Similar
results were obtained using a reconstituted toxin contain-
ing a fluorescein-conjugated CdtB subunit (data not
shown).
To show that HdCDT binding detected by fluorescence
microscopy was a general phenomenon, not limited to a
cell cluster, FACS analysis was performed. As shown in
Fig. 1B, the majority of HeLa cells exposed to reconsti-
tuted toxin showed an increased fluorescence intensity
compared with control cells exposed only to GST-CdtB.
It has been previously shown that proliferation of
BalbC3T3 mouse fibroblasts is not affected by HdCDT
(Cortes-Bratti 
 
et al
 
., 1999). In line with this observation,
HdCDT failed to induce cell cycle arrest 24 h and 48 h
after treatment (Fig. 1C), and we did not detect phospho-
rylation of the histone H2AX 4 h after toxin exposure
(Fig. 1D) in these cells. However, arrest in the G1 and G2
phases of the cell cycle and H2AX phosphorylation were
observed in BalbC3T3 cells exposed to ionizing radiation
(Fig. 1C and D). The lack of toxin sensitivity of these cells
correlated with their inability to bind HdCDT, as shown in
Fig. 1E.
To test whether HdCDT intoxication and binding were
dependent on the presence of cholesterol, cells were
exposed to 5 mM and 10 mM methyl-
 
b
 
-cyclodextrin
(m
 
b
 
CD) for 30 min, before intoxication or binding was
measured. m
 
b
 
CD is a well-characterized agent, which
extracts cholesterol from the plasma membrane and dis-
rupts lipid rafts (Orlandi and Fishman, 1998). The drug
concentration and the incubation time used did not affect
cell viability (data not shown). Ninety-five per cent of HeLa
cells exposed to HdCDT in the absence of m
 
b
 
CD were
arrested in the G2 phase of the cell cycle, while a dose-
dependent reduction of the G2 population to 65% and
51% was observed upon intoxication of 5 mM and 10 mM
m
 
b
 
CD-treated cells respectively (Fig. 2A).
To assess whether the effect of m
 
b
 
CD on cellular intox-
ication resulted from inhibition of toxin binding, cells were
left untreated or treated with 5 mM m
 
b
 
CD and exposed
for 20 min on ice either to HdCDT containing the GST-
tagged  CdtB  subunit  or  CdtA
 
+
 
CdtC  alone  as  control,
and fluorescence microscopy analysis was performed
(Fig. 2B). As expected a distinct membrane staining was
observed in untreated cells exposed to the reconstituted
HdCDT, while binding was completely prevented upon
m
 
b
 
CD treatment.
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HdCDT requires transit via the Golgi complex to exert its 
genotoxic effect
 
We have previously shown that disruption of the Golgi
integrity by BFA treatment (Fujiwara 
 
et al
 
., 1988) could
prevent HdCDT intoxication of HeLa cells, suggesting that
Golgi is an important organelle for its internalization
(Cortes-Bratti 
 
et al
 
., 2000). However, BFA can affect also
transit through endosomes (Prydz 
 
et al
 
., 1992; van Dam
 
et al
 
., 2002 and reviewed in Robinson, 2004). To discrim-
 
Fig. 1.
 
HdCDT binds to the cell membrane of sensitive cells.
A. HeLa cells were left untreated or exposed to the following subunit combinations: (i) CdtA
 
+
 
CdtC, (ii) GST-CdtB alone and (iii) CdtA
 
+
 
CdtC
 
+
 
GST-
CdtB for 20 min on ice. The final concentration of each subunit was 0.2 
 
m
 
g 
 
m
 
l
 
-
 
1
 
. Binding and fluorescence staining was performed as described 
in 
 
Experimental procedures
 
. Nuclei were counterstained with Hoechst 33258.
B. HeLa cells were exposed to the following subunit combinations: (i) GST-CdtB (dotted line) alone; (ii) CdtA
 
+
 
CdtC
 
+
 
GST-CdtB (thick line) for 
20 min on ice. The final concentration of each subunit was 0.2 
 
m
 
g 
 
m
 
l
 
-
 
1
 
. Binding was assayed by FACS analysis as described in 
 
Experimental 
procedures
 
.
C. BalbC3T3 cells were either left untreated, or intoxicated with reconstituted HdCDT (2 
 
m
 
g ml
 
-
 
1
 
), or irradiated (20 Gy) and further incubated for 
24 h and 48 h. Analysis of the cell cycle distribution was assessed by PI staining and flow cytometry as described in 
 
Experimental procedures
 
.
D. BalbC3T3 cells were either incubated with medium alone or treated with reconstituted HdCDT (2 
 
m
 
g ml
 
-
 
1
 
) or irradiated (20 Gy), fixed 4 h after 
treatment and stained with anti-phospho-H2AX-specific rabbit serum as described in 
 
Experimental procedures
 
.
E. BalbC3T3 cells were exposed to GST-CdtB alone or CdtA
 
+
 
CdtC
 
+
 
GST-CdtB as described in (A). Binding and fluorescence staining was 
performed as described in 
 
Experimental procedures
 
.
One out of three independent experiments is shown.
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inate whether HdCDT is internalized via the Golgi-
dependent or a Golgi-independent pathway, we performed
a set of experiments where HdCDT intoxication was
assessed in parallel in BFA-treated HeLa and MDCK cell
lines. MDCK cells were chosen, as their Golgi complex,
but not the endosomal compartment, has been shown to
be BFA resistant (Hunziker 
 
et al
 
., 1991).
Two parameters of HdCDT-induced intoxication were
assessed: (i) phosphorylation of the histone H2AX, which
was previously shown to occur in intoxicated cells as early
as 1 h after HdCDT exposure (Li 
 
et al
 
., 2002) and (ii)
accumulation of the hyperphosphorylated form of the
cyclin-dependent kinase cdc2 (Cortes-Bratti 
 
et al
 
., 1999),
which is required for induction of the G2 arrest.
Phosphorylation of H2AX and cdc2 was completely pre-
vented in BFA- and HdCDT-treated HeLa cells, compared
with the cells intoxicated in the absence of BFA (Fig. 3A
and B). In contrast, BFA treatment did not induce any
significant change in intoxication of MDCK cells. These
data indicate that transit via the Golgi complex is the main
pathway followed by HdCDT.
 
Haemophilus ducreyi
 
 CDT has been shown to cause
DNA DSBs in intoxicated cells (Frisan 
 
et al
 
., 2003). How-
ever, some authors still doubt that CDTs act as DNase
and that cellular internalization is required for the toxin
activity (Shenker 
 
et al
 
., 2004). To address this issue, we
assessed whether a structurally intact Golgi complex is
required for the HdCDT genotoxic activity. Disruption of
the Golgi structure by BFA, not only prevented the down-
stream effects caused by CDT intoxication [induction of
G2 arrest (Cortes-Bratti 
 
et al
 
., 2000), H2AX phosphoryla-
tion and cdc2 hyperphosphorylation], but completely pre-
vented the induction of DNA DSBs in HeLa cells (Fig. 3C).
The amount of DNA DSBs induced in HdCDT-treated cells
was comparable to a radiation dose of 27 Gy, and was
reduced by sevenfold in cells intoxicated in the presence
of BFA.
 
HdCDT is retrograde transported from the Golgi to the 
endoplasmic reticulum
 
The sets of experiments showed in Fig. 3 strongly sug-
gested that HdCDT required an intact Golgi complex for
a successful intoxication. To strengthen these observa-
tions and to investigate whether HdCDT is further retro-
gradely transported to the ER, we constructed two CdtB
mutants containing either a sulphation site (CdtB-Sulf1),
or a sulphation and three partially overlapping N-linked
glycosylation sites (CdtB-Sulf2) at the C-terminus of the
protein. Protein sulphation is a post-translational modifi-
cation, which occurs exclusively in the 
 
trans
 
-Golgi (Bae-
uerle and Huttner, 1987), while N-linked glycosylation
occurs exclusively in the ER (reviewed in Helenius and
Aebi, 2004).
 
Fig. 2.
 
Methyl-
 
b
 
-cyclodextrin (m
 
b
 
CD) prevents HdCDT intoxication 
and binding.
A. HeLa cells were pre-incubated for 30 min with the indicated con-
centrations of m
 
b
 
CD in FCS-free medium, and further exposed to 
HdCDT (2 
 
m
 
g ml
 
-
 
1
 
) for 15 min on ice. After extensive washing the cells 
were incubated for 24 h in RPMI complete medium. Cell cycle distri-
bution was assessed by PI staining and flow cytometry analysis as 
described in 
 
Experimental procedures
 
.
B. HeLa cells were pre-incubated for 30 min with the indicated con-
centrations of m
 
b
 
CD in FCS-free medium, and further exposed to: (i) 
CdtA
 
+
 
CdtC and (ii) CdtA
 
+
 
CdtC
 
+
 
GST-CdtB for 20 min on ice. The final 
concentration of each subunit was 0.2 mg ml-1. Binding and fluores-
cence staining was performed as described in Experimental 
procedures.
One out of two independent experiments is shown.
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Reconstituted HdCDTs containing either the CdtB-Sulf1
or the CdtB-Sulf2 subunits were equally efficient as the
toxin preparation containing the wild-type CdtB in inducing
G2 arrest in HeLa cells (Fig. 4A). Sulphation of HdCDT
was assessed in HeLa cells incubated in the presence of
Na235SO4 and further exposed to: (i) CdtA+CdtC, (ii)
CdtA+CdtC+GST-CdtB-Sulf1 and (iii) GST-CdtB-Sulf1
alone. A labelled protein corresponding to the molecular
weight of GST-CdtB-Sulf1 (approximately 60 kDa) was
present only in cells exposed to the reconstituted toxin
(Fig. 4B). Transit to the ER was monitored by testing man-
nosylation of a holotoxin containing the GST-CdtB-Sulf2
subunit in HeLa cells incubated in the presence of [3H]-
mannose. A specific band of approximately 60 kDa corre-
sponding to the GST-CdtB-Sulf2 was recovered only in
cells exposed to the reconstituted toxin, but not in control
cells (i.e. untreated or exposed to CdtA+CdtC, Fig. 4C, or
exposed to GST-CdtB-Sulf2 alone, data not shown).
Trafficking of HdCDT does not involve known ER–cytosol 
translocation pathways
Impairment of the ER-associated degradation (ERAD)
pathway interferes with the ER to cytosol translocation of
plant and bacterial toxins, such as ricin, ETA and cholera
toxin (Simpson et al., 1999; Teter and Holmes, 2002). To
assess whether this pathway is also necessary for an
efficient translocation and intoxication of target cells by
HdCDT, we used a set of Chinese hamster ovary (CHO)
clones, which have been selected for resistance to the
Fig. 3. HdCDT requires an intact Golgi complex to induce DNA double-stranded breaks (DSBs).
A and B. HeLa and MDCK cells were pre-incubated in the presence or absence of BFA (2.5 mg ml-1) for 1 h in RPMI complete medium, and 
further exposed to HdCDT (2 mg ml-1) for 4 h. Samples were analysed for phosphorylation of H2AX by indirect immunofluorescence (A), where 
the numbers represent the percentage of cells expressing pH2AX foci, or phosphorylation of cdc2 (pcdc2) by Western blot (B), where fold increase 
represents the increase of the phosphorylated cdc2 in HdCDT-treated cells compared with the untreated control cells. One out of three independent 
experiments is shown.
C. Twenty-five thousand HeLa cells per well were grown in 12-well plates in RPMI complete medium containing 4000 Bq ml-1 [methyl-14C]-thymidine 
for 48 h. The cells were then washed three times in PBS and chased for 2 h in complete medium, and further pre-incubated in the presence or 
absence of BFA (2.5 mg ml-1) for 1 h in RPMI complete medium. Cells were then exposed to: (i) CdtA+CdtC (negative control) and (ii) 
CdtA+CdtC+CdtB (the final concentration of the CdtB subunit was 20 mg ml-1) for 8 h, and processed for pulsed-field gel electrophoresis analysis. 
We already showed that HdCdtB alone does not induce DNA DSBs above the control (Frisan et al., 2003).
M, molecular weight marker. *Gy: equivalent radiation dose. One out of two independent experiments is shown.
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ricin, ETA and cholera toxins, due to an altered ERAD
system (Teter and Holmes, 2002; Teter et al., 2003). The
CHO mutant cell lines are subgrouped in two different
classes: (i) a clone that presents a deficient translocation
of proteins from the ER to the cytosol (CHO 16D) and (ii)
two clones which present an enhanced cytosolic degra-
dation of the retrotranslocated proteins (CHO 23G and
CHO 24D). Parental CHO cells were used as control. In
order to avoid artefact due to high toxin concentration,
titration experiments were performed to choose the mini-
mal toxin concentration able to induce cell cycle arrest in
the CHO parental cells (Fig. 5A). As shown in Fig. 5B, all
three CHO mutant cell lines were equally sensitive to
HdCDT intoxication (4 mg ml-1) as the parental cells, as
judged by the percentage of cells arrested in the G2 phase
of the cell cycle, 24 h after intoxication. HdCDT sensitivity
of the CHO cell lines was further confirmed with a colony
assay. CHO parental cells and the CHO 16D and CHO
23G clones were left untreated or exposed to HdCDT
(4 mg ml-1). Two weeks after intoxication a striking differ-
ence in colony outgrowth was evident. Untreated cells
grew to form distinct colonies, detected by Giemsa stain-
ing, while a very limited number of colonies were
observed in HdCDT-exposed cells, independently of the
status of the ERAD pathway (Fig. 5C).
Resistance of the CHO 16D, CHO 23G and CHO 24D
cells to ETA was confirmed in parallel experiments (data
not shown).
It has been recently shown that retrotranslocation into
the cytoplasm of a subset of proteins involves a human
homologue of the yeast Der1 protein, named Derlin-1
(Lilley and Ploegh, 2004; Ye et al., 2004). The homolo-
gous protein Derlin-2, which shared 36% identity with
Derlin-1 and whose function is at present unknown, was
not involved in this process (Lilley and Ploegh, 2004). To
assess whether HdCDT internalization was Derlin-1
dependent, we investigated the sensitivity to HdCDT of
HeLa cells expressing Derlin-1GFP, which acts in a domi-
nant negative manner, blocking the Cytomegalovirus-
dependent dislocation of MHC class I proteins from the
ER to the cytosol (Lilley and Ploegh, 2004). Cells trans-
duced with empty vector (pMSCV) or Derlin-2GFP were
used as controls.
Titration experiments showed that the minimal toxin
concentration inducing a complete G2 arrest in HeLa
pMSCV was 1 mg ml-1 (Fig. 6A), and HeLa cells express-
Fig. 4. HdCDT is retrogradely transported from the Golgi complex to the ER.
A. HeLa cells were left untreated or exposed to a reconstituted toxin (2 mg ml-1), containing the wild-type CdtB, or the modified CdtB-Sulf1 (carrying 
a sulphation site at the C-terminus), or CdtB-Sulf2 (carrying a sulphation site and three overlapping N-glycosylation sites at the C-terminus) for 
24 h in RPMI complete medium. Cell cycle distribution was assessed as described in Fig. 1.
B and C. Five hundred thousand HeLa cells were incubated with 600 mCi ml-1 Na235SO4 in DMEM without sulphate (B) or 100 mCi [3H]-mannose 
in DMEM without glucose (C) for 4 h at 37∞C. Cells were then exposed to: (i) CdtA+CdtC, (ii) CdtA+CdtC+GST-CdtB-Sulf1 (B) or GST-CdtB-Sulf2 
(C) (20 mg ml-1) and (iii) GST-CdtB-Sulf1 alone (B) for 4 h. GST fusion proteins were recovered as described in Experimental procedures, and 
fractionated in a 10% SDS-polyacrylamide gel. Labelled proteins were detected by PhosphoImager analysis.
One out of two independent experiments is shown.
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ing the dominant negative Derlin-1GFP were equally sensi-
tive to the toxin as the control cell lines (Fig. 6B).
Mutation of the CdtB Mg2+ binding site prevents induction 
of DNA DSBs
Mutations at the Mg2+ binding sites and at residues impor-
tant for the catalytic activity of the E. coli (Elwell and
Dreyfus, 2000) and C. jejuni (Lara-Tejero and Galan,
2000) CdtB are known to abolish the cytotoxic effects, and
expression of the CjCdtB mutated subunit in yeast pre-
vents DNA degradation (Hassane et al., 2001). However,
it was not previously investigated whether these mutations
affect the ability of CDTs to induce DNA DSBs in naturally
intoxicated mammalian cells. We constructed a CdtB sub-
unit where the Asp residue relevant for Mg2+ binding in
position 273 was substituted by site-directed mutagenesis
with an Arg residue. HdCDT containing the mutated CdtB
subunit (D273R) failed to block cellular proliferation in the
G2 phase of the cell cycle (Fig. 7A), and did not exert any
Fig. 5. Intoxication by HdCDT does not require the ERAD pathway.
A. CHO parental cells were exposed to HdCDT at the indicated concentration for 24 h. Cell cycle analysis was performed as described in Fig. 1.
B and C. CHO parental cells or CHO clones selected for resistance to ricin, ETA and cholera (CHO16D, CHO23G, CHO24D) were left untreated 
or exposed to HdCDT (4 mg ml-1) for 24 h (B, one out of four experiments is shown) or 2 weeks (C, one out of two independent experiments is 
shown) in Ham’s F21 complete medium. Cell cycle analysis (B) and colony assay (C) were performed as described in Experimental procedures.
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genotoxic activity, as judged by its inability to cause DNA
DSBs (Fig. 7B).
Discussion
HdCDT is transported to the ER, but further transit does 
not require known translocation pathways
Internalization of several cytosolic acting toxins, such as
ricin, cholera toxin and P. aeruginosa ETA, requires trans-
location via the endosomal compartment, transit through
the Golgi complex and transport to the ER (reviewed in
Sandvig and van Deurs, 2002). So far only one study has
analysed the internalization of CDTs (Cortes-Bratti et al.,
2000). Cortes-Bratti et al. demonstrated that HdCDT is
internalized via clathrin-coated pits, based on: (i) HeLa
cells expressing the dominant negative form of dynamin,
(ii) removal of clathrin coats by potassium depletion and
(iii) use of inhibitors, which prevent assembly of coated
pits at the cell surface. Further transit via the Golgi com-
plex was suggested, as BFA treatment could prevent
cellular intoxication. However, BFA can also impair trans-
location through the endosomal compartment (Prydz
et al., 1992; van Dam et al., 2002). Thus, BFA treatment
Fig. 6. HdCDT intoxication is Derlin-1 independent.
A. HeLa cells transduced with vector control (pMSCV) were exposed to the HdCDT holotoxin at the indicated concentration for 24 h in RPMI 
complete medium containing 0.5 mg ml-1 puromycin. Cell cycle distribution was assessed as described in Fig. 1. Expression of Derlin-1GFP 
(thick line) and Derlin-2GFP (dotted line) was assessed by FACs analysis (GFP expression). The vector control cells HeLa pMSCV were used as 
negative control (thin line).
B. HeLa cells transduced with vector control (pMSCV), Derlin-1GFP or Derlin-2GFP were exposed to HdCDT (1 mg ml-1) for 24 h in RPMI complete 
medium containing 0.5 mg ml-1 puromycin. Cell cycle distribution was assessed as described in Fig. 1.
One out of two independent experiments is shown.
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of HeLa cells alone cannot completely rule out that
HdCDT uses alternative internalization pathways. Indeed,
an alternative transport of ricin was demonstrated in cells
with an impaired Golgi to ER transport, due to a defect in
the e-coatomer protein (Llorente et al., 2003). To better
clarify whether the Golgi complex is required for HdCDT
intoxication, two different approaches were used: (i) we
assessed whether BFA has different effects on intoxica-
tion of MDCK cells, carrying a BFA-insensitive Golgi, com-
pared with HeLa cells, carrying a BFA-sensitive Golgi
(Fig. 3) and (ii) we constructed a CdtB subunit with a C-
terminal sulphation site (Fig. 4). Both these experiments
indicated that HdCDT transits via the Golgi apparatus.
Detection of early signs of intoxication, such as phospho-
rylation of H2AX, and sensitivity of BFA- and HdCDT-
treated MDCK cells, clearly rules out the possibility that
BFA treatment could directly interfere with the cell cycle
progression in the present experimental set-up (Mordente
et al., 1998).
The data collected so far demonstrated that HdCDT and
toxins such as ricin, ETA and cholera follow a similar
internalization pathway down to the ER. However, a major
difference was observed when the requirement for the
ERAD pathway was tested.
The ERAD pathway translocates misfolded secretory
and ER membrane proteins into the cytosol for pro-
teolytic degradation (reviewed in Hampton, 2002). Sev-
eral lines of evidence suggest that the ERAD pathway,
using the Sec61p translocon, is essential for mediating
cytosolic translocation of intracellularly acting toxins such
as ricin and Shiga toxins. Both CHO (Teter and Holmes,
2002) and Saccharomyces cerevisiae (Simpson et al.,
1999) cells defective in various aspects of the ERAD
pathway are resistant to ricin intoxication. Furthermore,
sulphated and glycosylated ricin can be co-precipitated
with anti-Sec61p-specific antibodies (Wesche et al.,
1999). Also cholera toxin is associated with and requires
a functional Sec61p complex to be translocated from
microsomes derived from porcine pancreas (Schmitz
et al., 2000). We used two different classes of CHO
mutant cells, which have been selected for their resis-
tance to ricin, ETA and cholera toxin (Teter and Holmes,
2002; Teter et al., 2003).
Our results (Fig. 5) suggest that HdCDT either does not
need to transit to the cytosol before entering the nucleus
to exert its genotoxic activity, or alternatively its transloca-
tion to the cytosol occurs via a different pathway. Data
presented in this work favour the former hypothesis,
because: (i) the clone CHO16D, which showed an
impaired ER to cytosol translocation, was still sensitive to
HdCDT and (ii) HdCDT could still intoxicate CHO cells that
have an enhanced cytosolic proteolytic degradation
(clones CHO23G and 24D). Furthermore, we could
exclude that HdCDT exits the ER via the other known ER–
cytosol translocation pathway (Lilley and Ploegh, 2004; Ye
et al., 2004), as HeLa cells expressing Derlin-1GFP were
still arrested in the G2 phase of the cell cycle upon intox-
ication (Fig. 6).
How the nuclear translocation of the CdtB subunit takes
place is still an open question. Two recent reports have
identified several NLSs located at the N-terminus of
AaCdtB and the C-terminus of EcCdtB-II respectively.
Fig. 7. HdCDT DNase activity is required to induce DNA double-
stranded breaks (DSBs).
A. HeLa cells were exposed to the HdCDT toxin (2 mg ml-1) containing 
either the wild-type CdtB or the mutated CdtBD273R for 24 h. 
Untreated cells or cells exposed to CdtA+CdtC were used as negative 
control. Cell cycle distribution was assessed as described in Fig. 1.
B. Twenty-five thousand HeLa cells per well were grown in 12-well 
plates in complete medium containing 4000 Bq ml-1 [methyl-14C]-
thymidine for 48 h. The cells were then washed three times in PBS, 
chased for 2 h in RPMI complete medium, and then exposed for 8 h 
to: (i) CdtA+CdtC (negative control), (ii) HdCDT containing wild-type 
CdtB (at the concentration of 20 mg ml-1), (iii) HdCDT containing the 
mutated CdtBD273R (at the concentration of 20 mg ml-1) and (iv) 
CdtBD273R alone (20 mg ml-1). Cells were processed for pulsed-field 
gel electrophoresis analysis.
M,  molecular weight marker. *Gy: equivalent radiation dose. One out 
of two independent experiments is shown.
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Nishikubo et al. (2003) showed that: (i) a 11-amino-acid
deletion (aa 114–124) was sufficient to abolish nuclear
translocation of the GFP–AaCdtB fusion protein and (ii) a
holotoxin containing the D11-124 AaCdtB failed to induce
cell cycle arrest in sensitive cells. Two different C-terminal
NLSs were instead identified in the E coli CdtB-II subunit,
named DNLS1 and DNLS2 (McSweeney and Dreyfus,
2004). Interestingly, deletion of each of these sequences
produced a differential localization of the active toxin sub-
unit. Cells intoxicated with a holotoxin containing the
EcCdtB-II-DNLS1 displayed a perinuclear distribution,
which is consistent with trapping of the active toxin com-
ponent in the late endosome and/or ER compartment. A
diffuse cytoplasmic staining was observed in cells
exposed to the EcCdtB-II-DNLS2 containing toxin. It is
possible that this second NLS may act as scavenger motif
to retrieve CdtB molecules, which have escaped to the
cytosol, similar to the suggested ER retention function of
the KDEL sequence in cholera toxin (Lencer and Tsai,
2003).
It is difficult to reconcile the results presented for the
NLSs in the Aa-CdtB and Ec-CdtB-II. We hypothesize that
the CdtB nuclear translocation requires an atypical mech-
anism, which has still not been identified, such as a direct
translocation from the ER to the nucleus. Very recently, a
new reticular network has been identified, and designated
as nucleoplasmic reticulum (Echevarria et al., 2003). This
organelle is described as a fine, branching intranuclear
network that is continuous with the nuclear envelope and
the ER. A high degree of complexity of the ER network is
further demonstrated by the fact that specific ER mole-
cules can be found on phagosomes, upon phagocytosis
(reviewed in Desjardins, 2003). Interaction between pha-
gosomes and the ER might also explain how the Salmo-
nella typhi CdtB (StCdtB), expressed upon bacterial
internalization in the absence of CdtA and CdtC, could
gain access to the nuclear compartment (Haghjoo and
Galan, 2004).
These studies highlight that the ER has a central role
in regulation and execution of processes involving intrac-
ellular trafficking, some of which are still unknown. In this
context, elucidation of the mechanism by which CdtB is
translocated into the nucleus becomes an important
issue, and our data show that this translocation does not
occur via any of the pathways so far described.
HdCDT requires internalization to exert its genotoxic 
activity
In a recent paper, Shenker and colleagues questioned
whether the relevant activity of the CDT family of toxins is
a DNase-like activity, and suggested that the cytotoxic
effects might be triggered upon toxin-induced transmem-
brane signalling from the cell membrane (Shenker et al.,
2004; Thelestam and Frisan, 2004b). Data shown in Fig. 3
demonstrate that inhibition of toxin internalization abol-
ished all the parameters relevant for CDT-mediated intox-
ication, such as induction of DNA DSBs, phosphorylation
of histone H2AX, hyperphosphorylation of the cyclin-
dependent kinase cdc2 and cell cycle arrest. Consistent
with the data of Elwell and Dreyfus (2000), Lara-Tejero
and Galan (2000) and Hassane et al. (2003) on EcCDT-II
and CjCDT, we also showed that HdCDT carrying a muta-
tion interfering with the DNase activity could not induce
cell cycle arrest, and this lack of effect resulted from the
inability of the mutant toxin to cause DNA DSBs (Fig. 7A
and B). It was previously shown that mutation of the Asp-
222 residue critical for the CjCdtB DNase activity inhibits
DNA degradation when the mutated CdtB gene was
expressed in yeast (Hassane et al., 2001). Our data
strengthen this observation and represent the first direct
demonstration of lack of induction of DNA DSBs in natu-
rally intoxicated mammalian cells by a toxin containing a
mutated CdtB subunit.
Taken together these data exclude that induction of
DNA DSBs and activation of DNA damage checkpoint
responses can be induced by transmembrane signalling.
Binding of HdCDT requires cholesterol
Binding of CDT to the plasma membrane of target cells
has recently been well documented by Lee et al. (2003)
(CjCDT) and McSweeney and Dreyfus (2004) (EcCDT-II).
These authors used either an enzyme-linked immunosor-
bent assay on living cells (CELISA) or FACS analysis. In
line with these observations, we could also detect by
immunofluorescence analysis binding of HdCDT on the
surface of the CDT-sensitive HeLa cells (Fig. 1A and B)
but not on the mouse BalbC3T3 cells (Fig. 1E), which are
completely resistant to the toxin treatment (Fig. 1C and
D). These data indicate that the BalbC3T3 resistance
results from a lack of the surface receptor, which is still
not identified. It is noteworthy that this is the first time that
CDT binding was directly visualized by fluorescence
microscopy in CDT-sensitive compared with CDT-insensi-
tive cells.
Cytolethal distending toxins are considered to act as AB
toxins, where CdtB is the active subunit (‘A’ unit), which
alone is unable to bind to the cell surface, while CdtA and
CdtC are required for toxin binding (‘B’ unit) (Lee et al.,
2003; McSweeney and Dreyfus, 2004 and Fig. 1). Inter-
estingly, both these subunits could compete with each
other and inhibit binding of the holotoxin, suggesting that
CdtA and CdtC bind to the same receptor (Lee et al., 2003;
McSweeney and Dreyfus, 2004). An increasing number of
bacterial toxins, such as cholera toxin, Aeromonas hydro-
phila aerolysin, Clostridium perfringens Iota-toxin and Heli-
cobacter pylori VacA, have been shown to interact with
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microdomains in the plasma membrane, known as lipid
rafts (Orlandi and Fishman, 1998; Wolf et al., 1998; Abrami
and van Der Goot, 1999; Zitzer et al., 1999; Waheed et al.,
2001; Schraw et al., 2002). These domains are enriched
in cholesterol, sphingolipids and glycosylphosphatidylinos-
itol (GPI)-anchored proteins (reviewed in Brown and Lon-
don, 1998), and their integrity can be disrupted by drugs
which extract cholesterol from the plasma membrane, such
as mbCD. It is therefore not surprising that treatment of
HeLa cells with mbCD abolished cellular intoxication and
HdCDT binding (Fig. 2). We still have to identify the toxin
receptor and we are currently pursuing a more detailed
analysis of HdCDT binding within lipid rafts.
Our study strongly contributes to the understanding of
the CDT biology, as it demonstrates for the first time how
a member of the CDT family is internalized via an intact
Golgi, and that it is further retrogradely transported to the
ER. We show beyond any doubt that the DNA damaging
activity of the toxin can be exerted only upon internaliza-
tion, thereby rejecting previous hypotheses regarding acti-
vation of transmembrane signalling pathways. These data
also suggest that the toxin may be translocated directly
from the ER to the nucleus and raise several questions
about the complexity of the nuclear translocation of CDTs,
highlighting once more the importance of bacterial toxins
as tools for characterization of cellular processes.
Experimental procedures
Cell lines
HeLa  and  BalbC3T3  (ATCC)  cells  were  cultivated  in  RPMI
1640 medium supplemented with 10% fetal calf serum (FCS),
5 mM L-glutamine, penicillin (100 units ml-1) and streptomycin
(100 mg ml-1) (RPMI complete medium) in a humid atmosphere
containing 5% CO2. HeLa cell lines stably expressing GFP fusion
Derlin-1 and Derlin-2 proteins (Derlin-1GFP and Derlin-2GFP) were
produced in Dr Hidde Ploegh’s laboratory, and will be described
in details elsewhere.
Chinese hamster ovary parental cells, and clones CHO16D,
CHO23G and CHO24D, selected for resistance to cholera toxin,
P. aeruginosa ETA and ricin (Teter and Holmes, 2002; Teter et al.,
2003) were cultivated in Ham’s F12 medium supplemented with
10% FCS, 5 mM L-glutamine, penicillin (100 units ml-1) and strep-
tomycin (100 mg ml-1) (Ham’s F12 complete medium) in a humid
atmosphere containing 5% CO2.
Reconstitution of the HdCDT holotoxin and intoxication
Reconstitution of the HdCDT toxin was achieved by incubation
of the purified CdtA, CdtB or GST-tagged CdtB (when specified)
and CdtC subunits for 30 min at 37∞C. We have used the follow-
ing nomenclature throughout this article: non-tagged CdtB sub-
unit is indicated as CdtB, while the GST fusion protein is
indicated as GST-CdtB. Similar nomenclature is used for the
CdtB-Sulf1 and CdtB-Sulf2 proteins. The term HdCDT indicates
the reconstituted toxin containing the non-tagged-CdtB subunit.
The reconstituted toxin containing the GST-CdtB subunit was
still able to induce cell cycle arrest in HeLa cells, as assessed
by propidium iodide staining, although with a 5- to 10-fold lower
efficiency than the holotoxin containing the non-tagged-CdtB
subunit (data not shown).
Treatments
Methyl-b-cyclodextrin (mbCD) treatment. Exponentially growing
cells were pre-incubated with mbCD (5 mM or 10 mM) for 30 min
in FCS-free medium at 37∞C. Cells were cooled on ice for 20 min
and washed twice with cold phosphate-buffered saline (PBS),
before addition of the ice-cold toxin. After toxin exposure on ice
for 20 min, cells were washed five times with cold PBS and either
incubated for 24 h at 37∞C in complete medium for the cell cycle
analysis, or processed for the toxin binding analysis as described
below.
Brefeldin A (BFA) treatment. Cells were pre-treated with BFA
(2.5 mg ml-1) for 1 h at 37∞C, and then exposed either to HdCDT
or to the negative control, in the presence of BFA, for the indi-
cated period. Cells were then processed for Western blot, phos-
pho-H2AX staining, or pulsed-field gel electrophoresis analysis
as described below.
Ionizing radiation. Cells were irradiated (20 Gy), washed once
with PBS and incubated for the indicated time periods in RPMI
complete medium.
Exotoxin A (ETA) treatment. Sensitivity of the CHO parental
cells and the clones CHO16D, CHO23G and CHO24D was
tested as previously described (Teter and Holmes, 2002).
Production and purification of the recombinant HdCDT 
subunits
GST-CdtB. Construction, expression and purification of GST-
CdtB was previously described (Frisan et al., 2003).
CdtA and CdtC. The pGEX-CdtA and pGEX-CdtC expression
vectors were constructed by polymerase chain reaction (PCR)
amplification of the H. ducreyi cdtA  and cdtC  genes from the
pAF-tac1cdtA and pAF-tac1cdtC plasmids, respectively (Frisk
et al., 2001), using the following primers:
CdtA_1 5¢-ATTCGGATCCTGTTCATCAAATCAACGAATGA-3¢
CdtA_2 5¢-TACCGAATTCTTAATTAACCGCTGTTGCTTCTAAT-3¢
CdtC_1 5¢-ATTCGGATCCAGTCATGCAGAATCAAATCCTGA-3¢
CdtC_2 5¢-TACCGAATTCTTAGCTACCCTGATTTCTT-3¢.
Each PCR fragment was cloned into the BamHI and EcoRI
restriction sites of the pGEX4T3 expression vector (Amersham
Biosciences, Little Chalfont, Buckinghamshire, UK). Purification
and thrombin cleavage of CdtA and CdtC was performed as
previously described (Lee et al., 2003).
GST-CdtB-Sulf1 and GST-CdtB-Sulf2. A C-terminal extension
containing a sulphation site (CdtB-Sulf1) was introduced using
as template the cdtB nucleotide sequence from the pGEX-CdtB
plasmid (Frisan et al., 2003). The following primers were used:
CdtB-Sulf1_1 5¢-ATTCGGATCCAACTTGAGTGACTTCAAAGTA
GC-3¢
CdtB-Sulf1_2 5¢-TACCGAATTCTCAAGATGGGTATTCGTAGTC
TTCTGCGCTGCGATCACGAACAAAACTAAC-3¢.
The CdtB-Sulf2 subunit, containing a sulphation and three partly
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overlapping N-linked glycosylation sites, was amplified using the
CdtB-Sulf1 as template. The following primers were used:
CdtB-Sulf1_1 5¢-ATTCGGATCCAACTTGAGTGACTTCAAAGTA
GC-3¢
CdtB-Sulf2_2 5¢-TACCGAATTCTCACTGGGATGTGTTATTTTT
GGTGCCGTTAGATGGGTATTCGTAGTCTTCTGCGCT-3¢.
The PCR fragment was cloned into the BamHI and EcoRI
restriction sites of the pGEX4T3 expression vector (Amersham
Biosciences). Purification and thrombin cleavage of the fusion
protein from the E. coli BL21 DE3 strain was performed according
to the instructions of the manufacturer (Amersham Biosciences).
CdtBD273R. Mutagenesis of the cdtB gene, where the Asp res-
idue in position 273, important for the Mg2+ binding was substi-
tuted with an Arg residue, was performed using the QuickChange
II Site-Directed mutagenesis kit from Stratagene (La Jolla, CA,
USA) according to the instructions of the manufacturer. The
pGEX-CdtB plasmid (Frisan et al., 2003) was used as template,
and the following primers were used:
CdtBD273R_1 5¢-CGCTCACAAATTACATCCAGACATTTTCCT
GTTAG-3¢
CdtBD273R_2 5¢-CTAACAGGAAAATGTCTGGATGTAATTTGT
GAGCG-3¢.
Purification and thrombin cleavage of the CdtBD273R protein,
which was found in inclusion bodies in the insoluble fraction, was
performed as previously described (Lee et al., 2003).
HdCDT binding assay
Fluorescence microscopy analysis. One hundred thousand cells
were grown on 13 mm slides for 24 h. Cells were washed twice
with cold PBS and cooled down on ice for 20 min. Cells were left
untreated or exposed for 20 min on ice to the following combina-
tions of subunits: (i) CdtA+CdtC, (ii) GST-CdtB alone and (iii)
CdtA+CdtC+GST-CdtB, washed five times with cold PBS, and
then fixed for 30 min in 1% formaldehyde in PBS on ice. Following
fixation, cells were washed twice with PBS, and then further
incubated with a goat serum anti-GST fluorescein-conjugated
antibody (1:50, Abcam, Cambridge, UK) for 30 min at 25∞C.
Nuclei were counterstained with Hoechst 33258 (0.5 mg ml-1,
Sigma, St Louis, MO, USA), and slides were mounted and viewed
via fluorescence microscopy.
FACS analysis. Five hundred thousand cells were grown in
60 mm culture dishes for 24 h. Cells were trypsinized and cooled
down on ice for 20 min. Cells were left untreated or exposed for
20 min on ice to the following combinations of subunits: (i) GST-
CdtB alone and (ii) CdtA+CdtC+GST-CdtB. After five times wash-
ing with cold PBS, cells were fixed for 30 min in 1% formaldehyde
in PBS on ice, and then further incubated with a goat serum anti-
GST fluorescein-conjugated antibody (1:50, Abcam, Cambridge,
UK) for 30 min on ice. Flow cytometry analysis was performed
using a FACSort flow cytometer (Becton and Dickinson, Mountain
View, CA). Data from 104 cells were collected and analysed using
the CellQuest software (Becton and Dickinson).
Detection of DNA DSBs by pulsed-field gel 
electrophoresis
Twenty-five thousand HeLa cells per well were grown in 12-well
plates in complete medium containing 4000 Bq [methyl-14C]-thy-
midine for 48 h. The cells were then washed three times in PBS
and chased for 2 h in complete medium. Cells were treated with
HdCDT (20 mg ml-1) for the indicated time periods or left
untreated for 8 h. Irradiated cells (20 Gy) were used as positive
control for detection of DSBs. Cells were washed once in PBS,
and trypsinized in a 150 ml volume. The cell suspension was
mixed with low gelling-point agarose (InCert, BMA, Rockland,
ME, USA) at 37∞C to a final agarose concentration of 0.6% and
1 ¥ 106 cells ml-1 and pipetted into plastic moulds for 100 ml
plugs. Moulds were incubated at 4∞C for 20 min to solidify the
plugs. The solid plugs were transferred into 1 ml of ice-cold lysis
buffer (2% sarkosyl, 1 mg ml-1 proteinase K, in 0.5 M Na3-EDTA,
pH 8.0) overnight at 4∞C, followed by a second lysis step in high
salt solution (1.85 M NaCl, 0.15 M KCl, 5 mM MgCl2, 2 mM
EDTA, 4 mM Tris, 0.5% Triton X-100, pH 7.5) overnight at 4∞C
(Stenerlow et al., 2003). Plugs were washed three times for 1 h
in 0.1 M EDTA and double-stranded DNA was separated on an
agarose gel (0.8% SeaKem Gold, BMA) in a PFGE unit (Gene
Navigator, Amersham Bioscience, Uppsala, Sweden) in TBE
¥0.5 as previously described (Stenerlow et al., 2003). Following
electrophoresis, the gels were sliced at the position of the 5.7 Mb
chromosome from S. pombe (BMA), and 14C in the gel segments
was measured by liquid scintillation. The fraction of radioactivity
corresponding to DNA smaller than 5.7 Mb was used to quantify
the number of DSBs (Stenerlöw et al., 1999). The number of
DNA DSBs was translated into the equivalent radiation dose
(Gy) generating the same amount of DNA DSBs, assuming an
induction of 25 DSBs per diploid cell per Gy (Stenerlow et al.,
2003).
Sulphation and mannosylation
Sulphation and mannosylation of GST-CdtB-Sulf1 and GST-
CdtB-Sulf2 were performed as previously described (Llorente
et al., 2003). Briefly, 500 000 HeLa cells were incubated with
600 mCi ml-1 Na235SO4 in DMEM without sulphate or with 100 mCi
[3H]-mannose in DMEM without glucose for 4 h at 37∞C. HdCDT
containing  either  GST-CdtB-Sulf1  or  GST-CdtB-Sulf2  (20 mg
ml-1) was added, and the incubation was continued for additional
4 h. Negative controls included: (i) untreated cells, (ii) cells
exposed to CdtA+CdtC and (iii) cells exposed to the GST-CdtB-
Sulf1 or GST-CdtB-Sulf2 alone. Cells were then washed five
times with cold PBS, and lysed in 1 ml lysis buffer (0.1 M NaCl,
10 mM Na2HPO4, 1 mM EDTA, 1% Triton X-100, 1 mM PMSF)
for 30 min on ice. Nuclei were removed by centrifugation, and the
GST fusion proteins were recovered with Gluthatione sepharose
as described by the manufacturer (Amersham Biosciences), and
analysed by SDS-PAGE as previously described (Rapak et al.,
1997). Labelled proteins were detected by PhosphoImager
analysis.
Western blot analysis
Proteins were fractionated by 12% SDS-polyacrylamide gels,
transferred to PVDF membranes (Millipore, Bedford, MA) and
probed with anti-cdc2 (Transduction Laboratories, Lexinton, KY).
Blots were developed with enhanced chemoluminescence (ECL;
Amersham Biosciences), using the appropriate horseradish per-
oxidase-labelled secondary antibody, according to the instruc-
tions of the manufacturer (Amersham Biosciences).
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Fluorescence microscopy
Fifty thousand cells were seeded on 13 mm diameter slides
(Merck, Darmstadt, Germany) in 24-well plates in 1 ml of RPMI
complete medium and allowed to adhere for 24 h. Cells were
treated as specified in the figure legends (Figs 1D and 3A) and
fixed with ice cold methanol for 20 min at -20∞C. Slides were
washed twice in PBS, blocked in 10% FCS in PBS for 30 min at
room temperature, and incubated for 1 h at 37∞C with the phos-
pho-H2AX-specific rabbit serum (Upstate Biotechnology, Lake
Placid, NY, USA), diluted 1:200 in 1% BSA in PBS. Slides were
washed three times for 5 min in PBS, and then incubated with
the appropriate fluorescein isothiocyanate (FITC)-conjugated
secondary antibody (Dako, Glostrup, Denmark, diluted 1:40 in
1% BSA in PBS) for 30 min at 37∞C. Nuclei were counter-stained
with Hoechst 33258 (Sigma, 0.5 mg ml-1 for 1 min at 20∞C). Slides
were mounted and viewed via fluorescence microscopy. Cells
were scored positive for pH2AX foci formation when more than
five foci/nucleus were detected.
Cell cycle analysis
Cells were trypsinized, centrifuged and washed once with PBS.
The cell pellet was resuspended and fixed on ice for 15 min with
1 ml of cold 70% ethanol. The cells were subsequently centri-
fuged and resuspended in 1 ml of propidium iodide (PI) solution
(0.05 mg ml-1 PI; 0.02 mg ml-1 RNase; 0.3% NP40; 1 mg ml-1
sodium citrate) for 1 h at 4∞C. Flow cytometry analysis was per-
formed using a FACSort flow cytometer (Becton and Dickinson,
Mountain View, CA). Data from 104 cells were collected and
analysed using the CellQuest software (Becton and Dickinson).
Colony assay
Ten thousand cells were grown in 100 mm culture dishes in 10 ml
of Ham’s F12 complete medium for 24 h. Cells were intoxicated
or left untreated and further incubated for 2 weeks (medium was
changed every fourth day). Cell growth was monitored as forma-
tion of foci (colonies). Cell colonies were stained with haematox-
ylin and eosin as follows: cells were washed twice with PBS, and
then stained with 2 ml of haematoxylin and eosin solution
(Giemsa solution, Merck Darmstadt, Germany) for 10 min at
22∞C, and excess dye was removed by gentle washing with
distilled water. Plates were allowed to dry at 22∞C.
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Toxin translocationtoxin catalytic subunit may be a common property of toxins that exit the
endoplasmic reticulum (ER) by exploiting the mechanism of ER-associated degradation (ERAD). The Hae-
mophilus ducreyi cytolethal distending toxin (HdCDT) does not utilize ERAD to exit the ER, so we predicted
the structural properties of its catalytic subunit (HdCdtB) would differ from other ER-translocating toxins.
Here, we document the heat-stable properties of HdCdtB which distinguish it from other ER-translocating
toxins. Cell-based assays further suggested that HdCdtB does not unfold before exiting the ER and that it may
move directly from the ER lumen to the nucleoplasm. These observations suggest a novel mode of ER exit for
HdCdtB.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
The Haemophilus ducreyi cytolethal distending toxin (HdCDT) is an
AB-type genotoxin that consists of a catalytic A moiety (HdCdtB) and a
cell-binding B moiety (HdCdtA+HdCdtC) [1]. Like many AB toxins,
HdCDT must travel from the plasma membrane to the endoplasmic
reticulum (ER) before its A moiety can escape the endomembrane
system to reach its target [2,3]. Translocation of the A chain from the
ER to the cytosol is thought to involve the ER-associated degradation
(ERAD) quality control system [4,5], but HdCDT intoxication is not
inhibited by alterations to ERAD that generate resistance against ﬁve
other ER-translocating toxins: Pseudomonas aeruginosa exotoxin A,
Escherichia coli heat-labile toxin IIb, cholera toxin (CT), plasmid-
encoded toxin, and ricin [3,6–9]. Thus, exit of HdCdtB from the ER
occurs by an ERAD-independent mechanism or by an ERAD mechan-
ism that is signiﬁcantly different from the pathway utilized by many
other ER-translocating toxins. HdCDT is also unique in that it mustsm; CDT, cytolethal distending
reticulum-associated degrada-
s ducreyi cytolethal distending
rtussis toxin
ex, 12722 Research Parkway,
+1 407 384 2062.
l rights reserved.reach the nucleus in order to function whereas other ER-translocating
toxins act in the cytosol.
ERAD-mediated toxin translocation may depend upon the heat-
labile nature of the isolated toxin A chain. The catalytic CTA1
polypeptide, the A subunit of pertussis toxin (PT S1), and ricin A
chain are all in partially or fully unfolded states at near-physiological
temperatures [10–12]. However, thermal instability is not apparent
when the toxin A chain is present in a holotoxin [13–15]. A/B subunit
dissociation, an event that occurs in the ER translocation site, could
thus serve as the trigger for toxin unfolding. This structural shift
would identify the toxin A chain as a misfolded protein and would
thereby promote its ERAD-mediated export into the cytosol. Most
ERAD substrates are rapidly degraded in the cytosol by the ubiquitin-
26S proteasome system, but the A chains of ER-translocating toxins
are thought to avoid this fate because they have a paucity of the lysine
residues that serve as ubiquitin attachment sites [4]. The translocated
A chains may instead be degraded by a relatively slow, ubiquitin-
independent mechanism involving the core 20S proteasome
[11,12,16].
The distinctive nature of the HdCDT translocation mechanism
suggested that HdCdtB may not exhibit the same physical character-
istics observed for the A chains of other ER-translocating toxins. To test
this prediction, biophysical and biochemical experiments were
performed on the puriﬁed HdCdtB protein. We found that, in contrast
to the A chains of other ER-translocating toxins, HdCdtB was heat-
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assays further suggested that HdCdtB does not unfold before exiting
the ER and that it may move directly from the ER lumen to the
nucleoplasm. These results highlight the distinctive nature of CDT and
suggest the cellular processing of HdCdtB differs from host–toxin
interactions involving other ER-translocating toxins.2. Materials and methods
2.1. Biophysical studies
HdCdtB was puriﬁed from E. coli transformed with a glutathione S-
transferase (GST)-CdtB expression vector as previously described [17].
After removal of the GST tag, biophysical measurements were
performed on 0.15 mg HdCdtB in 0.2 ml 10 mM Hepes (pH 7.0) with
1 mM CaCl2 as described [11]. For ﬂuorescence measurements, the
samples were excited at 280 nm and emission spectra recorded
between 300 to 400 nm. For circular dichroism (CD) measurements,
ellipticity, θ, was measured between 200 nm and 250 nm using a J-810
spectroﬂuoropolarimeter (Jasco Corp., Tokyo, Japan). After subtracting
the spectra of the buffer, the mean residue molar ellipticity was
calculated as [θ]=θ /ncl, where θ is the measured ellipticity in
millidegrees, n is the number of residues per molecule, c is the
molar concentration, and l is the optical path-length in mm. The
temperature dependencies of the maximum ﬂuorescence emission
wavelengths or the ellipticities were ﬁtted with theoretical curves as
described previously [11].
2.2. Degradation assays
The protease sensitivity assay and the 20S proteasome assay were
performed as previously described [11]. The CTA1/CTA2 heterodimer
was purchased from Calbiochem (La Jolla, CA); thermolysin was
purchased from Sigma-Aldrich (St. Louis, MO); and the 20S protea-
some was purchased from Boston Biochem (Cambridge, MA).
2.3. Toxicity assays
The assay for HdCDT induction of H2AX phosphorylation was
performed as previously described [18]. HdCDT was reconstituted
from individual subunits as described in [3]. The 2 μg/ml concentra-
tion of HdCDT used for this assay represents the minimal amount of
toxin required to elicit an effect in 100% of the cells after 2 h of
intoxication. Toxicity assays with ricin (Vector Laboratories, Burlin-
game, CA) were based upon the toxin-induced inhibition of protein
synthesis as described in [16].
2.4. Construction of CdtB-CVIM
A C-terminal extension containing the -CVIM farnesylation site
was introduced into CdtB using the cdtB nucleotide sequence from the
pGEX-CdtB-sulf1 plasmid [3] as a template. The following primers
were used:
5′-ATTCGGATCCAACTTGAGTGACTTCAAAGTAGC-3′ and 5′-
TACCGAATTCTCACATGATCACACACCCAGATGGGTATTCGTAGTCTTCTG-
CGCTGCGATCACGAACAAAACTAAC-3′
The PCR fragment was cloned into the BamHI and EcoRI restriction
sites of the pGEX4T3 expression vector (GE Healthcare, Piscataway,
NJ). Puriﬁcation of the fusion protein produced in E. coli strain BL21Fig. 1. HdCdtB thermal stability. Temperature-induced changes to the structure of
HdCdtB were monitored by ﬂuorescence spectroscopy (A, B) and far-UV CD (C). Both
measurements were conducted near-simultaneously on the same sample after
equilibration at each temperature for 3 min. Three scans per spectra were collected
and averaged to improve the signal-to-noise ratio. (A) The change in color from blue to
red corresponds to a step-wise increase in temperature from 18 °C to 60 °C. Dotted lines
are spectra of samples cooled to 50 °C, 40 °C, 37 °C, 25 °C, and 18 °C after HdCdtB was
heated to 60 °C; colors indicate the same temperatures as the solid lines. (B) The
maximum emission wavelengths (λmax) from panel A were plotted as a function of
temperature. Data points from the cooled HdCdtB spectra are presented as open circles.
(C) For far-UV CD analysis, the mean residue molar ellipticities at 220 nm ([θ]220) were
plotted as a function of temperature. Data points from the cooled HdCdtB spectra are
presented as open circles. The solid lines in panels B and C are best ﬁt curves simulated
as described in Ref. [11].
Fig. 2. HdCdtB proteolysis. (A) HdCdtB or the CTA1/CTA2 heterodimer was placed in
20 mM Na-phosphate buffer (pH 7.0) containing 10 mM β-mercaptoethanol. After
incubation at the indicated temperatures for 45 min, thermolysin was added for an
additional 45 min at 4 °C. Proteolysis was halted by the addition of EDTA and sample
buffer. The toxins were then visualized by SDS-PAGE and Coomassie staining. For both
gels, the upper thermolysin band is denoted with an asterisk. (B) HdCdtB or the reduced
CTA1/CTA2 heterodimer was placed in assay buffer with 100 nM of the 20S proteasome.
Proteolysis was halted after 0, 4, 8, or 20 h of incubation at 37 °C. The toxins were then
visualized by SDS-PAGE and Coomassie staining.
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2.5. Farnesylation assays
Detergent phase partitioning of lysates from cells exposed for 4 h
to 50 μg/ml of a CDT holotoxin containing the GST-CdtB-CVIM subunit
was performed as previously described [19]. GST-CdtB-CVIM was
recovered from aqueous and detergent phases of the lysates by afﬁnity
puriﬁcationwith glutathione sepharose 4B for 1 h at 4 °C.Western blot
was then performed using a horse radish peroxidase-conjugated anti-
GST antibody (Novus Biologicals, Littleton, CO). In vitro farnesylation
of GST-CdtB-CVIM was demonstrated by mixing 5 μg of the protein
with 35 μl rabbit reticulocyte lysate (Sigma-Aldrich), 1 mMMgCl2, and
5 mM farnesyl pyrophosphate (Sigma-Aldrich) for 1 h at 37 °C.
Detergent phase partitioning of the reaction product was performed
as described in [19].
2.6. Confocal microscopy
HeLa cells grown on coverslips were transfected with 2 μg of the
pDSRed2-ER vector (Clontech, Mountain View, CA) using the Lipo-
fectamine 2000 Reagent (Invitrogen, Carlsbad, CA) according to the
manufacturer's instructions. The pDSRed2-ER vector encodes a
recombinant protein consisting of a Discosoma sp. red ﬂuorescent
protein appended with an amino-terminal signal sequence for co-
translational targeting to the ER lumen and a carboxy-terminal KDEL
ER retention motif. At 24 h post-transfection, cells were exposed for
4 h to 10 μg/ml of a CDT holotoxin containing a GST-tagged CdtB
subunit [17]. The cells were then ﬁxed with 4% paraformaldehyde and
permeabilized with 0.2% Triton X-100 in phosphate buffered saline for
10 min at 22 °C. Non-speciﬁc antibody binding was blocked by
incubation with 3% bovine serum albumin in phosphate buffered
saline for 30min at 22 °C. GST-CdtBwas visualized using a ﬂuorescein-
conjugated goat anti-GST antibody (Abcam, Cambridge, MA) at 1:50
dilution for 30 min at 25 °C. Cells were viewed with a Nikon TE 300
confocal microscope, and images were captured using the Perkin
Elmer (Waltham, MA) UltraViewERS software.
3. Results
3.1. Thermal stability of HdCdtB
Fluorescence spectroscopy and far-UV CD were used to examine
the thermal stability of HdCdtB (Fig. 1), a 29 kDa proteinwith ∼13% α-
helix content and ∼40% β-sheet content [20,21]. Measurements were
conducted with buffer conditions (pH 7.0, 1 mM Ca2+) that
approximated the physiological conditions of the ER (pH 7.2,
0.5 mM Ca2+) [22–25]. Fluorescence spectroscopy detected the solvent
exposure of previously buried aromatic residues by a red shift in the
maximum emission wavelength (Fig. 1A and B). These readings
demonstrated that substantial disordering of the HdCdtB tertiary
structure did not occur at 37 °C. In fact, sample heating to 60 °C was
required to observe the disordering of HdCdtB tertiary structure. Near-
simultaneous measurements of ﬂuorescence and CD spectra were
performed on the same HdCdtB sample in a 4 mm×4 mm optical
path-length rectangular quartz cuvette in order to reduce sample-to-
sample variability. This procedure generated some noise in the far-UV
CD spectra because of the relatively large optical path-length (not
shown). Nevertheless, analysis of the ellipticity at 220 nm (which
reﬂects theα-helical and β-sheet secondary structures) demonstrated
that substantial denaturation of the HdCdtB secondary structure only
occurred at temperatures above 50 °C (Fig. 1C). Thus, signiﬁcant
unfolding of HdCdtB did not occur at physiological temperature. The
conformational changes that occurred at high temperatures were not
completely reversible, as the red shift of the ﬂuorescence spectra andthe reduced ellipticity did not return to their initial values upon
sample cooling to 18 °C (Fig. 1B and C).
3.2. Proteolysis of HdCdtB
The thermal stability of HdCdtB was also examinedwith a protease
sensitivity assay (Fig. 2A). This technique is often used to probe the
folding state of a protein, as properly folded proteins are generally
more resistant to proteolysis than unfolded variants of the same
protein [10,26–28]. To detect temperature-induced changes in the
folding state of HdCdtB, toxin samples were incubated at tempera-
tures ranging from 4 °C to 45 °C for 45 min. The samples were then
placed on ice and incubated with thermolysin for another 45 min at
4 °C. Finally, EDTA and sample buffer were added to halt the
proteolytic digestions. Thermolysin is a calcium-dependent metallo-
protease that hydrolyzes peptide bonds on the amino side of bulky
hydrophobic residues [27]. The use of this speciﬁc protease thus
allowed us to detect temperature-induced conformational changes
that resulted in the exposure of previously buried hydrophobic
residues. For comparative purposes, parallel experiments were run
with the reduced CTA1/CTA2 heterodimer. Reduction of the CTA1/
CTA2 disulﬁde bond normally occurs in the ER of an intoxicated cell
[29]; this event was reproduced in vitro by including 10 mM
β-mercaptoethanol in the assay buffer. Previous work has demon-
strated the complete dissociation of CTA1 from CTA2 under this
reducing condition [12].
HdCdtB exhibited considerable resistance to proteolysis with
thermolysin when incubated at temperatures up to 45 °C. In contrast,
reduced CTA1 was completely degraded at temperatures≥41 °C, and
substantial degradation of the CTA1 sample pre-incubated at 37 °C
was observed as well. Temperatures≥33 °C also induce PT S1 to
assume a thermolysin-sensitive conformation [11]. Thus, at physiolo-
gical temperature CTA1 and PT S1 contain surface-exposed hydro-
phobic residues that could trigger the ERAD translocationmechanism.
HdCdtB, in contrast, exhibited remarkable heat stability and thermo-
lysin resistance when compared to the A chains of other ER-
translocating toxins.
Fig. 3. HdCDT toxicity. (A, B) HeLa cells were incubated with no toxin or with 2 μg/ml
of HdCDT for 2 h in medium alone (control) or medium supplemented with 10%
glycerol. As indicated, one set of cells were pretreated with 10% glycerol medium for
1 h before a further 2 h incubation with glycerol in the absence (no toxin) or presence
of HdCDT. (A) Toxin-induced phosphorylation of histone H2AX was visualized in ﬁxed
cells with a rabbit anti-phospho-H2AX antibody and a FITC-conjugated swine anti-
rabbit IgG antibody. One of two experiments is shown. (B) The graph charts the
average percentage (±range) of nuclei positive for H2AX foci from both experiments.
(C) HeLa cells were incubated with various concentrations of ricin for 4 h in the
absence or presence of 10% glycerol before protein synthesis levels were quantiﬁed.
Measurements taken from unintoxicated cells incubated in the absence or presence of
glycerol were used to establish the 100% value for the corresponding experimental
condition. The average±range of two independent experiments with triplicate
samples is shown.
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ubiquitin-independent degradation by the core 20S proteasome
[11,12]. As the 20S proteasome only acts upon unfolded substrates
[30], toxin processing by this form of the proteasome is likely linked to
thermal instability in the toxin A chain. The relatively heat-stable
nature of HdCdtB would therefore render it resistant to degradation
by the 20S proteasome. To test this prediction, we incubated HdCdtB
or the reduced CTA1/CTA2 heterodimer with the puriﬁed 20S
proteasome (Fig. 2B). Little to no degradation of HdCdtB occurred
during the 20 h time frame of this experiment. In contrast,
degradation of the reduced 21 kDa CTA1 polypeptide was evident at
4 h of incubation and was nearly complete by 8 h of incubation. Thus,
HdCdtB was not an effective substrate for the 20S proteasome.
3.3. Unique features of HdCdtB translocation
Most proteins require at least partial unfolding in order to move
from the ER to the cytosol, yet our data indicated that the isolated
HdCdtB subunit is in a folded conformation at 37 °C. To examine the
role of A chain unfolding in HdCDT intoxication, we performed
toxicity assays with glycerol-treated HeLa cells (Fig. 3). Chemical
chaperones such as glycerol prevent protein unfolding [31] and block
intoxication with ﬁve distinct ER-translocating toxins: ricin [32],
exotoxin A [32], plasmid-encoded toxin [33], CT, and Shiga toxin 2
(Teter et. al, unpublished observations). An inhibition of HdCDT
activity in glycerol-treated cells would therefore suggest that a
chaperone-assisted unfolding step may be necessary for HdCdtB to
reach its target.
Toxicity assays were performed on HdCDT-treated HeLa cells
incubated in the absence or presence of 10% glycerol (Fig. 3A, B). Cells
were exposed to HdCDT and glycerol for a 2 h co-incubation before
screening for toxic effects. In parallel experiments, cells were also pre-
incubated with glycerol for 1 h before a 2 h co-incubationwith HdCDT
and glycerol. Prolonged incubationwith glycerol was toxic to the cells,
so we could not assess HdCDT intoxication by its long-term effect of
cell cycle arrest. Phosphorylation of the histone H2AX has been shown
to occur early in the CDT intoxication process [18] and was therefore
used as an alternative measure of intoxication. Exposure to glycerol
did not prevent the phosphorylation of H2AX in HdCDT-treated cells
(Fig. 3A, B), but it did block intoxication with ricin (Fig. 3C). The latter
result demonstrated that our experimental procedure was sufﬁcient
to inhibit the activity of a prototypical ER-translocating toxin.
Importantly, glycerol treatment alone did not result in the phosphor-
ylation of H2AX (Fig. 3A, B). These collective observations emphasized
the unusual aspects of HdCDT intoxication, a process which may not
require A chain unfolding prior to translocation.
We have previously suggested that HdCdtB may bypass the cytosol
and move directly from the ER to the nucleus [1,3]. This atypical
translocation mechanism would be distinct from the ERAD-mediated
pathway that exports heat-labile toxin A chains to the cytosol. To
further examine this putative translocation route, we generated a
recombinant HdCDT that contains a CVIM-tagged HdCdtB subunit.
The C-terminal CVIM farnesylation motif can serve as an indicator of
protein localization to the cytosol because farnesylation, which
increases the hydrophobicity of the target protein, is a cytosolic
modiﬁcation [34]. The recombinant HdCdtB also contained an
N-terminal GST tag to facilitate protein puriﬁcation and detection.
A farnesylated protein will partition into the detergent phase of
Triton X-114, whereas an unmodiﬁed variant of the same protein will
partition into the aqueous phase. We conﬁrmed that GST-HdCdtB-
CVIM behaved in this predicted manner by performing an in vitro
farnesylation assay. Puriﬁed GST-HdCdtB-CVIM partitioned into the
aqueous phase of Triton X-114 (Fig. 4A, left panel). However, GST-
HdCdtB-CVIM partitioned into the detergent phase of Triton X-114
when it was exposed to the farnesylation machinery present in a
reticulocyte lysate (Fig. 4A, right panel). The farnesylation of GST-HdCdtB-CVIM could therefore be detected by detergent phase
partitioning of the modiﬁed toxin.
For in vivo experiments, we incorporated GST-HdCdtB-CVIM into
a CDT holotoxin. HeLa cells were exposed to 50 μg/ml of the
recombinant holotoxin for 4 h before cell extracts were generated
with a Triton X-114 lysis buffer. As shown in Fig. 4B, GST-HdCdtB-
CVIM could only be found in the aqueous phase of the cell extract.
This indicated that no detectable pool of HdCdtB was modiﬁed by
Fig. 4. HdCdtB translocation. (A) Puriﬁed GST-HdCdtB-CVIM was incubated in the
absence or presence of rabbit reticulocyte lysate before placement in cold 1% Triton X-
114. Aqueous (A) and detergent (D) phases of Triton X-114 were isolated by
centrifugation of the warmed samples. The distribution of GST-HdCdtB-CVIM was
then determined by Western blot analysis of the separate detergent and aqueous
phases. (B) For in vivo farnesylation of GST-HdCdtB-CVIM, HeLa cells were exposed for
4 h to 50 μg/ml of a recombinant CDT holotoxin that contained the GST-HdCdtB-CVIM
subunit. After lysis in 1% Triton X-114, aqueous (A) and detergent (D) phases were
separated. GST-HdCdtB-CVIM was recovered by afﬁnity puriﬁcation and visualized by
Western-blot analysis as described in Materials and methods.
Fig. 5. Intracellular distribution of HdCdtB. Transfected HeLa cells expressing DsRed2-
ER, a ﬂuorescent marker for the ER, were exposed for 4 h to 10 μg/ml of a recombinant
CDT holotoxin that contained a GST-HdCdtB subunit. The cells were then ﬁxed and
stained with a ﬂuorescein-conjugated anti-GST antibody. (A) Labeling patterns for
DsRed2-ER and GST-CdtB from two Z-sections of a single cell. (B) The merged image of
DsRed2-ER and GST-CdtB distributions. Arrows denote the nuclear envelope; arrow-
heads denote invaginations of the nucleoplasmic reticulum.
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HdCdtC heterodimer or to GST-HdCdtB-CVIM alone did not produce
an HdCdtB signal (data not shown). This demonstrated that the
protein detected in vivo was GST-HdCdtB-CVIM and that, as
expected, an intact holotoxin was required to deliver GST-HdCdtB-
CVIM into the target cell. Given the robust HdCdtB signal present in
the aqueous phase of the HeLa cell extract, any trace amount of
farnesylated GST-HdCdtB-CVIM would represent an exceedingly
small pool of the total protein.
Methods such as Western blot analysis that directly monitor the
toxin itself are less sensitive than toxicity assays and therefore require
higher toxin doses for experimentation. Thus, it was necessary to use
25-fold more HdCDT for the farnesylation assay than for the toxicity
assay of Fig. 3. The relatively short-term intoxication periods of 2–4 h
for our in vivo experiments also required the use of high toxin
concentrations. In our previous work, a 4 h exposure to 20 μg/ml of
HdCDT was required to detect sulfation and mannosylation of the
recombinant HdCdtB subunit [3]. This toxin concentration did not
alter the cellular responses in terms of biochemical signaling.
Likewise, the 4 h exposure to 50 μg /ml of toxin that was required
for our farnesylation assay did not alter the cell morphology as
determined by actin and nuclear staining. Furthermore, the cellular
distension that is only seen after long-term intoxications was not
observed in cells exposed to 50 μg/ml of HdCDT for 4 h. Collectively,
these observations indicated that the high toxin concentration
required for our farnesylation assay did not alter the cellular response
to HdCDT intoxication.
A direct ER-to-nucleoplasm translocation route would bypass the
cytosolic farnesylation machinery and therefore leave HdCdtB in an
unmodiﬁed state. Confocal microscopy was used to further examine
this putative translocation route (Fig. 5). HeLa cells were exposed for
4 h to 10 μg/ml of a recombinant CDT holotoxin that contained a GST-
tagged CdtB subunit [17]. The cellular location of GST-CdtB was then
compared to the distribution of DsRed2-ER, a ﬂuorescent marker for
the ER. GST-CdtB and DsRed2-ER could be found in a branching,
tubularized network that was contiguous with the nuclear envelope
(arrows). GST-CdtB could also be found in the nucleus but could not be
detected in the cytosol. As with the farnesylation data, this suggested
that HdCdtB bypasses the cytosol and moves directly from the ER to
the nucleus. Finally, GST-CdtB and DsRed2-ER were visualized in
invaginations of the nuclear envelope that protruded into the nucleus
(arrowheads). These structures have been previously visualized in
unintoxicated cells and are morphologically deﬁned as the nucleo-
plasmic reticulum [35–37]. By visualizing DsRed2-ER in unintoxicated
HeLa cells, we conﬁrmed that the tubular protrusions were a normal
cellular structure rather than a byproduct of HdCDT intoxication and
that the DsRed2-ER signal did not bleed into the ﬂuorescein channel
used to visualize GST-CdtB (not shown). Localization to the nucleo-
plasmic reticulum (i.e., the nuclear protrusions) has not been reported
for other toxins that have been visualized in the ER [19,24,38–40]. Thisagain emphasized the unique aspects of HdCDT intoxication. The
functional relevance of these nuclear protrusions in regards to CDT
intoxication has yet to be determined.
4. Discussion
CDTs are produced by numerous Gram-negative pathogens [1].
They are the only known bacterial AB toxins that function primarily by
direct damage to the host cell DNA. CdtB accordingly acts within the
nucleus, whereas other toxin A chains act within the cytosol. Our
current study demonstrates that, in addition to its unique target and
unique site of action, CdtB also exhibits unique structural properties
which affect its interaction with the host cell and distinguish it from
the A chains of other ER-translocating toxins.
With the exception of the Salmonella Typhi CDT [41], the family of
CDTs are tripartite toxins composed of a cell-binding CdtA/CdtC
subunit and a catalytic CdtB subunit. Both CdtA and CdtC are required
for the optimal biological activity of CDT, but the two proteins do not
appear to play equivalent roles in cell binding and cellular uptake
[1,42–46]. Although the exact roles of CdtA and CdtC in toxin
endocytosis and intracellular trafﬁcking remain to be determined, it
is well-established that CdtB must exit the endomembrane system
and reach the nucleus in order to elicit a cytotoxic effect [2,3,45,47].
HdCdtB escape from the endomembrane system occurs at the level of
the ER and involves an ERAD-independent mechanism or an ERAD
mechanism that is signiﬁcantly different from the pathway utilized by
other ER-translocating toxins [3].
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cytosol [4,5]. For three of these toxins – CT, PT, and ricin – thermal
instability in the isolated catalytic subunit may activate the ERAD
mechanism [10–12]. The heat-labile nature of the toxin A chain could
also facilitate its ubiquitin-independent degradation by the 20S
proteasome. Our results provide previously unknown evidence that
HdCdtBmaintains its folded conformation at 37 °C in buffer conditions
that mimic the physiology of the ER. This offers a structural basis for
the previously reported ERAD-independent mechanism of HdCdtB
export from the ER [3]: since HdCdtB does not unfold at 37 °C, it is not
recognized as an ERAD substrate. The thermal stability of HdCdtB also
protects it from degradation by the 20S proteasome, a proteolytic
machine that can only act upon unfolded proteins. Finally, CDT is the
only known ER-translocating toxin that can function in glycerol-
treated cells. The structural and cellular events involved with HdCdtB
export from the ER are therefore distinct from those events involving
other ER-translocating toxins.
The productive intoxication of glycerol-treated cells suggests that
HdCdtB unfolding is not required for its exit from the ER. It is
structurally feasible for HdCdtB to exit the ER in a folded state, as
passage of folded proteins through the Sec61 translocon pore has
been documented [48]. The translocon, which can dilate to 60 Å in
diameter [49], could accommodate the 45 Å diameter of an isolated,
folded CdtB subunit [50]. Flexibility in the structure of CdtB [50]
could also allow the folded toxin to assume a conformation suitable
for passage through the Sec61p translocon or other pores in the ER
membrane.
Our data further suggest that HdCdtB follows a unique transloca-
tion route involving direct passage from the ER to the nucleus.
However, we cannot currently discount the possibility that HdCdtB
ﬁrst enters the cytosol and then rapidly moves into the nucleus
through the nuclear pore complex. Atypical nuclear localization
sequences in other CdtB subunits [51,52] are often used as evidence
for a cytosol-to-nucleus transport route, but these sequences could
also serve as retrieval motifs to return an escaped pool of toxin to the
nucleus. Likewise, the KDEL motif in CT is thought to act as an ER
retentionmotif rather than as a primary ER targeting motif [53]. Given
the many unique aspects of HdCdtB translocation, we favor the ER-to-
nucleus model of HdCdtB translocation and are currently working to
deﬁne the molecular details of this process.
Acknowledgements
This work was supported by NIH grants K22 AI054568 and R01
AI073783 to K. Teter. T. Frisan was supported by funds from the
Swedish Research Council, the Swedish Cancer Society, The Åke-
Wiberg Foundation, and the Karolinska Institutet. We thank Sandra
Geden for technical assistance with the in vitro farnesylation assay.
References
[1] M. Thelestam, T. Frisan, Cytolethal distending toxins, in: J.E. Alouf, M.R. Popoff
(Eds.), The Comprehensive Sourcebook of Bacterial Protein Toxins, Academic
Press, San Diego, 2006, pp. 448–467.
[2] X. Cortes-Bratti, E. Chaves-Olarte, T. Lagergard, M. Thelestam, Cellular internaliza-
tion of cytolethal distending toxin from Haemophilus ducreyi, Infect. Immun. 68
(2000) 6903–6911.
[3] L. Guerra, K. Teter, B.N. Lilley, B. Stenerlow, R.K. Holmes, H.L. Ploegh, K. Sandvig, M.
Thelestam, T. Frisan, Cellular internalization of cytolethal distending toxin: a new
end to a known pathway, Cell. Microbiol. 7 (2005) 921–934.
[4] B. Hazes, R.J. Read, Accumulating evidence suggests that several AB-toxins subvert
the endoplasmic reticulum-associated protein degradation pathway to enter
target cells, Biochemistry 36 (1997) 11051–11054.
[5] J.M. Lord, L.M. Roberts, W.I. Lencer, Entry of protein toxins into mammalian cells
by crossing the endoplasmic reticulum membrane: co-opting basic mechanisms
of endoplasmic reticulum-associated degradation, Curr. Top. Microbiol. Immunol.
300 (2005) 149–168.
[6] S.E. Geden, R.A. Gardner, M.S. Fabbrini, M. Ohashi, O. Phanstiel IV, K. Teter,
Lipopolyamine treatment increases the efﬁcacy of intoxication with saporin and
an anticancer saporin conjugate, FEBS J. 274 (2007) 4825–4836.[7] K. Teter, R.K. Holmes, Inhibition of endoplasmic reticulum-associated degradation
in CHO cells resistant to cholera toxin, Pseudomonas aeruginosa exotoxin A, and
ricin, Infect. Immun. 70 (2002) 6172–6179.
[8] K. Teter, M.G. Jobling, R.K. Holmes, A class of mutant CHO cells resistant to cholera
toxin rapidly degrades the catalytic polypeptide of cholera toxin and exhibits
increased endoplasmic reticulum-associated degradation, Trafﬁc 4 (2003)
232–242.
[9] F. Navarro-Garcia, A. Canizalez-Roman, K.E. Burlingame, K. Teter, J.E. Vidal, Pet, a
non-AB toxin, is transported and translocated into epithelial cells by a retrograde
trafﬁcking pathway, Infect. Immun. 75 (2007) 2101–2109.
[10] R.H. Argent, A.M. Parrott, P.J. Day, L.M. Roberts, P.G. Stockley, J.M. Lord, S.E. Radford,
Ribosome-mediated folding of partially unfolded ricin A-chain, J. Biol. Chem. 275
(2000) 9263–9269.
[11] A.H. Pande, D. Moe, M. Jamnadas, S.A. Tatulian, K. Teter, The pertussis toxin S1
subunit is a thermally unstable protein susceptible to degradation by the 20S
proteasome, Biochemistry 45 (2006) 13734–13740.
[12] A.H. Pande, P. Scaglione, M. Taylor, K.N. Nemec, S. Tuthill, D. Moe, R.K. Holmes,
S.A. Tatulian, K. Teter, Conformational instability of the cholera toxin A1
polypeptide, J. Mol. Biol. 374 (2007) 1114–1128.
[13] B. Goins, E. Freire, Thermal stability and intersubunit interactions of cholera toxin
in solution and in association with its cell-surface receptor ganglioside GM1,
Biochemistry 27 (1988) 2046–2052.
[14] T. Krell, F. Greco, M.C. Nicolai, J. Dubayle, G. Renauld-Mongenie, N. Poisson,
I. Bernard, The use of microcalorimetry to characterize tetanus neurotoxin,
pertussis toxin and ﬁlamentous haemagglutinin, Biotechnol. Appl. Biochem.
38 (2003) 241–251.
[15] L.S. Jackson, W.H. Tolleson, S.J. Chirtel, Thermal inactivation of ricin using infant
formula as a food matrix, J. Agric. Food Chem. 54 (2006) 7300–7304.
[16] E.D. Deeks, J.P. Cook, P.J. Day, D.C. Smith, L.M. Roberts, J.M. Lord, The low lysine
content of ricin A chain reduces the risk of proteolytic degradation after
translocation from the endoplasmic reticulum to the cytosol, Biochemistry 41
(2002) 3405–3413.
[17] T. Frisan, X. Cortes-Bratti, E. Chaves-Olarte, B. Stenerlow, M. Thelestam, The Hae-
mophilus ducreyi cytolethal distending toxin induces DNA double-strand breaks
and promotes ATM-dependent activation of RhoA, Cell. Microbiol. 5 (2003)
695–707.
[18] L. Li, A. Sharipo, E. Chaves-Olarte, M.G. Masucci, V. Levitsky, M. Thelestam,
T. Frisan, The Haemophilus ducreyi cytolethal distending toxin activates
sensors of DNA damage and repair complexes in proliferating and non-
proliferating cells, Cell. Microbiol. 4 (2002) 87–99.
[19] K. Teter, R.L. Allyn, M.G. Jobling, R.K. Holmes, Transfer of the cholera toxin A1
polypeptide from the endoplasmic reticulum to the cytosol is a rapid process
facilitated by the endoplasmic reticulum-associated degradation pathway, Infect.
Immun. 70 (2002) 6166–6171.
[20] L.D. Cope, S. Lumbley, J.L. Latimer, J. Klesney-Tait, M.K. Stevens, L.S. Johnson, M.
Purven, R.S. Munson Jr., T. Lagergard, J.D. Radolf, E.J. Hansen, A diffusible cytotoxin
of Haemophilus ducreyi, Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 4056–4061.
[21] D. Nesic, Y. Hsu, C.E. Stebbins, Assembly and function of a bacterial genotoxin,
Nature 429 (2004) 429–433.
[22] M.M. Wu, J. Llopis, S.R. Adams, J.M. McCaffery, K. Teter, M.S. Kulomaa, T.E. Machen,
H.P. Moore, R.Y. Tsien, Studying organelle physiology with fusion protein-targeted
avidin and ﬂuorescent biotin conjugates, Methods Enzymol. 327 (2000) 546–564.
[23] M.J. Barrero, M. Montero, J. Alvarez, Dynamics of [Ca2+] in the endoplasmic
reticulum and cytoplasm of intact HeLa cells. A comparative study, J. Biol. Chem.
272 (1997) 27694–27699.
[24] J.H. Kim, L. Johannes, B. Goud, C. Antony, C.A. Lingwood, R. Daneman, S. Grinstein,
Noninvasive measurement of the pH of the endoplasmic reticulum at rest and
during calcium release, Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 2997–3002.
[25] A.M. Hofer, I. Schulz, Quantiﬁcation of intraluminal free [Ca] in the agonist-
sensitive internal calcium store using compartmentalized ﬂuorescent indicators:
some considerations, Cell Calcium 20 (1996) 235–242.
[26] B. Tsai, C. Rodighiero, W.I. Lencer, T.A. Rapoport, Protein disulﬁde isomerase acts as
a redox-dependent chaperone to unfold cholera toxin, Cell 104 (2001) 937–948.
[27] S.J. Bark, N. Muster, J.R. Yates 3rd, G. Siuzdak, High-temperature protein mass
mapping using a thermophilic protease, J. Am. Chem. Soc. 123 (2001) 1774–1775.
[28] J.P. Renn, P.L. Clark, A conserved stable core structure in the passenger domain
beta-helix of autotransporter virulence proteins, Biopolymers 89 (2008) 420–427.
[29] P.A. Orlandi, Protein-disulﬁde isomerase-mediated reduction of the A subunit of
cholera toxin in a human intestinal cell line, J. Biol. Chem. 272 (1997) 4591–4599.
[30] O. Coux, K. Tanaka, A.L. Goldberg, Structure and functions of the 20S and 26S
proteasomes, Annu. Rev. Biochem. 65 (1996) 801–847.
[31] K. Romisch, A cure for trafﬁc jams: small molecule chaperones in the endoplasmic
reticulum, Trafﬁc 5 (2004) 815–820.
[32] K. Sandvig, I.H. Madshus, S. Olsnes, Dimethyl sulphoxide protects cells against
polypeptide toxins and poliovirus, Biochem. J. 219 (1984) 935–940.
[33] P. Scaglione, K.N. Nemec, K.E. Burlingame, A. Grabon, J. Huerta, F. Navarro-Garcia,
S.A. Tatulian, K. Teter, Structural characteristics of the plasmid-encoded toxin from
enteroaggregative Escherichia coli, Biochemistry 47 (2008) 9582–9591.
[34] S. Clarke, Protein isoprenylation and methylation at carboxyl-terminal cysteine
residues, Annu. Rev. Biochem. 61 (1992) 355–386.
[35] M. Fricker, M. Hollinshead, N. White, D. Vaux, Interphase nuclei of many
mammalian cell types contain deep, dynamic, tubular membrane-bound
invaginations of the nuclear envelope, J. Cell Biol. 136 (1997) 531–544.
[36] W. Echevarria, M.F. Leite, M.T. Guerra, W.R. Zipfel, M.H. Nathanson, Regulation of
calcium signals in the nucleus by a nucleoplasmic reticulum, Nat. Cell Biol. 5
(2003) 440–446.
495L. Guerra et al. / Biochimica et Biophysica Acta 1793 (2009) 489–495[37] T.A. Lagace, N.D. Ridgway, The rate-limiting enzyme in phosphatidylcholine
synthesis regulates proliferation of the nucleoplasmic reticulum, Mol. Biol. Cell
16 (2005) 1120–1130.
[38] I.V. Majoul, P.I. Bastiaens, H.D. Soling, Transport of an external Lys-Asp-Glu-Leu
(KDEL) protein from the plasma membrane to the endoplasmic reticulum: studies
with cholera toxin in Vero cells, J. Cell Biol. 133 (1996) 777–789.
[39] L. Johannes, D. Tenza, C. Antony, B. Goud, Retrograde transport of KDEL-bearing
B-fragment of Shiga toxin, J. Biol. Chem. 272 (1997) 19554–19561.
[40] M.G. Castro, U. McNamara, N.H. Carbonetti, Expression, activity and cytotoxi-
city of pertussis toxin S1 subunit in transfected mammalian cells, Cell.
Microbiol. 3 (2001) 45–54.
[41] S. Spano, J.E. Ugalde, J.E. Galan, Delivery of a Salmonella Typhi exotoxin from a host
intracellular compartment, Cell Host Microbe 3 (2008) 30–38.
[42] K. Deng, J.L. Latimer, D.A. Lewis, E.J. Hansen, Investigation of the interaction among
the components of the cytolethal distending toxin of Haemophilus ducreyi,
Biochem. Biophys. Res. Commun. 285 (2001) 609–615.
[43] R.B. Lee, D.C. Hassane, D.L. Cottle, C.L. Pickett, Interactions of Campylobacter jejuni
cytolethal distending toxin subunits CdtA and CdtCwith HeLa cells, Infect. Immun.
71 (2003) 4883–4890.
[44] X. Mao, J.M. DiRienzo, Functional studies of the recombinant subunits of a
cytolethal distending holotoxin, Cell. Microbiol. 4 (2002) 245–255.
[45] S. Akifusa, W. Heywood, S.P. Nair, G. Stenbeck, B. Henderson, Mechanism of
internalization of the cytolethal distending toxin of Actinobacillus actinomyce-
temcomitans, Microbiology 151 (2005) 1395–1402.[46] M. Lara-Tejero, J.E. Galan, CdtA, CdtB, and CdtC form a tripartite complex that is
required for cytolethal distending toxin activity, Infect. Immun. 69 (2001)
4358–4365.
[47] K. Boesze-Battaglia, D. Besack, T. McKay, A. Zekavat, L. Otis, K. Jordan-Sciutto,
B.J. Shenker, Cholesterol-rich membrane microdomains mediate cell cycle
arrest induced by Actinobacillus actinomycetemcomitans cytolethal-distending
toxin, Cell. Microbiol. 8 (2006) 823–836.
[48] E. Fiebiger, C. Story, H.L. Ploegh, D. Tortorella, Visualization of the ER-to-cytosol
dislocation reaction of a type I membrane protein, EMBO J. 21 (2002) 1041–1053.
[49] B.D. Hamman, J.C. Chen, E.E. Johnson, A.E. Johnson, The aqueous pore through the
translocon has a diameter of 40–60 Å during cotranslational protein translocation
at the ER membrane, Cell 89 (1997) 535–544.
[50] J.S. Hontz, M.T. Villar-Lecumberri, B.M. Potter, M.D. Yoder, L.A. Dreyfus, J.H. Laity,
Differences in crystal and solution structures of the cytolethal distending toxin B
subunit: relevance to nuclear translocation and functional activation, J. Biol. Chem.
281 (2006) 25365–25372.
[51] L.A. McSweeney, L.A. Dreyfus, Nuclear localization of the Escherichia coli cytolethal
distending toxin CdtB subunit, Cell. Microbiol. 6 (2004) 447–458.
[52] S. Nishikubo, M. Ohara, Y. Ueno, M. Ikura, H. Kurihara, H. Komatsuzawa, E.
Oswald, M. Sugai, An N-terminal segment of the active component of the
bacterial genotoxin cytolethal distending toxin B (CDTB) directs CDTB into the
nucleus, J. Biol. Chem. 278 (2003) 50671–50681.
[53] W.I. Lencer, B. Tsai, The intracellular voyage of cholera toxin: going retro, Trends
Biochem. Sci. 28 (2003) 639–645.
A Bacterial Cytotoxin Identifies the RhoA Exchange
Factor Net1 as a Key Effector in the Response to DNA
Damage
Lina Guerra1., Heather S. Carr3., Agneta Richter-Dahlfors2, Maria G. Masucci1, Monica Thelestam1,
Jeffrey A. Frost3, Teresa Frisan1*
1Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden, 2Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden,
3Department of Integrative Biology and Pharmacology, University of Texas Health Science Center at Houston, Houston, Texas, United States of America
Abstract
Background: Exposure of adherent cells to DNA damaging agents, such as the bacterial cytolethal distending toxin (CDT) or
ionizing radiations (IR), activates the small GTPase RhoA, which promotes the formation of actin stress fibers and delays cell
death. The signalling intermediates that regulate RhoA activation and promote cell survival are unknown.
Principal Findings: We demonstrate that the nuclear RhoA-specific Guanine nucleotide Exchange Factor (GEF) Net1
becomes dephosphorylated at a critical inhibitory site in cells exposed to CDT or IR. Expression of a dominant negative Net1
or Net1 knock down by iRNA prevented RhoA activation, inhibited the formation of stress fibers, and enhanced cell death,
indicating that Net1 activation is required for this RhoA-mediated responses to genotoxic stress. The Net1 and RhoA-
dependent signals involved activation of the Mitogen-Activated Protein Kinase p38 and its downstream target MAPK-
activated protein kinase 2.
Significance: Our data highlight the importance of Net1 in controlling RhoA and p38 MAPK mediated cell survival in cells
exposed to DNA damaging agents and illustrate a molecular pathway whereby chronic exposure to a bacterial toxin may
promote genomic instability.
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Introduction
Cytolethal distending toxins (CDTs), produced by several
pathogenic Gram-negative bacteria, are protein toxins which
cause DNA damage (reviewed in [1]). The active holotoxin is a
tripartite complex [2,3], formed by the CdtA, CdtB and CdtC
subunits, (reviewed in [1]). Cellular intoxication with CDT induces
DNA double strand breaks and activation of checkpoint responses
that, depending on the cell type, lead to arrest in the G1 or G2
phases of the cell cycle [4–6]. These effects are similar to those
caused by ionizing radiation (IR), which is a well-characterized
DNA-damaging agent. Activation of the DNA damage responses
by CDT is consistent with the functional and structural homology
of the CdtB subunit with mammalian DNase I [7–9].
In adherent cells, CDT intoxication and exposure to IR are
associated with the formation of actin stress fibers, via activation of
the small GTPase RhoA [6]. While a large amount of data is
available regarding the activation of RhoA upon stimulation of
plasma membrane-bound receptors [10], the molecular mecha-
nisms regulating RhoA activation in response to these and other
DNA-damaging agents are still unknown. It is noteworthy that,
since RhoA activation occurs in the cytosol, the signals that
regulate its activation in response to DNA damage must be then
transduced from the nucleus.
Guanine nucleotide exchange factors (GEFs) are key activators
of the small GTPases that regulate the switch between the inactive
GDP-bound and the active GTP-bound forms of the GTPase
(reviewed in [11]). The vast majority of the known RhoA-specific
GEFs exhibit a cytoplasmic localization. One remarkable
exception is the RhoA-specific GEF encoded by the neuroepithe-
lioma transforming gene 1 (Net1) that is normally found in the
nucleus of mammalian cells (reviewed in [11]). Net1 was originally
isolated in a tissue culture screen for transforming genes in NIH
3T3 cell focus formation assays [12]. The oncogenic form of Net1
isolated from this screen lacked the first 145 amino acids. A
deletion mutant of Net1 lacking the first 121 amino acids was
shown to be constitutively active and induced: i) formation of actin
stress fibers; ii) activation of the Mitogen-Activated Protein Kinase
(MAPK) JNK; and iii) activation of the serum response factor
(SRF) [13,14].
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The regulation of Net1 activity is poorly understood. PAK1-
dependent phosphorylation of Net1 on Ser152 and Ser153 inhibits
its GEF activity and abolishes Net1-dependent RhoA activation and
stress fiber induction [15]. In addition, translocation of Net1 from
the nucleus to the cytoplasm is required for activation of RhoA. The
amino-terminus of Net1 contains multiple nuclear localization
signals, and deletion of this domain is associated with accumulation
of a constitutively active Net1 in the cytoplasm [14]. Taken together
these data suggest that the activation of Net1 requires both changes
in the phosphorylation pattern of specific inhibitory sites and
shuttling between the nucleus and the cytoplasm, but the signals that
trigger these events are still unknown.
In the present study, we have identified DNA damage as a
trigger for Net1 activation. We show that inhibition of Net1
prevents RhoA activation and stress fiber formation, and promotes
cell death upon intoxication or irradiation. We also demonstrate
that the Net1/RhoA dependent signals converges on the
activation of p38 MAPK and its downstream target MK2,
indicating that RhoA plays an important role in controlling the
activation of this MAPK pathway in response to genotoxic agents.
Results
DNA damage induces Net1 activation
We have previously shown that exposure to DNA damaging
agents induces activation of the small GTPase RhoA, which delays
cell death [6]. In order to investigate how the signal delivered by
DNA damage is transduced from the nucleus to the cytosol, we
have studied the activation of the RhoA specific GEF Net1 in
response to CDT or IR. These genotoxic agents were chosen since
they both induce DNA double strand breaks and activate identical
DNA damage checkpoint responses in mammalian cells [4–6].
Decreased phosphorylation of Net1 on the key negative regulatory
site Ser152 was used as the hallmark of Net1 activation [15].
Endogenous Net1 was immunoprecipitated from HeLa cells left
untreated or exposed to CDT for 12h, and the levels of Ser152
phosphorylation were assessed by western blot using a phospho-
specific antibody. As shown in Figure 1A, the phosphorylation of
endogenous Net1 on Ser152 (pS152-Net1) was significantly
decreased in intoxicated cells. To assess whether dephosphoryla-
tion of Net1 is a reproducible effect of DNA damage, HeLa cells
were transfected with a plasmid expressing an HA-epitope-tagged
Net1A, the major Net1 isoform expressed in these cells [16]. The
transfected cells were then exposed to CDT or IR and the
expression of total and phosphorylated Net1 was monitored over
time. A 70% decrease in the levels of pS152-Net1A was observed
within 30 min after irradiation. The effect was similar to that
achieved by CDT intoxication where low levels of p152-Net1A
were maintained for at least 12h (Figure 1B and data not shown).
Thus, exposure to DNA damage induces dephosphorylation of
Net1 on its negative regulatory site.
Net1 is required for activation of RhoA and remodelling
of the actin cytoskeleton in response to DNA damage
To assess whether Net1 is required for activation of RhoA, the
expression of endogenous Net1 was knocked down by RNAi prior
to intoxication or irradiation. Transfection with a short hairpin
loop interfering RNA expressing plasmid or siRNA oligonucleo-
tides were used to inhibit Net1 expression. Transfection of cells
with Net1 specific shRNA resulted in 90% reduction of the
endogenous Net1 96h after transfection (Figure 2A), while
transfection with a specific siRNA resulted in 60 to 70 percent
reduction 72h after transfection (Figure 2B). Since the effects of
Net1 specific shRNA or siRNA were reproducibly similar, the
results of Net1 knock down experiments have been summarized
together and are henceforth indicated as iRNA. Consistent with
our previous results [6], a 2- to 4-fold increase in the levels of
GTP-bound RhoA was observed in irradiated or intoxicated HeLa
cells as compared to the untreated controls. Knock down of
endogenous Net1 blocked the activation of RhoA in response to
IR or CDT (Figure 2C). Similar results were obtained in cells
expressing the dominant negative Net1DDH (data not shown).
This effect was not due to a general impairment of RhoA-
dependent responses since Net1 knock down did not prevent
RhoA activation or the formation of actin stress fibers in cells
treated with cytotoxic necrotizing factor 1 (CNF1) that constitu-
tively activates RhoA by deamidating Gln-63 and preventing
hydrolysis of bound GTP (Figures 2C and 2D).
We next examined whether blockade of Net1 affected the
RhoA-dependent formation of actin stress fibers in HeLa cells
exposed to CDT. Induction of stress fibers was detected upon
intoxication in approximately 80% of control non-transfected cells
Figure 1. Decreased phosphorylation of Net1 upon induction
of DNA damage. A) HeLa cells were left untreated or treated with
CDT (2 mg ml21) for 12h. The endogenous Net1 protein was
immunoprecipitated using a goat a-Net1 antibody, and samples were
analyzed by western blot using a rabbit serum specific for Net1
phosphorylated on Ser152 (pS152-Net1). B) HeLa cells, grown in 12-well
plate, were transfected with a HA-epitope tagged Net1A expression
plasmid (4 mg/well). Twenty-four hours after transfection, the cells were
left untreated (indicated as CTR), or: i) irradiated (20 Gy), and incubated
for the indicated time; ii) exposed to CDT (2 mg ml21) for 12h. The HA-
Net1A protein was immunoprecipitated using an a-HA antibody, and
the levels of Net1 phosphorylated on Ser152 (pS152-HA-Net1) were
assessed as in Figure 1A. The same membrane was re-probed with an a-
HA antibody (GA-Net1). The fold increase represents the ratio between
the levels of pS152-Net1 in treated cells and the levels of pS152-Net1 in
untreated cells (mean6SD of three independent experiments).
doi:10.1371/journal.pone.0002254.g001
DNA Damage Activates Net1
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Figure 2. Net1 knock down prevents RhoA activation upon induction of DNA damage. HeLa cells were transfected with plasmids
expressing the control or Net1 specific shRNAs (panel A), or control or Net1 specific siRNA (panel B). Expression of the endogenous Net1 was
analysed by western blot 96h (A) or 72h (B) after transfection. Percentage inhibition was calculated as (1- residual Net1)6100, where residual Net1 is
defined as the ratio between the optical density of the Net1 specific band in cells transfected with the Net1 iRNA or control iRNA and the optical
density of the Net1 specific band in the non-transfected cells. C) HeLa cells, transfected with control or Net1 specific shRNA or shRNA, were left
untreated, or exposed to IR (20 Gy), CDT (2 mg ml21), or CNF-1 (1 mg ml21), respectively, and further incubated for 4h. Activation of RhoA was
assessed by RhoA specific G-LISATM (mean 6SD of 5 independent experiments for IR and CNF, mean6SD of 3 independent experiments for CDT).
Since the effects of transfection with specific Net1 shRNA or siRNA were similar, the data from all these experiments have been summarized together
and indicated as iRNA. The fold increase represents the ratio between the levels of GTP-bound RhoA in treated cells and the levels of GTP-bound
RhoA in untreated cells. According to the paired t test, the reduced RhoA activation in irradiated or intoxicated cells transfected with Net1 iRNA is
statistically significant, while the effect of iRNA on the CNF1-induced RhoA activation is not statistically significant. D) HeLa cells non-transfected or
transfected with control or Net1 specific siRNA were exposed to CNF1 (1 mg ml21) for 6h. The actin cytoskeleton was visualized by TRITC-phalloidin
staining. The values represent the percentage of cells with stress fibers. Cells exhibiting more than 5 stress fibers were scored as positive.
doi:10.1371/journal.pone.0002254.g002
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or cells transfected with non-silencing siRNA or shRNA. In
contrast, knock down of endogenous Net1 expression prior to
intoxication resulted in significant reduction in the number of cells
presenting actin stress fibers (Figures 3A and 3B). This effect was
quantified by measuring the intensity of the phalloidin staining
using the ImageJ software. A significant decrease in the intensity of
fluorescence induced by intoxication was demonstrated in the
Net1 RNAi treated cells as compared to controls (Figure 3C).
Net1 regulates cell survival in response to DNA damage
Activation of RhoA promotes the survival of cells exposed to
CDT [6]. In order to investigate whether Net1 is required for this
RhoA mediated response, Net1 expression was inhibited by RNAi
prior to intoxication and cell death was assessed by monitoring
chromatin condensation. Down-regulation of Net1 resulted in a 4-
to 5-fold increase in the number of cells presenting chromatin
condensation 48h after intoxication (Figure 4A). Similar results
were obtained in cells expressing the dominant negative Net1DDH
(data not shown). Induction of cell death upon Net1 knock down
was confirmed by cleavage of the caspase-3 substrate PARP, as
detected by western-blot analysis (Figure 4B), and activation of the
pro-apoptotic protein Bax, as detected by immunostaining using
the conformation-dependent antibody 6A7 (Figures 4C and 4D).
The effect was already observed after 24h and became highly
significant within 48h of treatment. The late occurrence of CDT-
induced cell death observed upon Net1 knock down was similar to
that observed in cells expressing a dominant negative RhoA
(RhoAN19) [6]. These results indicate that Net1 is an essential
component in the survival response to DNA damage.
Net1/RhoA-dependent activation of p38 MAPK is
required for cell survival in intoxicated or irradiated cells
DNA damage was shown to induce activation of p38 MAPK
[17]. We therefore tested whether exposure of HeLa cells to CDT
or IR stimulates p38 MAPK activity, and whether this is required
for protection from cell death. Both CDT intoxication and
irradiation induced activation of p38 MAPK within 3h after
treatment and this effect was maintained for at least 24h, as
assessed by western blot using a p38 MAPK phospho-specific
antibody (p-p38) (Figure 5A). The kinetics of p38 MAPK
phosphorylation is in line with the previously reported kinetics of
RhoA activation, which peaks at 4h after exposure to CDT or IR
Figure 3. Net1 knock down prevents actin stress fiber formation upon intoxication. A) HeLa cells non-transfected, or transfected with
control or Net1 specific shRNA or siRNA, were left untreated or treated with CDT (2 mg ml21) for 24h. The actin cytoskeleton was visualized by TRITC-
phalloidin staining (red). B) Quantification of cells with actin stress fibers (mean6SD of 5 independent experiments: three performed with shRNA and
two performed with siRNA). One hundred and fifty cells were counted for each experiment. Cells carrying more than 5 stress fibers were scored as
positive. C) The fluorescence intensity per each cell was quantified using the ImageJ software. Data are presented as ratio between the mean
fluorescence intensity and the cell area. iRNA is defined as in Figure 2B.
doi:10.1371/journal.pone.0002254.g003
DNA Damage Activates Net1
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[6]. To determine whether p38 MAPK activation is important for
cell survival, the cells were treated with the p38 MAPK specific
inhibitors SB203580 or SB202190 (20 mM) prior to irradiation or
intoxication. Inhibition of p38 MAPK was associated with a 2- to
4-fold increase in the number of cells exhibiting chromatin
condensation 48h after treatment (Figure 5B and data not shown).
The increased rate of cell death was confirmed by monitoring
activation and increased expression of Bax (Figures 5C and 5D).
Activation of p38 MAPK in response to DNA damage was also
observed in the colorectal carcinoma cell line HCT116 upon
irradiation (Figure 6A). As in HeLa cells, pre-treatment of
HCT116 cells with SB203580 prior to irradiation was associated
with increased activation of Bax (Figure 6B). Quantification of the
Bax positive cells in this set of experiments was hampered by the
low number of cells that survived irradiation upon pre-treatment
with SB203580 (Figure 6C). These results indicate that activation
of p38 MAPK protects the cells from death induced by DNA
damage.
To assess whether the activation of p38 MAPK was dependent
on RhoA and its regulator Net1, the levels of irradiation-induced
phosphorylation were assessed in cells where the expression of the
two proteins was independently knocked down by RNAi.
Transfection with two independent RhoA specific siRNA
oligonucleotides consistently induced a 70 to 80 percent reduction
of the endogenous levels of RhoA (Figure 7A), and this effect was
associated with a strong inhibition of p38 MAPK activation in
response to IR and CDT (Figures 7B and 7C). Similar levels of
inhibition were obtained by blocking RhoA activity using the cell
Figure 4. Net1 knock down increases the rate of cell death upon induction of DNA damage. HeLa cells were transfected with control or
Net1 specific shRNA or siRNA and exposed to CDT (2 mg ml21) for 48h. Cell death was assessed by quantifying the percentage of cells presenting
chromatin condensation by Hoechst 33258 staining (panel A), detection of the cleaved form of PARP (PARP*) by western-blot (panel B) and detection
of activated Bax, using the anti-Bax 6A7 antibody (red; panel C). D) Quantification of the Bax positive cells (mean6SD of 5 independent experiments:
three performed with siRNA and two performed with shRNA). iRNA is defined as in Figure 2B. According to the t test, the increased number of cells
expressing the activated form of Bax upon transfection with Net1 specific iRNA is statistically significant both at 24h and 48h after intoxication.
doi:10.1371/journal.pone.0002254.g004
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Figure 5. p38 MAPK regulates cell survival in response to DNA damage. A) HeLa cells were: i) left untreated; ii) exposed to CDT (2 mg ml21)
for the indicated time periods; iii) irradiated (20 Gy) and further incubated in complete medium for the indicated time periods. Samples were
subjected to western blot analysis using a a-p38 antibody (p38*) or a p38 phospho-specific antibody (p-p38). B) HeLa cells, pre-treated with the
specific p38 MAPK inhibitor SB203580 (20 mM) in complete medium for 30 min, were left untreated, or irradiated (20 Gy) and further incubated for
48h. Cell death was assessed by quantifying the number of cells presenting chromatin condensation by Hoechst 33258 staining. C) HeLa cells were
treated as described in Figure 5B, and the activated form of Bax was detected by indirect immunofluorescence using the anti-Bax 6A7 antibody
(upper panel). Nuclei were counterstained with Hoechst 33258 (lower panel). As a positive control for Bax staining the cells were treated with 50 ng/
ml TNFa and 100 mg/ml cyclohexmide in complete medium for 6h at 37uC. D) HeLa cells, pre-treated with the specific p38 MAPK inhibitor SB203580
(20 mM) in complete medium for 30 min, were left untreated, treated with CDT (2 mg ml21) for 48h, or irradiated (20 Gy) and further incubated for
48h. Expression of Bax was detected by western blot analysis using antibodies specific for Bax or actin. Fold increase represents the ratio between the
optical density of the Bax specific band in treated cells and optical density of the Bax specific band in the untreated cells.
doi:10.1371/journal.pone.0002254.g005
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permeable inhibitor C3 transferase (data not shown). Knock down
of endogenous Net1 expression, by either siRNA or shRNA,
resulted in an equally potent inhibition of p38 MAPK activation in
irradiated cells (Figures 8A and 8B). These results indicate that
Net1 and RhoA are upstream signals in the p38 MAPK activation
cascade in response to DNA damage.
To determine whether the RhoA activated kinases ROCKI and
ROCK II are required for p38 MAPK activation, HeLa cells were
treated with the ROCKI/II inhibitors H-1152 or Y27632 prior to
irradiation. As expected, pre-treatment of control HeLa cells with
both inhibitors altered the organization of the actin cytoskeleton
and prevented the formation of actin stress fibers upon irradiation
(Figure 9A), confirming that these effectors were efficiently
blocked. However, the treatment did not impair the activation
of p38 MAPK (Figure 9B), indicating that ROCKI/II were not
required for signalling to this kinase.
The MAPK-activated protein kinase 2 (MK2) is a direct
substrate of the p38 MAPK a-and b-isoforms [18]. We asked
Figure 6. DNA damage activates p38 MAPK in HCT116 cells. A) HCT116 cells were left untreated or irradiated (20 Gy) and further incubated in
complete medium for 3h. Samples were subjected to western blot analysis as described in Figure 5A. B) HCT116 cells, pre-treated with the specific
p38 MAPK inhibitor SB203580 (20 mM) in complete medium for 30 min, were left untreated or irradiated (20 Gy) and further incubated for 48h. Cell
death was assessed by detection of activated Bax, using the anti-Bax 6A7 antibody (upper panel). Nuclei were counterstained with Hoechst 33258
(lower panel). C) HCT116 cells, pre-treated with the specific p38 MAPK inhibitor SB203580 (20 mM) in complete medium for 30 min, were irradiated
(20 Gy) and further incubated for 48h. Cells were visualized by contrast phase microscopy.
doi:10.1371/journal.pone.0002254.g006
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therefore whether this protein is also activated in a Net1- and
RhoA-dependent manner upon induction of DNA damage. As
illustrated in Figure 10, a 2- to 4-fold increase in the
phosphorylation of MK2 on its activating site Thr334 (p-MK2)
was observed in HeLa cells 4h after irradiation or intoxication
(Figure 10A), and a similar effect was observed in irradiated
HCT116 cells (Figure 10B). As expected, this effect was prevented
by pre-treatment with the p38 MAPK specific inhibitor SB203580
(Figure 10A). Importantly, the phosphorylation of MK2 following
irradiation was abrogated by knock down of either Net1 or RhoA,
indicating that these proteins are required for MK2 activation
(Figures 10C and 10D).
Discussion
The transforming ability of a truncated form of Net1 described
by Chen et al. [12] suggests that this protein may be involved in
regulating the delicate balance between cell growth and cell death.
This possibility is substantiated by our finding that Net1 regulates
the activation of RhoA and p38 MAPK, and promotes cell
survival in response to genotoxic agents. Furthermore, our data
identify genotoxic stress as a trigger for Net1 activation and
contribute to the characterization of a novel DNA damage-
induced survival pathway involving Net1 and its downstream
targets RhoA and p38 MAPK.
Net1 is activated and regulates RhoA-dependent actin
stress fiber formation upon induction of DNA damage
Alberts et al. have previously shown that phosphorylation of Net1
on Ser152 prevents RhoA activation and concluded therefore that
pSer152 inhibits the GEF activity of Net1 [15]. We now show that
exposure to CDT or IR decreases the levels of pSer152
phosphorylation of the endogenous as well as an ectopically
expressed Net1 (Figure 1), thus identifying genotoxic stress as a
signal for Net1 activation in vivo. The mechanisms involved in Net1
de-phosphorylation remain unknown. A constitutively active form of
the Rac1-activated protein kinase PAK1 (PAK1*) was identified as
the Ser152-specific Net1 kinase in vitro, and expression of PAK1*
prevented Net1-induced stress fiber formation in Swiss 3T3 cells
[15]. We did not observe any significant change in the level of Rac1
or Cdc42 activation in HeLa cells or primary fibroblasts exposed to
CDT or IR [6], and PAK1 activity was not changed within 30 min
after irradiation, a time when the dephosphorylation of pS152-Net1
was maximal (data not shown). This suggests that the decrease in
pSer152-Net1 observed in our experiments does not involve
inactivation of PAK1. Conceivably, a different, as yet unknown
Net1 specific kinase may be down-regulated. Alternatively, exposure
to CDT or IR may enhance the rate of p-S152-Net1 de-
phosphorylation by activation of a phosphatase.
Inhibition of endogenous Net1 by RNAi and expression of a
dominant negative Net1 demonstrated that this GEF is required
for RhoA activation and for the subsequent re-organization of the
actin cytoskeleton in response to intoxication or irradiation
(Figures 2 and 3). It is noteworthy that stress fiber formation
is detected in epithelial cells that are arrested in G1 following
treatment with TGF-b [19–21], and similar changes occur in cells
exposed to bacterial toxins that inhibit, Cycle inhibiting factor (Cif)
[22], or promote, Pasteurella multocida toxin (PMT) [23], cell cycle
progression. Net1 is a major player in the morphological changes
that characterize both TGF-b [21] and DNA damage (in this
work). It is thereby tempting to speculate that Net1-regulated
cytoskeleton rearrangements may be a common feature of the
response to stress signals that deregulate the cell cycle.
Net1/RhoA-dependent survival signals
Our RNAi experiments demonstrate that Net1 and RhoA are
critical for protecting intoxicated and irradiated cells from cell
death induced by DNA damage (Figure 4), and identify p38
MAPK as a key mediator in the delivery of the survival signals
(Figures 5 to 9). The mechanism by which RhoA controls p38
MAPK phosphorylation remains still unclear. Marinissen at al.
demonstrated that RhoA stimulates c-jun expression via activation
of the p38c MAPK isoform, resulting in aberrant cell growth and
malignant transformation [24]. Interestingly, we have found that
Figure 7. DNA damage-induced p38 phosphorylation is RhoA-
dependent. A) HeLa cells were transfected with the control siRNA or
two independent RhoA specific siRNA (siRNA1: Hs_RHOA_6; siRNA2:
Hs_RHOA_7). Expression of the endogenous RhoA levels was analysed
by western blot. Percentage inhibition was calculated as in Figure 2A.
B) Untransfected HeLa cells or cells transfected with control siRNA, or
two independent RhoA specific siRNA were left untreated or irradiated
(20 Gy), and further incubated for 4h in complete medium. p38
phosphorylation was assessed as in Figure 5A. p-p38 ratio represents
the ratio between the optical density of the phospho-p38 band in
treated cells and optical density of the phospho-p38 band in the
untreated cells. C) Quantification of the changes in the levels of p38
phosphorylation in HeLa cells transfected with control siRNA, RhoA
specific siRNA1 or siRNA2. Mean6SD of 6 independent experiments
performed with cells exposed to IR (left panel), and 3 independent
experiments performed cells exposed to CDT (right panel) cells. p-p38
ratio is defined as in Figure 7B.
doi:10.1371/journal.pone.0002254.g007
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the activation of p38 MAPK in response to DNA damage was
abrogated by SB203580 and SB202190 that are specific inhibitors
for the a- and b-isoforms of p38 MAPK [25], suggesting that
different isoforms may be targeted by RhoA depending on the
triggering stimulus. A large number of effector proteins mediate
signalling downstream of RhoA [26]. Since the RhoA activated
kinases ROCKI and ROCKII regulate many of the cytoskeletal
effects of RhoA, we examined whether they transduced the signal
from RhoA to p38 MAPK. Interestingly, pre-treatment with
pharmacological inhibitors of ROCK did not prevent p38 MAPK
activation, but inhibited stress fiber formation (Figure 9),
suggesting that RhoA may utilize different sets of effector proteins
to control these cellular responses. This is likely to require the
selective clustering of the downstream effectors on distinct scaffold
proteins, as suggested by the finding that the RhoA-dependent
activation of JNK involves the association of Net1 and the JNK
activators MLK2, MLK3 and MKK7 with the scaffold protein
CNK1, while this is not required for induction of stress fibers [27].
The current literature identifies JNK as the main MAPK induced
by irradiation [17]. Consistent with our previous results showing that
CDT or IR do not activate the JNK regulators Rac and Cdc42 [6],
we detected only low levels of JNK phosphorylation and AP1
activation 4h and 12h after intoxication in HeLa cells (data not
shown). In contrast, up to 10 fold increase of p38 MAPK
phosphorylation was consistently observed both in HeLa and
HCT116 cells (Figures 5 and 6). This result is not surprising
since, depending on the experimental models, p38 MAPK was
shown to contribute to either survival or death signals in response to
DNA damage [17]. The downstream signals involved in the survival
response remain unclear. Reinhardt at al. recently showed that the
survival in p53-deficient fibroblasts exposed to cisplatin and
doxorubicin is enhanced by ATM-dependent activation of p38
MAPK and its downstream effector MK2 [28]. This pathway has
been defined as the third cell cycle-dependent checkpoint, in
addition to the well-characterized ATM/Chk2 and ATR/Chk1
responses [28]. Our findings demonstrate that these signals operate
also in tumor cells, such as HeLa and HCT116, since blockage of
p38 MAPK activation by specific inhibitor abrogates their capacity
to survive irradiation or intoxication (Figures 5 and 6).
Furthermore, we have identified Net1 and RhoA as key molecules
controlling the activation of this novel checkpoint pathway
(Figures 7 and 8). A schematic illustration of the Net1-regulated
signal cascade identified in this work is shown in Figure 11.
Conclusions
Any event capable of promoting the survival of cell with
damaged DNA is detrimental since it would favour tumor
initiation and/or progression (reviewed in [29,30]). Our finding
that induction of DNA damage by CDT is accompanied by the
concomitant activation of survival signals suggests that chronic
infection with CDT producing bacteria may promote genomic
instability and favour malignant transformation. The association
between bacterial infections and cancer is poorly understood. The
only bacterium classified as human carcinogen is Helicobacter pylori,
but a possible involvement in oncogenesis has been suggested for
other bacteria, such as for example the Gram-negative bacterium
Salmonella typhi [31]. Indeed, several Gram-negative bacteria have
been shown to produce DNA damaging toxins [32,33]. The work
Figure 8. DNA damage-induced p38 phosphorylation is Net1-dependent. A) Untransfected HeLa cells or cells transfected with either the
Net1 specific siRNA (left panel) or shRNA (right panel), or the relevant controls were left untreated or irradiated (20 Gy), and further incubated for 4h
in complete medium. p38 phosphorylation was assessed as in Figure 5A. B) Quantification of the changes in the levels of p38 phosphorylation in
irradiated HeLa cells transfected with control or Net1 specific iRNA. iRNA is defined as in Figure 2B. Mean6SD of 6 independent experiments (three
performed with siRNA, and three performed with shRNA).
doi:10.1371/journal.pone.0002254.g008
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described in this paper provides the first molecular characteriza-
tion of a survival pathway triggered by CDT intoxication. Further
dissection of this pathway will provide new tools to elucidate the
mechanisms of bacterial-induced carcinogenesis, and may also
help to design specific inhibitors that can act synergistically with
conventional chemotherapy.
Materials and Methods
Cell lines and plasmids
HeLa and HCT116 cell lines were obtained from the ATCC
and grown as described [6]. The plasmid expressing the c-Myc
epitope-tagged Net1DDH was a kind gift from Drs. A. Hall and A.
Schmidt (Medical Research Council Laboratory for Molecular
Cell Biology, University College London, London, UK). The
plasmid expressing the Net1A protein was previously described
[16].
CDT and treatments
Production of the H. ducreyi CdtA, CdtB and CdtC subunits and
reconstitution of the active holotoxin (here named as CDT) was
previously described [6,34].
CDT intoxication. Cells were incubated for the indicated
time periods with CDT (2 mg ml21) in complete medium.
Ionizing radiation. Cells were irradiated (20 Gy), washed
once with PBS and incubated for the indicated time periods in
complete medium.
SB203580/SB202190 treatment. Cells were pre-treated
with the p38 MAPK specific inhibitors SB203580 or SB202190
(20 mM) (Calbiochem) in complete medium for 30 min at 37uC,
before exposure to CDT or IR.
ROCK inhibitors. Cells were pre-treated with the ROCK
inhibitors H-1152 and Y27632 (10 mM) (Calbiochem) in complete
medium for 1h at 37uC, before exposure to CDT or IR, and then
further incubated in the presence of the inhibitor for the indicated
periods of time.
Immunofluorescence
Phalloidin staining. Phalloidin staining of actin filaments
was performed as previously described [6].
Bax 6A7 staining. Cells were fixed with 4% paraformaldehyde,
and permeabilized with 0.2% Triton X-100 for 2 min at 22uC.
Antibody non-specific binding was blocked with 3% BSA in PBS
for 30 min at 22uC. Slides were further incubated for 1h at 22uC
with the conformation-specific monoclonal antibody (6A7, BD
Pharmingen), which recognizes the activated form of Bax. Slides
were washed three times with PBS and then incubated with TRITC-
conjugated rabbit anti-mouse antibody (DAKO; diluted 1:100 in
Figure 9. ROCK inhibitors do not prevent DNA damage-induced p38 MAPK phosphorylation. A) HeLa cells, were left untreated or pre-
treated with the specific ROCK inhibitors H-1152 or Y27632 (10 mM) in complete medium for 1h prior to irradiation (20 Gy), and further incubated in
the presence or absence of the inhibitor for 12h. The actin cytoskeleton was visualized by FITC-phalloidin staining (green). B) HeLa cells, pre-treated
with the specific ROCK inhibitors H-1152 or Y27632 (10 mM) in complete medium for 1h, were left untreated or exposed to IR (20Gy), and further
incubated in the presence or absence of the inhibitors for the indicated periods of time. p38 MAPK phosphorylation was assessed as in Figure 5A.
doi:10.1371/journal.pone.0002254.g009
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PBS) for 30 min at 22uC. Nuclei were counterstained with Hoechst
33258 (Sigma; 0.5 mg ml21).
iRNA
Net1 shRNA. The following oligonucleotides were used for
production of Net1 specific shRNAs:
shRNA-A (target nucleotides: 312–332):
5 9 -TCTCAATCTCTCCTGTAAGAAATGGACAC-
CATTTCTTACAGGAGAGATTCT-39
59-CTGCAGAATCTCTCCTGTAAGAAATGGTCTC-
CATTTCTTACAGGAGAGATT-39
shRNA-B (targets nucleotides: 615–635):
59-TCTCAAAGTTGTCCATCATGTCAGAACATCTGA-
CATGATGGACAACTTCT-39
59-CTGCAGAAAGTTGTCCATCATGTCAGATGTTCT-
GACATGATGGACAACTTT-39
shRNA-C (targets nucleotides: 819–837):
59-TCTCCAAAGCTCTTCTTGATCAATTCAAGAGATT-
GATCAAGAAGAGCTTTGCT-39
59-CTGCAGCAAGCTCTTCTTGATCAATCTCTT-
GAATTGATCGSTCAAGAAGAGCTTTG-39
Non targeting shRNA (scrambled sequence from Dlg1):
59-TCTCGAGAATGCGAGGTCAAGTTCTTCCTGT-
CAAACTTGACCTCGCATTCTCCT-39
59-CTGCAGGAGAATGCGAGGTCAAGTTTGACAG-
GAACAACTTGACCTCGCATTCTC-39
Figure 10. The p38 MAPK effector MK2 is phosphorylated in a Net1- and RhoA-dependent manner in response to genotoxic agents.
A) Untreated HeLa cells, or cells pre-treated with the specific p38 MAPK inhibitor SB203580 (20 mM) in complete medium for 30 min, were exposed to
CDT (2 mg ml21) for 4h, or irradiated (20 Gy) and further incubated in complete medium for 4h. Samples were subjected to western blot analysis
using antibodies specific for phospho-MK2 (p-MK2) or actin. B) HCT116 cells were left untreated or irradiated (20 Gy) and further incubated in
complete medium for 3h. Samples were subjected to western blot analysis as described in Figure 10A. C) HeLa cells transfected with: i) control siRNA;
ii) Net1 specific siRNA (left panel); iii) the RhoA specific siRNA1 (right panel) were left untreated or irradiated (20 Gy), and further incubated for 4h in
complete medium. MK2 phosphorylation was assessed as in Figure 10A. p-MK2 ratio represents the ratio between the optical density of the phospho-
MK2 band in irradiated cells and optical density of the phospho-MK2 band in the untreated cells. D) Quantification of the changes in the levels of
MK2 phosphorylation in irradiated HeLa cells: mean of 3 independent experiments performed with the Net1 specific siRNA (left panel) and 2
independent experiment performed with the RhoA specific siRNA (right panel).
doi:10.1371/journal.pone.0002254.g010
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The oligonucleotides were annealed and ligated into the
pGENECLIP-puromycin vector (Promega) according to the
manufacturer’s instructions.
Efficient down-regulation of the endogenous Net1 levels
required co-transfection with the three Net1 specific shRNA
expressing plasmids.
siRNA. The Net1 specific siRNA (HP validated 1027400), two
RhoA specific siRNAs (Hs_RHOA_6 HP validated SI02654211,
and Hs_RHOA_7 HP validated SI02654267), and the Alexa Fluor
488-labelled control siRNA (AATTCTCCGAACGTGTCACGT,
1022076) were purchased from Qiagen.
Transfection
HA-Net1A. Two hundred thousand and one hundred
thousand HeLa cells per well were grown in 12-well plates, or
24-well plates, respectively in complete medium. Transfections
were performed with the indicated amount of the relevant plasmid
using the Lipofectamine 2000 Reagent (Life Technologies),
according to the manufacturer’s instructions. Twenty-four hours
after transfection, cells were either intoxicated or irradiated and
incubated for the indicated time periods.
shRNA. One million Hela cells were grown in 6 cm diameter
Petri dishes in complete medium, and transfected with the
indicated shRNA plasmids (2 mg ml21) using the Lipofectamine
2000 Reagent. Twenty-four hours after transfection, complete
medium supplemented with puromycin (10 mg ml21) was added
and cells were further incubated for 72h.
siRNA. One hundred thousand HeLa cells were grown in 12-
well plate in complete medium. Transfection was performed with
75 ng/well of the indicated siRNA with HiPerFect Reagent
(Qiagen), according to the manufacturer’s instructions, and cells
were further incubated for 72h.
RhoA activation
RhoA activation was assessed by the G-LISATM RhoA
Activation Assay Biochem KitTM (Cytoskeleton) according to the
manufacturer’s instructions.
Immunoprecipitation
Immunoprecipitations were performed as previously described
[15]. The endogenous Net1 protein was immunoprecipitated using
a goat a-Net1 specific antibody (Abcam).
Western blot analysis
The following antibodies were used: a-HA, a-Bax (B-9) (Santa
Cruz Biotechnology), a-phospho-Net1-Ser152 [15], a-Net1 spe-
cific rabbit serum, a-Net1 goat serum (Abcam), a-actin (Sigma), a-
phospho-p38, a-p38, a-phospho-MK2 (Thr334), a-RhoA (Cell
Signaling), and a-PARP (BD Biosciences). Blots were developed
with enhanced chemiluminescence, using the appropriate horse-
radish peroxidase-labelled secondary antibody, according to the
instructions of the manufacturer (GE Healthcare).
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Abstract 
Several human pathogenic Gram-negative bacteria produce a DNA damaging toxin: the 
cytolethal distending toxin (CDT). Since incorrectly repaired DNA can result in 
carcinogenesis, insight into how intoxicated cells can survive may help to understand the 
carcinogenic potential of chronic infections with CDT-producing bacteria. 
 
Activation of the actin regulating protein RhoA and phosphorylation of the downstream 
Mitogen-Activated Protein Kinase (MAPK) p38 following CDT-induced DNA damage is 
important to prolong cell survival. The details of this signaling pathway are still 
unknown. To identify novel CDT-induced survival signals, we screened a Saccharomyces 
cerevisiae deletion library. A total of 4492 mutants, carrying deletions in nonessential 
genes, were transformed with an inducible CdtB expression vector and screened for 
delayed growth, which is indicative of defective survival. 
The screening identified 78 genes whose deletion confers hypersensitivity to CdtB 
expression, and 73% of those shared homology with human genes. Systems biology 
analysis demonstrated that 20 of the proteins encoded by the human orthologs are 
involved in the regulation of the actin cytoskeleton in higher eukaryotes. We focused our 
analysis on TSG101 (yeast ortholog VPS23), FEN1 (yeast ortholog RAD27) and vinculin 
(VCL), and demonstrated that they are all required to induce actin stress fibers formation 
in response to DNA damage. FEN1 and VCL also regulated the RhoA-dependent p38 
MAPK phosphorylation, and delayed cell death in response to CDT intoxication. Our 
data highlight a complex and still poorly characterized cross-talk between DNA damage 
and actin cytoskeleton in the regulation of cell survival to genotoxic stresses. 
 3 
Introduction 
The cytolethal distending toxins (CDTs) are produced by a variety of Gram negative 
bacteria, such as Escherichia coli, Actinobacillus actinomycetemcomitans, Haemophilus 
ducreyi, Shigella dysenteriae, Campylobacter sp. and Helicobacter sp, and Salmonella 
enterica (reviewed in [1]). 
The active holotoxin is a tripartite complex [2,3], formed by the CdtA, CdtB and CdtC 
subunits. The CdtB component is the active subunit, that shares structural and functional 
homology with mammalian deoxyribonuclease I (DNase I) [4,5,6]. The CdtA and CdtC 
subunits are ricin-like lectin domains [6], involved in cellular internalization of the toxin 
[7,8,9]. 
 
CDT induction of DNA double strand breaks (DSBs) was demonstrated in naturally 
intoxicated mammalian cells by pulsed field gel electrophoresis (PFGE) [10], in 
agreement with the data reported by Hassane and co-workers who previously observed 
DSBs in Saccharomyces cerevisiae cells transfected with the active CdtB subunit [11]. In 
both cases, mutations within the DNase conserved motives prevented induction of DNA 
DSBs.  
The cellular effects of CDT intoxication are identical to those induced by exposure to 
ionizing radiation (IR), a well-characterized DNA-damaging agent. Both CDT and IR 
stimulate the phosphorylation of histone H2AX and relocalisation of the DNA repair 
complex Mre11 ([12,13]. In addition, cell cycle checkpoints are activated in a cell type 
dependent manner. For example, human primary fibroblasts are arrested in the G1 and 
G2 phases of the cell cycle, while HeLa cells are arrested in G2 upon intoxication 
[13,14]. 
In adherent cells, irradiation or CDT intoxication is associated with formation of actin 
stress fibers [15,16]. This effect is regulated by activation of the small GTPase RhoA, 
which is dependent on the DNA damage sensor kinase ataxia-telangiectasia mutated 
protein (ATM). Inhibition of RhoA function in intoxicated cells leads to an increased rate 
of cell death [10]. Activation of RhoA and actin stress fiber formation in response to 
CDT is dependent on the RhoA-specific Guanine nucleotide Exchange Factor (GEF) 
Net1. 
The DNA-damage-dependent Net1/RhoA signalling diverges into two different effector 
cascades: one dependent on the RhoA kinases ROCKI and ROCKII, which controls 
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formation of actin stress fibers; and one regulated by the Mitogen-Activated Protein 
Kinase (MAPK) p38 and its downstream target MAPK-activated protein kinase 2, which 
promotes cell survival [17]. 
 
Survival of cells with damaged DNA is detrimental since it may favor tumor initiation 
and/or progression (reviewed in [18,19]. Characterization of the survival signals activated 
in response to CDT intoxication are therefore indispensable to elucidate the exact 
mechanisms by which bacterial infections can contribute to carcinogenesis. To identify 
novel CDT-induced survival signals, we have screened a yeast deletion library, 
expressing the CdtB active subunit under the galactose promoter.  
The screening identified 78 deletion mutants with reduced growth rate upon induction of  
CdtB expression. Systems biology analysis demonstrated that 20 human orthologs of 
these 78 genes are involved in the regulation of the actin cytoskeleton. Further studies on 
mammalian cells showed that TSG101, FEN1 and Vinculin (VCL) are important to 
induce RhoA activation and actin stress fibers formation in response to DNA double 
strand breaks. We further identified FEN1 and VCL as two effectors regulating p38 
MAPK phosphorylation, and ultimately cell survival in response to CDT intoxication. 
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Material and Methods 
 
Cell line 
HeLa cell lines were obtained from ATCC and were cultivated in RPMI 1640 medium 
supplemented with 10% fetal calf serum (FCS), 5mM L-glutamine, penicillin (100 
units/ml) and streptomycin (100µg/ml) (complete medium) in a humid atmosphere 
containing 5% CO2. 
 
Yeast strains and plasmids 
The complete EUROpean Saccharomyces cerevisiae ARchive for Functional analysis 
(EUROSCARF) library, purchased from Open Biosystems, Thermo Scientific, consists of 
diploid mutants that are homozygous in deletions of non-essential genes [20]. The CdtB 
and the control plasmids were previously described [11]. 
The library and the control BY4743 strain (MATa/MATα, his3Δ1/his3Δ1, 
leu2Δ/leu2Δmet15Δ0/MET15, LYS2/lys2Δ0, ura3Δ0/ura3Δ0) were transformed with the 
pDCH-CdtB [11] or vector control plasmids. Dropout synthetic medium was prepared 
according to the manufacturer’s instructions (Clontech). Transformants were selected and 
maintained in synthetic dropout medium without leucine (selective medium) 
supplemented with 2% glucose. For induction of CdtB expression, cells were grown in 
selective medium supplemented with 2% galactose and 2% raffinose. 
 
Yeast transformation 
Systematic yeast transformation experiments were performed using the S. cerevisiae 
direct transformation in 96-well format, previously described in [21] with minor 
modifications. Yeast deletion strains were grown on yeast extract/peptone/glucose 
(YPGluc) square plates (12cmx12cm, Greiner Bio-one) for 48h at 30°C. Twenty-five 
microliters of the transformation solution (27% PEG600, 200mM Litium Acetate, 50mM 
DTT, Carrier DNA 5µg/µl, and 15µg of the pDCH-CdtB or control plasmids) were added 
in 96-well plates and the yeast deletions strains were transferred using a 48-pin replicator, 
mixed well and incubated for 2h at 42°C. After mixing, 10µl aliquots of the mixture were 
transferred on plates of synthetic dropout selective medium containing 2% glucose using 
a multi-channel pipette. Plates were let to dry at 22°C and incubated for 4 days at 30°C. 
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Screening and characterization of CdtB hypersensitive strains 
For the first round of selection, transformants were picked, transferred to 100µl of sterile 
H2O in 96-well plates and spotted onto square plates containing selective medium 
supplemented with 2% glucose (CdtB OFF) or 2% raffinose and 2% galactose (CdtB 
ON) using a 48-pin replicator and incubated for 48h at 30°C. Clones that grew equally in 
glucose or galactose/raffinose were considered non hypersensitive to CdtB and not 
further screened. 
For the subsequent experiments, the deletion mutants were transferred to 100µl sterile 
H2O in 96-well plates, and diluted to a value of optical density at 600nm (OD600) of 1. 
Three microliters of five-fold dilution series were transferred onto 10cm diameter round 
plates containing selective medium supplemented with 2% glucose (CdtB OFF) or 2% 
raffinose/galactose (CdtB ON) using a 48-pin replicator and incubated at 30°C for 48h. 
Yeast strains that did not grow after the third dilution step in raffinose/galactose were 
considered as CdtB hypersensitive. 
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Survival assay 
Clones transformed with the pDCH-CdtB or control plasmids were incubated for 24h in 
medium containing 2% raffinose. Cell were diluted to OD600 of 0.3, and transferred to 
3ml selective medium containing 2% raffinose and 2% galactose (CdtB ON), and 
incubated at 30°C. One thousand cells were collected at time 0h and 48h and plated on 
glucose selective plates (CdtB OFF). Colony forming units (CFUs) were counted after 
48h incubation at 30°C. 
 
Flow cytometer analysis 
Cells were centrifuged and the cell pellet was resuspended and fixed with 1ml 70% 
ethanol at 4°C for at least 24h. After an additional centrifugation, cells were resuspended 
in 0.8ml RNase solution (50mM Tris HCl, pH 7.8, 20µg/ml RNase) and incubated over 
night at 37°C. Samples were centrifuged and resuspended in 0.5ml PI solution (200mM 
Tris HCl pH 7.5, 211mM NaCl, 78mM MgCl2, 25µg/ml propidium iodide), and sonicated 
for 5 seconds at medium voltage. Thirty microliters of cell suspension were mixed in a 
tube together with 0.6 ml 50mM TrisHCl pH 7.5. Samples were analyzed with a FACS 
Calibure flow cytometer. Data from 30,000 cells were collected and analyzed using the 
CellQuest software. 
 
Search for human orthologs 
The human orthologs of yeast genes were identified using the Inparanoid database [22], 
BLAST sequence alignment against all human protein sequences and literature search. 
 8 
Mapping the actin cytoskeleteon network 
The 217 proteins that regulate the actin cytoskeleton re-arrangements were downloaded 
from the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway database (KEGG 
ID: hsa04810) [23]. The protein-protein interaction network (defined henceforth as the 
actin-network) was then generated using the search tool for the retrieval of interacting 
genes/proteins (STRING) database [24]. The STRING database contains both 
experimentally validated and computationally predicted interaction data from different 
resources. For this analysis, we considered only experimentally reported interactions. 
Data from the STRING database were further used to add proteins shown experimentally 
to interact directly with any component of the actin-network. The Cytoscape software 
[25] was used to generate the extended network depicted in Figure 2A. 
 
CDT and treatments 
Production of the H. ducreyi CdtB was previously described [10]. The His-tagged CdtA 
and CdtC were constructed by PCR amplification of the H. ducreyi cdtA and cdtC genes 
from the pAF-tac1cdtA and pAF-tac1cdtC plasmids, respectively [26] using the following 
primers: 
CdtA_F 5´- ATTCGGATCCATGTTCATCAAATCAACGAATGA-3 
CdtA_R 5’-TACCGAATTCTTAATTAACCGCTGTTGCTTCTAAT-3’ 
 
CdtC_F 5´- ATTCGGATCCAAGTCATGCAGAATCAAATCCTGA-3 
CdtC_R 5´-5’-TACCGAATTCTTAGCTACCCTGATTTCTT -3’ 
 
Each PCR fragment was cloned into the BamHI and EcoRI restriction sites of the 
pACYC-Duet-1 expression vector (Novagen). Purification of the His-tagged CdtA and 
CdtC subunits from inclusion bodies was performed as previously described [27]. 
Reconstitution of the active holotoxin (named as CDT) was previously described [10]. 
 
CDT intoxication. Cells were incubated for the indicated time periods with CDT (2µg/ml) 
in complete medium.  
Ionizing radiation. Cells were irradiated (20 Gy), washed once with PBS and incubated 
for indicated time periods in complete medium. 
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siRNA and transfections 
One hundred thousand HeLa cells were plated in 12-well plate. The siRNA were 
purchased from Qiagen, and transfection was performed using the fast-forward protocol 
from Polyplus Transfection, according to the manufacturer’s instructions. Gene silencing 
was assessed by western-blot analysis 72h after transfection. The following siRNA 
duplex was used: Hs_FEN1_6 #SI02663451; Hs_VCL_10 #SI02664207; Hs_VCL_11 
#SI02664214; Hs_TSG101_6 #SI02655184; Hs_TSG101_7 #SI02664522; Allstars 
Negative Control siRNA #102780. 
 
Immunofluorescence 
Immunofluorescence analysis was performed as previously described [10,17], using the 
conformation-specific monoclonal antibody (6A7, BD Pharmingen), which recognizes 
the active form of Bax. The actin cytoskeleton was visualized by Phalloidin staining, as 
previously described [10]. Nuclei were counterstained with DAPI (Vector Laboratories 
Inc). 
RhoA activation  
RhoA activation was assessed using the G-LISATM RhoA Activation Assay Biochem 
KitTM (Cytoskeleton), according to the instructions of the manufacturer. 
 
Western blot analysis 
Proteins were fractionated by SDS-polyacrylamide gels, transferred to PVDF membranes 
(Millipore) and probed with the following antibodies: α-phospho-p38, α-p38, α-FEN1 
(Cell Signaling), α-TSG101, α-Vinculin and α-Actin (Sigma). Blots were developed with 
enhanced chemoluminescence, using the appropriate horseradish peroxidase-labelled 
secondary antibody, according to the instructions of the manufacturer (GE Healthcare). 
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Results 
 
Screening of the S. cerevisiae deletion library 
Activation of the small GTPase RhoA and phosphorylation of the downstream p38 
MAPK following CDT-induced DNA damage is an important stress response, which 
leads to delayed cell death. However, the details of this signaling pathway are still 
unknown [17]. 
To identify novel CDT-induced survival signals, we screened a S. cerevisiae deletion 
library. In the first set of experiments we expressed the active subunit CdtB derived from 
the Campylobacter jejuni CDT under the galactose promoter into the S. cerevisiae control 
BY4743 strain. Induction of CdtB expression by addition of galactose into the culture 
medium induced G2 arrest (Figure 1A upper panel) and delayed cell growth (Figure 1A, 
lower panel) in cells transformed with the pDCH-CdtB plasmid, while no effect was 
observed in cells grown in the presence of glucose (CdtB OFF) or in cells transformed 
with the vector control in presence or absence of galactose. 
Subsequently, we performed a genome-wide screen using the EUROpean Saccharomyces 
cerevisiae ARchive for Functional analysis (EUROSCARF) library, derived from the 
BY4743 strain [20]. Deletion strains that showed growth aberrations, for example 
respiration deficiency (petite strains), were excluded. A total number of 4492 deletion 
mutants out of the 4793 carrying deletions in nonessential genes were inoculated on 
YPGluc plates. From the frozen stocks, seven strains could not be recovered. The 4485 
recovered strains were successfully transformed with the CdtB-expressing pDCH–CdtB 
plasmid via the high-throughput yeast transformation method. To select for CdtB-
sensitivity, we performed replica plating serial dilutions on plates containing selective 
medium supplemented with either glucose to inhibit CdtB expression (CdtB OFF), or 
galactose/raffinose to induce CdtB expression (CdtB ON). 
As expected, the wild type cells (wt) presented a inhibited growth in the presence of 
galactose/raffinose, compared to cells grown in glucose, however, several deletion 
mutants showed a more pronounced phenotype when CdtB expression was induced 
(Figure 1B, left panel). Transformants were defined as CdtB hypersensitive when growth 
was not detected after the third dilution step. This screening was performed three times, 
and a total of 121 deletion mutants that did not grow after the third dilution step in all the 
three rounds were considered as CdtB hypersensitive (Figure 1B, right panel). To ensure 
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that the delayed growth was due only to the expression of CdtB, and not to an intrinsic 
characteristic of the deletion, each of the 121 deletion mutants were transformed with the 
vector control plasmid, and a similar serial dilution screening in the presence or absence 
of galactose/raffinose was performed (data not shown). This analysis restricted the 
number of CdtB hypersensitive deletion mutants to 78 (Table 1). PCR analysis, 
performed in 30 out of the 78 mutants, demonstrated that all the cloned tested carried the 
proper deletion, and validated the quality of the library used in this study (Supplementary 
Tables 1 and 2). 
 
Hypersensitivity to CdtB, as assessed by the serial dilution assay described above, does 
not allow to discriminate between delayed growth or cell death induced by the toxin 
expression. Therefore we performed a survival assay by determining the reduction of 
colony forming unit (CFU) ability for six deletion mutants hypersensitive to CdtB, two 
clones that did not show CdtB hypersensitivity, and the wild type cells (Figure 1C). 
Each deletion mutant, transformed either with the CdtB expression plasmid or the vector 
control, was grown in selective medium in the presence of galactose/raffinose (CdtB 
ON). After 48h, one thousand cells were plated on glucose selective plates (CdtB OFF), 
and the number of CFU was counted after 48h incubation at 30°C. The data are presented 
as percentage of the number of CFUs derived from the CdtB expressing cells relative to 
the number of CFUs derived from cells transformed with the vector control. As shown in 
Figure 1C, the viability of the hypersensitive CdtB mutants Δslt2, Δrvs161, and Δrad27, 
was significantly reduced compared to that of the mutants Δcka2, Δsrv2, and Δvps23 or 
the two non-hypersensitive Δhog1 and Δsmk1, indicating that for some of the clones, the 
reduced cell recovery observed in Figure 1B was associated with enhanced cell death in 
response to CdtB-induced DNA damage. 
 
The identity of the yeast genes, whose deletion confers hypersensitivity to CdtB, is 
summarized in Table 1. Based on the annotated function derived from the Saccharomyces 
Genome Database (SGD) [28], we classified these genes into twelve groups, five genes 
could not be grouped because they encode proteins with unknown function (Figure 1D 
and Table 1). As expected the majority of them encodes for proteins involved in the 
regulation of the DNA damage checkpoint responses, genome integrity and DNA repair 
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(39%, groups 1 to 4). Interestingly, the next larger functional group comprises genes 
encoding for effectors involved in the control of vesicular transport and endocytosis 
(13%, group 5). A smaller proportion of the identified genes regulates the actin 
cytoskeleton (8%, group 7), and this was the target of interest in our screening. 
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Identification of novel CDT-induced survival signals in higher eukaryotes 
The Inparanoid database [22] and BLAST sequence alignment were subsequently used to 
identify 59 human orthologs of the 78 yeast genes found in the EUROSCARF library 
screening (Table 1). 
To assess whether any of the human orthologs encoded for proteins that regulate cell 
survival via activation of actin cytoskeleton in response to DNA damage in higher 
eukaryotes, we constructed a protein-protein interaction network for all the effectors 
involved in regulation of the actin cytoskeleton and their interacting partners. The 
network obtained is composed of 185 nodes (proteins) and 448 edges (interactions). The 
nodes of the pathway are shown in blue circles. Node size and label size indicates that the 
protein has multiple interacting partners (Figure 2A). 
Twenty of the 59 human orthologs were found within the network, and are listed in Table 
2, together with their interacting partners. Four clusters were clearly identified. Two 
encoded for proteins involved either in the regulation of the DNA damage checkpoint 
(centred on CHK1) and DNA replication and repair (centred on FEN1) (red circles). One 
comprises proteins of the MAPK pathways (green circle) (Figure 2A). The fourth cluster, 
marked with the blue circle, included the Ser/Thr protein phosphatase PPM1A, the 
vacuolar protein sorting TSG101, and the ATPse ATP6V1E1. No homogenous function 
could be defined for this cluster. 
Figure 2B represents part of the network described in Figure 2A, where three key 
proteins were chosen to perform functional studies in mammalian cells. The selected 
proteins, marked with green squares, are: TSG101, FEN1 and Vincunlin (VCL). TSG101 
(yeast ortholog: VPS23) and FEN1 (yeast ortholog: RAD27) were found in the 
EURPSCARF library screening, and were selected because TSG101 interacts with the 
RhoA kinase ROCK, a key factor that promotes actin stress fibers [29], while FEN1 is 
involved in DNA repair and was found as a central node in one of the clusters defined in 
Figure 2A. VCL, not present in S. cerevisiae, was selected based on its central role in the 
integrin-dependent regulation of the actin cytoskeleton, and for its reported interaction 
with FEN1 [30]. 
 
FEN1 and VCL prolong cell survival in response to DNA damage 
To assess whether TSG101, VCL and FEN1 are important to delayed cell death upon 
CDT-induced DNA damage, expression of the endogenous proteins were knocked down 
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by specific siRNAs in HeLa cells 72 h prior intoxication. iRNA interference induced 80% 
and 60% reduction of TSG101 and VCL expression, respectively, while the levels of 
expression of endogenous FEN1 were reduced more than  90% (Figure 3A). 
Cell death was assessed 72h after intoxication by monitoring chromatin condensation 
(data not shown) and by detection of the activated form of the pro-apoptotic protein Bax, 
by immunostaining with the conformation-dependent antibody 6A7 (Figure 3B). Fifteen 
to twenty percent of apoptotic cells, corresponding to a three-fold increase compared to 
the untreated cells, were observed in cells transfected with the non-silencing siRNA 72h 
after intoxication. A similar proportion was observed in cells where expression of 
TSG101 was knocked down by specific siRNA (Figures 3C and 3D), indicating that this 
protein does not promote cell survival in response to CDT intoxication. However, 
approximately a 11-fold increase in apoptotic cells was detected in intoxicated HeLa cells 
where the endogenous levels of VCL or FEN1 were knocked down by specific siRNA 
(Figures 3B, 3C and 3D). Down-regulation of FEN1 and TSG101 in mammalian cells 
recapitulated the phenotype observed in the S. cerevisiae mutants, where the orthologs 
RAD27 and VPS23 have been deleted, since the Δrad27 mutant, but not Δvps23 showed 
reduced viability upon induction of CdtB expression. (Figure 1C). 
 
Activation of RhoA and actin stress fibers in response to DNA damage is dependent 
on TSG101, VCL and FEN1 
We have previously shown that exposure to DNA damaging agents, such as IR and CDT, 
induced actin stress fiber formation, activation of RhoA, and delayed cell death [17], 
therefore we assessed whether TSG101, VCL and FEN1 were involved in this still poorly 
characterized signalling pathway. As expected, induction of DNA double strand breaks 
by CDT intoxication or irradiation induced formation of actin stress fibers in 50% and 
40% of control HeLa cells or cells transfected with non-silencing siRNA, respectively 
(Figures 4A and 4B). This was associated with approximately a three-fold increased of 
RhoA activation (Figure 4C). 
Down-regulation of the endogenous levels of TSG101 or VCL was associated with 
increased levels of stress fiber formation in untreated cells, but no significant changes 
were observed upon induction of DNA DSB by irradiation or intoxication (Figures 4A 
and 4B). FEN1 knock down did not alter the actin cytoskeleton in untreated cells, but 
significantly reduced stress fiber formation in intoxicated or irradiated cells (Figures 4A 
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and 4B). These data indicate that all these three proteins regulated induction of actin 
stress fibers in response to DNA damage. However, only knock down of VCL and FEN1 
completely prevented RhoA activation, while, a similar increase of GTP-bound RhoA 
was observed in irradiated or intoxicated cells transfected with the TSG101 specific 
siRNA compared to control cells or cells transfected with non-silencing siRNA (Figure 
4C). Based on these results, we concluded that FEN1 and VCL regulate activation of 
RhoA and consequent stress fiber formation, while TSG101 induces the stress fiber 
formation down-stream of RhoA activation. 
 
Activation of p38 MAPK in response to DNA damage is dependent on VCL and 
FEN1 
Induction of DNA double strand breaks stimulates the activity of the p38 MAPK in a 
RhoA dependent manner, and this is required to delay cell death in HeLa cells [17]. Since 
we have demonstrated that VCL and FEN1 are required for RhoA activation, we next 
assessed whether these two proteins are also important for the activation of p38 MAPK. 
As previously shown, we observed a four- to five-fold increase in p38 MAPK activation, 
assessed by western-blot analysis using a p38 MAPK phospho-specific antibody (p-p38) 
in control HeLa cells or cells transfected with non-silencing siRNA 4h after irradiation 
(Figures 5A and 5B). In line with the previous results, showing that TSG101 does not 
affect RhoA activation, similar levels of p38 MAPK phosphorylation were detected in 
irradiated HeLa cells, where expression of the endogenous levels of TSG101 where 
knocked down with specific siRNA. Conversely, down-regulation of either VCL or 
FEN1 resulted in decreased p38 MAPK activation upon induction of DNA damage 
(Figures 5A and 5B). 
 
These data identified FEN1 and VCL as two important effectors that activate RhoA in 
response to DNA damage. We further demonstrated that DNA damage triggers two 
distinct pathways: i) induction of actin stress fibers, which requires both the RhoA kinase 
ROCKI and II [17], and TSG101 (this work); ii) activation of p38 MAPK, associated 
with a delayed cell death, which is FEN1 and VCL dependent. Our results are 
summarized in Figure 6. 
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Discussion 
 
The exact mechanism by which bacteria contribute to carcinogenesis is still poorly 
characterized. Several Gram-negative pathogenic bacteria have been shown to produce 
cytolethal distending toxins (CDTs) that induce DNA damage in their target cells. As 
incorrect repair of DNA damage may lead to genetic instability and eventually to tumour 
development, it is conceivable that chronic infection with CDT-producing bacteria can be 
a risk factor for cancer development. One key factor in the tumorigenic process is 
activation of survival signals, which can prevent cell death induced by DNA damage 
and/or oncogene activation. We used S. cerevisiae transformed with a CdtB-expressing 
plasmid as a model for CDT-intoxicated cells and screened a yeast deletion library to 
identify novel genes required for the CdtB-induced survival response. 
 
A genome-wide screen for the cellular response to CdtB in S. cerevisiae has been 
previously described by Kitagawa et al. [31]. However, the focus of their study was the 
characterization of the DNA damage repair mechanisms in response to CDT intoxication, 
while we were interested in identifying RhoA-dependent effectors that transduce the 
stress response of the damaged DNA into survival signals. The identity of the genes that 
influence the response to CdtB found in our study largely overlap with that reported by 
Kitagawa and co-workers and with those identified by Bennett et al. [32] who performed 
a genome-wide screen in yeast to identify genes that confer resistance to IR. 
Similarly to Kitagawa et al, our screen identified: homologous recombination repair 
genes such as RAD50, RAD51 and RAD57, protein products involved in all three known 
complexes for nonessential replication factor C (RFC) that, in complex with 
proliferating-cell nuclear antigen (PCNA), forms the replication fork structure [33], the 
S-phase checkpoint proteins TOF1 and MRC1 [34], the DNA damage mediator Rad9 
[34], the SAE2 endonuclease for processing of hairpin DNA [35], the SRS2 helicase 
required for recovery from stalled replication forks [36], the MUS81-MMS4 
endonuclease for replication fork stability [37], and proteins required for efficient sister 
chromatid cohesion (CHL1 and MCM21) [38]. 
The overlapping of our data with the two previous reports indicates that the results of our 
screening are highly reliable. 
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Systems biology analysis of the actin-cytoskeleton network (Figure 2A) indicates that the 
link between proteins regulating the actin cytoskeleton and the stress response to DNA 
damage in the mammalian system is rather complex, and still poorly characterized. To 
shed some light, we focused our functional analysis on three proteins: two that were 
identified in the screening (Table 1, Figures 2A and 2B): FEN1 (RAD27) and TSG101 
(VPS23), and VCL that is not present in yeast, but was chosen for its reported interaction 
with FEN1 [30] and for its essential role in transducing the integrin signaling to the actin 
cytoskeleton regulating proteins. 
 
The FEN1 dependency of RhoA activation, actin stress fiber formation and p38 MAPK 
phosphorylation in response to DNA DSB induced by CDT is novel and not previously 
reported. FEN1 (flap endonuclease 1) is a multifunction nuclease that possesses 
endonuclease activity required for the maturation of the Okazaki fragments during DNA 
replication and long patch DNA base excision repair [39], but has also a 5’-exonuclease 
activity (EXO) required for proper homologous DNA recombination, and a gap-
dependent endonuclease (GEN), which cleaves the ssDNA region of gapped DNA duplex 
or DNA forks generating DNA DSBs [40,41]. It has been shown that the EXO and GEN 
activities can be abrogated by mutation of the Glu to Asp mutation in position 60 (E60D), 
leading to frequent spontaneous mutations both in yeast and mammalian cells and 
promotion of cancer progression in a knock-in mouse model [42]. These effects of FEN1 
E60D are well on line with its role in maintenance of genomic stability. Interestingly, 
mouse embryo fibroblasts (MEFs) expressing the E60D FEN1 show also an increased 
susceptibility to cell death in response to UV irradiation compared to the cells expressing 
the wild type FEN1, indicating that the EXO and/or GEN activities are required for cell 
survival in response to certain genotoxic stresses. Our data demonstrate that the role of 
FEN1 in cells survival is also relevant in response to DNA damage caused by the 
bacterial genotoxin CDT (Figure 3). 
How FEN1 could induce activation of the small GTPase RhoA is still not known. We 
have previously shown that DNA damage induced by IR or CDT promotes 
dephosphorylation of the RhoA specific GEF Net1 at the inhibitory site Ser152, essential 
to trigger its GEF activity [43,44]. It is possible that the FEN1-dependent DNA repair 
mechanisms, evoked by CDT intoxication, trigger indirectly Net1 dephosphorylation, via 
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activation of a specific phosphatase or inhibition of a kinase. Preliminary data showed 
that dephosphorylation of Net1 is inhibited 2h after irradiation in FEN1 knock down 
HeLa cells (data not shown). Alternatively, FEN1 may exert additional function(s) not 
related to its nuclease activity in a different subcellular compartment. This has been 
previously demonstrated for other components of the DNA repair machinery. The DNA-
dependent protein kinase (DNA-PK), which forms a complex with the Ku heterodimer 
(Ku70/Ku80), is an essential component of the non-homologous end-joining 
recombination (reviewed in [45]). However, a fraction of DNA-PK is localized in the 
lipid rafts microdomains of the plasma membrane [46], and can phosphorylate Akt at 
Ser473 [47]. Furthermore, the Ku70/Ku80 heterodimer has been shown to regulate cell 
adhesion to the extracellular matrix and to protect cells form apoptosis via suppression of 
the translocation of the pro-apoptotic Bax at the mitochondrial membrane (reviewed in 
[48]). It is conceivable that also FEN1 may exert additional non-repair function(s), 
associated with the activation of the actin cytoskeleton. 
 
The down-regulation of the FEN1 and VCL genes exerted similar effects on RhoA 
activation, stress fiber formation and p38 MAPK phosphorylation (Figures 3 to 5), 
however, it is nor clear whether these two effector proteins act sequentially or trigger 
different signaling pathways that converge on RhoA. 
Integrin activation and adhesion of cells to ECM confer higher resistance to ionizing 
radiation and cytotoxic drugs (review in [49]). In a hepatoma cell culture model it was 
shown that the anti-apoptotic effect of β1-integrin in response to a variety of 
chemotherapeutic agents, such as cisplatin and doxorubicin, was mediated by the MAPK 
p42/p44 and p38 [50]. FAK, integrin-linked kinase (ILK), Src-tyrosine kinase, PI3K and 
several adaptor proteins such as talin and VCL are some of the key players in the 
integrin-dependent signaling complex, that promote cell survival [51,52]. Therefore, it is 
possible that VCL may contribute to the formation of an adhesome leading to RhoA 
activation and consequent p38 MAPK phosphorylation in response to CDT intoxication. 
 
The role of TSG101 in induction of actin stress fibers in response to irradiation or 
intoxication is very interesting. TSG101, together with VPS28 and VPS37 form one of 
the four ESCRT complexes, the ESCRT I, that regulate protein sorting into 
multivesicular bodies (reviewed in [53,54]. We found several components of the ESCRT 
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complexes or ESCRT-binding proteins in the screen for genes that promote cell 
growth/survival in response to CdtB, including CHMP3/Vps24, CHMP4B and Vps4 
(Table 1). 
Several recent reports showed that members of the ESCRT induce regulation of the actin 
cytoskeleton. Mutation in the Drosophila Vps28 gene causes early embryonic lethality, 
associated with perturbation of the actin cytoskeleton [55]. Alix, an ESCRT associated 
protein, regulates cell morphology and actin stress fiber formation in non-transformed 
human fibroblasts [56]. Furthermore, knock down of Syntaxin (STX) 6, a v-SNARE 
protein that mediates vesicle transport [57], leads to decreased expression of the α5-
integrin and the FAK kinase, leading to reduced cell adhesion and cell death, via up-
regulation of both basal and DNA damage-induced levels of p53 [58]. Interestingly, we 
also identify a member of the STX family in the yeast genome wide screening: PEP12, 
which is the yeast orthologue to STX12 (Table 1). Our data suggest that several proteins 
that regulate protein and vesicular trafficking play a broader role in regulation of cell 
adhesion and cell survival in basal conditions or in response to stresses, such as DNA 
damage, possibly by functioning as a scaffold for the compartmentalization of specific 
signaling complexes. 
We demonstrated that TSG101 promoted stress fibers down-stream of RhoA in response 
to DNA damage, since TSG101 knock down did not affect RhoA activation (Figure 4). 
The effects of TSG101 down-regulation (Figures 4 and 5) are similar to those observed 
when the RhoA kinases ROCK I and II are inhibited [17], suggesting that the role of this 
ESCRT protein is to activate the branch of RhoA signaling that leads to stress fiber 
formation, but does not alter the activation of the MAPK pathway. 
 
In conclusion, we have identified three novel effector proteins in the signaling pathways 
that promote actin cytoskeleton re-arrangements and cell survival in response to CDT 
intoxication: FEN1, VCL and TSG101, as summarized in Figure 6. Our data contribute to 
disclose the complex net of cellular responses that promote cell survival to genotoxic 
stresses. Identification of survival signals triggered by chronic infections with CDT-
producing bacteria is crucial to understand whether these infections can promote genomic 
instability and favor malignant transformation. Up to date the mechanisms of bacterial-
induced carcinogenesis are still poorly characterized. The only bacterium classified as 
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human carcinogen is Helicobacter pylori [59]. However, a possible involvement in 
oncogenesis has been suggested for other bacteria, such as for example the Gram-
negative bacterium Salmonella typhi [60]. Identification of an association between 
infection with CDT-producing bacteria and cancer promotion/progression can help to 
develop specific therapeutic protocols aimed at an early and rapid eradication of the 
bacterial infection, preventing the initial steps of tumor development. 
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Figure legend 
 
Figure 1. Screening of the EUROSCARF deletion library 
A) CdtB induces cell cycle arrest in the G2 phase and inhibits cell growth in S. 
cerevisiae. Yeast cells (strain BY4743) transfected with the control (CTR) or the pDCH-
CdtB (CdtB) plasmids were incubated for 7h in presence of either 2% glucose or 2% 
galactose/raffinose. Analysis of the cell cycle distribution was assessed by PI staining and 
flow cytometry as described in Material and Methods (upper panel). Serial five-fold 
dilutions of the yeast culture were incubated on plates containing selective medium 
supplemented with 2% glucose or 2% galactose/raffinose for 72h (lower panel). 
B) Screening of EUROSCARF library. Replica plating of five-fold serial dilutions of the 
wild-type cells (wt) and deletion mutatants transformed with the pDCH-CdtB plasmid 
were incubated on plates containing selective medium supplemented with 2% glucose 
(CdtB OFF) or 2% galactose/raffinose (CdtB ON) for 72h. The left panel shows a 
selection of the tranformants. The right panel shows the summary of the growth pattern 
of all the 4492 transformants. The strains that grown up only to the third dilution step 
(1/125) or less are scored as CdtB hypersensitive. 
C) Survival assay. Eight selected deletion mutants and the wild type cells (wt) transfected 
with the pDCH-CdtB or the control plasmids were incubated overnight in selection 
medium containing 2% raffinose (CdtB OFF). Equal number of cells were transferred to 
3ml synthetic medium containing raffinose/galactose (CdtB ON), and incubated for the 
indicated period of times at 30°C. One thousand cells were taken at time 0h and 48h and 
plated on glucose selective plates. Colony forming units (CFUs) were counted after 48h 
incubation at 30°C. The number of CFU at 48h has been normalized against the number 
of CFU at time 0 in order to exclude any error due to different growth rate of the 
transformants. The percentage of cell survival was calculated as follow (CFU of cells 
carrying the pDCH-CdtB plasmid/CFU of cells carrying vector control plasmid) x 100. 
** highly statistically significant; * statistically significant. 
D) Functional grouping of the genes identified in the screen. 
 
Figure 2. Actin cytskeleton network 
A) The black squares indicate the 20 human orthologs of the genes found in the 
EUROSCARF screen. Four hubs were identified: two formed by proteins involved in 
DNA damage (red circle), one formed by proteins associated with MAPK pathway (green 
circle). A fourth group is identified with the blue circle. 
B) Part of the network presented in panel A. The green boxes highlight the genes that 
were further analyzed in mammalian cell lines. 
 
Figure 3. VCL and FEN1 knock down increases the rate of cell death upon 
intoxication 
A) HeLa cells were transfected with non-silencing siRNA (siCTR), TSG101, VCL, or 
FEN1 specific siRNA. Expression of endogenous protein levels were analyzed by 
western blot 72h after transfection. Actin is used as loading control. B) HeLa cells were 
transfected with non-silencing siRNA (siCTR), TSG101, VCL, or FEN1 specific siRNA, 
and further left untreated or exposed to CDT (2µg/ml) for 72h. Cell death was assessed 
by immunoflurescence, using the conformational-dependent anti-Bax 6A7 antibody. C) 
Quantification of the Bax positive cells. One out of two experiments is shown. D) Data 
are presented as ratio of the number of Bax positive cells upon intoxication and the 
number of Bax positive cells in untreated control. Mean of two independent experiments. 
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Figure 4. Actin stress fiber formation and RhoA activation upon knock down of 
VCL, FEN1 and TSG101 
A) Non transfected HeLa cells or cells transfected with non-silencing siRNA (siCTR), 
TSG101, VCL, or FEN1 specific siRNA were left untreated (-DSB) or exposed to IR 
(20Gy) or CDT (2µg/ml) for 48h (+DSB). The actin cytoskeleton was visualized by 
TRITC-phalloidin staining. Cells exhibiting more than 5 stress fibers were scored as 
positive. 
B) Quantification of cells with stress fibers. The values represent the percentage of cells 
with stress fibers (mean ±SD of 3 independent experiments, two performed with CDT 
and one performed with IR). 
C) HeLa cells, non transfected or cells transfected with non-silencing siRNA (siCTR), 
TSG101, VCL, or FEN1 specific siRNA, were left untreated (-DSB), or exposed to CDT 
((2µg/ml; +DSB), and further incubated for 4h. Activation of RhoA was assessed by 
RhoA specific G-LISATM (mean ±SD of 3 independent experiments). Pos: internal 
positive control of the RhoA specific G-LISATM assay. 
 
Figure 5. VCL and FEN1 knock down prevent phosphorylation of p38 MAPK upon 
induction of DNA damage. 
A) Non transfected HeLa cells or cells transfected with non-silencing siRNA (siCTR), 
TSG101, VCL, or FEN1 specific siRNA were left untreated (-DSB), or exposed to 
ionizing radiation (20Gy, +DSB), and further incubated for 4h in complete medium. 
Samples were subjected to western blot analysis using an α-p38 phospho-specific 
antibody (p-p38) or an α-p38 specific antibody (p-38). B) Quantification of the 
experiment presented in panel A. Data are presented as ratio between the optical density 
of the p-p38 specific band in irradiated cells and the optical density of the p-p38 specific 
band in untreated cells (mean ±SD of 3 independent experiments). 
 
Figure 6. Summary of the data presented in this work. RhoA activation regulates two 
distinct pathways in response to DNA damage: i) induction of actin stress fibers, which 
requires both the RhoA kinase ROCKI and II, and TSG101; ii) activation of p38 MAPK, 
associated with a delayed cell death, which is FEN1 and VCL dependent. 
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Table 1. Genes identified in the EUROSCARF screen 
 
a: the red color identifies genes that present human orthologs. 
 
Group Function # genes Yeast genesa Human orthologs 
1 Replication 
recombination repair 
13 DCC1, DDC1, DIA2, ELG1, MMS4, 
MUS81, RAD27, RAD50, RAD51, 
RAD57, SAE2, SHU1, SRS2 
DSCC1, DIAPH3, MUS81, 
FEN1, RAD50, RAD51, 
XRCC3, UBA2, UBE2B 
2 Checkpoint 5 CHK1, MEC3, MRC1, RAD9, TOF1 CHEK1, PIP3-E, MRC1L.1, 
RAD9A, 
3 Chromatin silencing 
telomeres 
8 CST6, ESC1, NAM7, NAT3, NMD2, 
NPT1, UPF3, YPL205C 
CST6, UPF1, NAT5, UPF2, 
SLC17A1, UPF3A 
4 Mitotic chromosome 
transmission 
5 CHL1, CHL4, CTF4, MCM21, 
MCM22 
DDX11, CENPN, REPS2, 
NFIC 
5 Vacuolar/ Golgi/ 
endocytosis 
10 DRS2, PEP7, PEP12, PMR1, SNF7, 
VPS3, VPS4, VPS8, VPS21, VPS23, 
VPS24 
ATP8A2, LAP3, STX12, 
ATP2C1, CHMP4B, 
VPS4B, VPS8, RAB5A, 
TSG101, VPS24 
6 Mitochondrial 8 ADK1, ALT1, FMP37, HFA1, 
MRPL10, OAR1, PDB1, SOD2 
AK2, GPT, MRPL10, 
PDHB, SOD2 
7 Cytokinesis, spindle, 
cytoskeleton 
rearrangements 
6 CTF3, NIP100, PTC1, RVS161, SLT2, 
SRV2 
PTCH2, BIN3, MAPK7, 
CAP1 
8 Translation/Ribosomal 6 KAP123, RPL27A, RPL36A, RPS0B, 
RPS17A, ZUO1 
IPO4, RPL27A, RPL36AL, 
LOC387867, RPS17, 
DNAJC2 
9 Transcription/ RNA 
metabolism 
3 BUR2, CKA2, NPL3 CST4, CSNK2A1, TAF15, 
10 Ubiquitin proteasome 
system 
2 DOC1, SHP1 TBX6, NSFL1C 
12 Others 6 LAT1, LIP5, MKC7, RTS1, TPD3, 
TPS1 
DLAT, LIAS,, PPP2R5C, 
PPP2R1A, TPSAB1/TPSB2 
13 Unknown 5 YBR099C, YDR109C, YEL045C, 
YMR252C, YOR376W 
 
   78 genes 59 genes 
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Table 2: Proteins encoded by the human orthologs identified in genome-wide screen 
and their interacting partners 
 
Protein Interacting partners 
APC10 APC2, RAD2 
APC2 APC10 
ATP6V1E1 SOS1 
B56G/PPP2R5C PR65B, ERK2 
BMK1/ERK5 RAF1 
CAP2 ACTG1 
CHEK1 TP53BP1, CLSPN, TIMELESS, CSNK2A1P 
CLSPN CHEK1 
CSNK2A1P/CSNK2A1/CSK2 CHEK1, FGFB, FGF1, APV, WAS, PAK1 
NAT3 RAD2 
PKLR ARHGEF6, PAK1 
PPM1A MSN, PI3K 
PR65B/PPP2R1B B56G 
FEN1 GP3A, APC10, RAD50, GP2B, NAT3, VCL 
RAD50 RAD2 
RSN/CLIP1 P195 (SAR1) 
TIMELESS TIPIN, CHEK1 
TIPIN TIMELESS 
TP53BP1 CHEK1 
TSG101 P195, ROCK1 
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Supplementary data 
PCR 
PCR was performed as previously described in Single Tube Confirmation PCR Protocol 
(http://www-sequence.stanford.edu/group/yeast_deletion_project/single_tube_protocol.html). 
Briefly, one colony was suspended in 50µl of 60U/ml Zymolase 20T solution (Seikagaku 
Corporation) and incubated at 37°C for 1h, followed by 10min at 95°C. PCR was 
performed as followed: five microliter of each primer was added in the PCR tubes 
followed by 5µl of yeast suspension. The PCR master mix was added and the PCR was 
carried out accordingly using the following conditions: Step1, 3min at 95°C; Step 2, 
15sec at 94°C, 15sec at 57°C, 1min at 72°C, repeated for 35 cycles; Step3, 3min at 
72°C). PCR products were analyzed in 1.5% agarose gels. 
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Supplementary Table 1: PCR primer sequencesa 
 
ORF Encoded protein Primer name Primer sequence (5' to 3') 
C_BUR2 TTTTGAATCATATTGAAACAAGGGT YLR226W   BUR2 
D_BUR2 TCGAAAATATTATTGATGCTTGTGA 
C_CKA2 TTGATCCTACGGAACGTAAACTAAG YOR061W   CKA2 
D_CKA2 GAACAATTCCAAAACTATTCCATTG 
C_CTF3 AACGCTAAATTTTTCACGATAACTG YLR381W   CTF3 
D_CTF3 ACTTTTTGAAATTAGGTAGGGATGC 
C_DCC1 ATACCGTTTATAGCTCAGTGGTACG YCL016C   DCC1 
D_DCC1 TTGATTTCAACATCTTCCAGTTGTA 
C_DIA2 TCCAATTGTTAATTTGGATGAAGAT YOR080W   DIA2 
D_DIA2 TGGAACAATTTCCTCTTATGATGTT 
C_DOC1 ATAACTACGATACGTTTTGGCAGAG YGL240W   DOC1 
D_DOC1 ATGAAATTTTTGAAGAACAAAGCAC 
C_DRS2 GTGGGCAAGAAAAAATTGTCAGAA YAL026C   DRS2 
D_DRS2 TAAGGTACGTACCCAGTCGAAGCAA 
C_FMP37 GGTGTTTTCATGAAGTATGCTCTTT YGL080W   FMP37 
D_FMP37 AATACAAAGGAGATGAGAGGGAAAT 
C_HFA1 AGAAAATGATAGAGACGATGATTCG YMR207C   HFA1 
D_HFA1 GAATGTCAGATTTTCTCTTTTCGG 
C_KAP123 TTCATGAAATGCTAGAAGCCTTAGT YER110C   KAP123 
D_KAP123 ATCAACTTTACAGGACGAAACTCAC 
C_MEC3 AATTGTGAATGAATTAGATTGGCAT YLR288C   MEC3 
D_MEC3 GTGCAGTTCATGTAGCCTTTAAAAT 
C_NIP100 AGAAATGTTCAACTTCGTGAGTACC YPL174C   NIP100 
D_NIP100 CATGATAGCGTGTCTAAAATGTACG 
C_NPT1 TTCTCGAAGATTATCTGTTATTCCG YOR209C   NPT1 
D_NPT1 GTGAATGAATTAAGAAAGCAAAGGA 
C_PDB1 ATCAAAACTGTCAAGAAGACAAACC YBR221C   PDB1 
D_PDB1 CGTATTCTAACCATGAAACAGGAAC 
C_PEP12 AACTTGTGAGGGATGTCAGTTACTC YOR036W   PEP12 
D_PEP12 ACTTATGAAGCCTACGTGTTATTCG 
C_PEP7 TTGCTAAATATGATAGCATGCAAAA YDR323C   PEP7 
D_PEP7 CTGCTCCTCTTTCTTCTTAGCATTA 
C_PMR1 GGACTGTCTCTGTTAGGTCAAATGT YGL167C   PMR1 
D_PMR1 TTTGTCGAAGGTATAAATGAGGAAG 
C_PTC1 ATTATAGAGCAAAACATTTTGGCAG  YDL006W   PTC1 
D_PTC1 CTATTGACTTGTAAACCGTGTTGTG 
C_RVS161 ACAAAGTTTTCGACGTATTTCAAAG YCR009C   RVS161 
D_RVS161 CGTATCTTATTCCTCGCTTCTATTG 
C_SAC6 CCTTAGAAAACACCAACTATGCAGT YDR129C   SAC6 
D_SAC6 CATTTTCTGCATATTTCAAAGAACC 
C_SAE2 GACTACGAATTTGCGTTTGATAACT YGL175C   SAE2 
D_SAE2 CCTGGTAAGTTAGGTGTCATTTGTT 
YBL058W   SHP1 C_SHP1 GAAGACAACACTTCACAATCACAAC 
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  D_SHP1 CTTCATACAACCCAATTATGACACA 
C_SLT2 AAAAGAGCTGGAGTTTGGATTAGAT YHR030C   SLT2 
D_SLT2 TAAAGGGCTTCTCAGTGAATACATC 
C_SNF7 GTGGAAGAGGCTCATCATTTAGATA YIR025W   SNF7 
D_SNF7 AACTACAAGGCAAGCAAGAGTTAGA 
C_SRV2 ATTCAAGTTAACCATTCCCTACCTC YNL138W   SRV2 
D_SRV2 AAATGGTAAATGATCGTCGTGTATT 
C_VPS21 AGCAGTTGGTAAATCGTCAATAGTC YOR089C   VPS21 
D_VPS21 CAATATTAACTAATCCATCTCCCGA 
C_VPS24 AGGGAGGTAAATTCATTGGTTAGAC YKL041W   VPS24 
D_VPS24 TATGTGGATGAAGTGAAAGAAGTGA 
C_VPS3 AAAATACATAGGCAAGCAGAACTTG YDR495C   VPS3 
D_VPS3 CCAGAAGATTTTCATAGGCAAGTAA 
C_VPS4 AAACAAGAAAACTAACACCATGCTC YPR173C   VPS4 
D_VPS4 TTTGTTACAGGAGTTAAATCAAGCC 
C_VPS8 ATGTACAGCGCCACCAAGATATGA YAL002W   VPS8 
D_VPS8 TAGGTGTCGTGAAGTACTTTCGCTT 
Kanamycin cassette KanR C_Kan TGATTTTGATGACGAGCGTAAT 
 
a: The primer sequences were obtained from: 
http://www-sequence.stanford.edu/group/yeast_deletion_project/strain_homozygous_diploid.txt) 
 31 
Supplementary Table 2: Confirmation PCR for 30 out of the 80 homozygous  
deletion mutantsa 
 
ORF Encoded protein PCR product for the 
Kanamycin cassette 
PCR product for the 
ORF coding region 
YLR226W BUR2 + - 
YOR061W CKA2 + - 
YLR381W CTF3 + - 
YCL016C DCC1 + - 
YOR080W DIA2 + - 
YGL240W DOC1 + - 
YAL026C DRS2 + - 
YGL080W FMP37 + - 
YMR207C HFA1 + - 
YER110C KAP123 + - 
YLR288C MEC3 + - 
YPL174C NIP100 + - 
YOR209C NPT1 + - 
YBR221C PDB1 + - 
YOR036W PEP12 + - 
YDR323C PEP7 + - 
YGL167C PMR1 + - 
YDL006W PTC1 + - 
YCR009C RVS161 + - 
YDR129C SAC6 + - 
YGL175C SAE2 + - 
YBL058W SHP1 + - 
YHR030C SLT2 + - 
YIR025W SNF7 + - 
YNL138W SRV2 + - 
YOR089C VPS21 + - 
YKL041W VPS24 + - 
YDR495C VPS3 + - 
YPR173C VPS4 + - 
YAL002W VPS8 + - 
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a: Strains were considered as homozygous deletion mutants when positive for the PCR 
product corresponding to the kanamycin cassette and negative for the PCR product 
relative to the ORF coding region. 
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Abstract 
The MYC protein controls cellular functions such as differentiation, proliferation, and 
apoptosis. In response to genotoxic agents, cells expressing MYC undergo apoptosis. 
However, the MYC-regulated effectors acting upstream of the mitochondrial 
apoptotic pathway are still unknown. In this study, we demonstrate that expression of 
Myc is essential to activate the Ataxia telangiectasia mutated (ATM)-dependent DNA 
damage checkpoint responses in cells exposed to ionizing radiation (IR) or the 
cytolethal distending toxin (CDT). Phosphorylation of the ATM kinase and its 
downstream effectors, such as histone H2AX, were impaired in the myc null rat cell 
line HO15.19, compared to the myc positive TGR-1 and HOmyc3 cells. Nuclear foci 
formation of the Nijmegen Breakage Syndrome (Nbs)1 protein, essential for efficient 
ATM activation, was also abrogated in absence of myc. Interestingly, phosphorylation 
of the ATM- and Rad3-related (ATR) substrate Chk1 was not hampered in the 
HO15.19 cells in response to irradiation. Accordingly, the cellular response to UV 
irradiation, known to activate an ATR-dependent checkpoint, was similar in all the 
cell lines, independently of the myc status. These data demonstrate that Myc is 
required for activation of the ATM-dependent pathway, which recognizes DNA 
damage and orchestrates the checkpoint responses in order to preserve genomic 
integrity. 
 
 
Keywords: Myc, ionizing radiation (IR), cytolethal distending toxin (CDT), DNA 
damage response, Ataxia Telangiectasia Mutated (ATM), checkpoint responses 
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Introduction 
 
The MYC transcription factor regulates a wide variety of cellular functions such as 
normal cell turnover, differentiation, cellular motility, and apoptosis (reviewed in [1]). 
Since it controls the delicate balance between cell proliferation and cell death, MYC 
expression can be found deregulated in many different types of tumors [2-4]. The 
oncogenic capacity of MYC is not only dependent on its ability to regulate expression 
of genes that enhance cell proliferation (e.g up-regulation of E2F) or suppress cell 
cycle arrest (e.g. down-regulation of p21CIP1 or p15INK4B, reviewed in [5]), but it may 
contribute to tumorigenesis by induction of DNA damage, and consequent genomic 
instability [6, 7] (and reviewed in [8]). 
 
Stress signals, such as growth factor deprivation, hypoxia, and exposure to genotoxic 
agents trigger MYC dependent apoptosis [9, 10]. The apoptotic response is dependent 
on release of cytochrome C from the mitochondria through activation or up-regulation 
of the pro-apoptotic members of the Bcl-2 family [9, 11-13]. Our previous studies 
were aimed at understanding the role of MYC in cells exposed to conventional DNA 
damaging cytotoxic drugs. We found that doxorubicin, camptothecin and etoposide 
induced a strong apoptotic response in the Rat1 cell line TGR-1, expressing 
physiological levels of Myc, via activation of Bid and Bax. Cell death in response to 
camptothecin and etoposide was further enhanced by the pro-apototic enzyme PKCδ. 
The apoptotic response was dependent on Myc expression, since activation of these 
proteins was not detected in the myc null cells HO15.19 [14, 15]. However, the 
molecular signaling pathway that regulates the MYC dependent Bax activation in 
response to DNA damage is not known. 
 
In normal cells, exposure to genotoxic agents triggers activation of checkpoint 
responses that lead to cell cycle arrest or cell death. A key protein in orchestrating this 
complex response to DNA double strand breaks (DSB) is the Ataxia telangiectasia 
mutated (ATM) kinase [16]. ATM exists as an inactive dimer, which undergoes a 
conformational change upon induction of DNA DSB. The change in protein structure 
stimulates intermolecular autophosphorylation on Ser1981, resulting in dissociation of 
the dimer, and consequent activation of the kinase [17]. Full activation of ATM 
requires interaction with the MRN complex (Mre11/Rad50/Nbs1), which enhances 
 4 
the recruitment of ATM to the site of DNA damage [18, 19]. Proteins identified as 
ATM substrates regulate recruitment of DNA repair complexes (e.g. H2AX), activate 
checkpoint responses to block cell proliferation (e.g. Chk2 kinase), or induce 
apoptosis (e.g. the tumor suppressor p53) [20]. Despite the well-established role of 
MYC in activating p53-dependent apoptosis, the exact role of MYC in regulating the 
DNA damage response (apoptosis versus repair) remains poorly understood [21-24]. 
 
To identify the MYC-regulated effectors acting upstream of the mitochondrial 
apoptotic pathway in response to genotoxic stress, we have used Rat1 cells with 
different Myc status: the parental TGR-1 cells expressing physiological levels of 
Myc, the myc null cells HO15.19, and the HOmyc3 cells, where expression of the 
murine Myc has been reconstituted [25, 26]. We demonstrated that Myc deletion 
impairs activation of the ATM dependent DNA damage checkpoint responses to 
agents causing DNA double strand breaks (ionizing radiation and cytolethal 
distending toxin), including impairment of nuclear foci formation of the MRN 
complex, lack of phosphorylation of ATM and its downstream targets, such as histone 
H2AX. These data contribute to identify MYC as an important regulator of one of the 
key pathways that control genomic stability in normal cells. 
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Material and methods 
 
Cell lines 
Myc null HO15.19 Rat1 fibroblasts were generated from parental TGR-1 cells by 
homologous recombination, deleting both myc alleles, and HOmyc3 cells were 
generated by reconstitution of the murine myc gene into the HO15.19 cells [25, 26]. 
Cells were cultivated in Dulbecco’s modified eagle medium (DMEM), supplemented 
with 10% fetal calf serum (FCS) and 5 mM L-glutamine (complete medium) in a 
humid atmosphere containing 5% CO2. 
 
Treatments 
CDT intoxication. Cells were incubated for the indicated time periods with bacterial 
lysate (diluted 1:2000 in complete medium) derived from the Helicobacter hepaticus 
strain ATCC51449, expressing the wild type CDT, or the control strain H. hepaticus 
cdtB, (HhcdtBm7) expressing a mutant inactive CDT [27]. Bacteria were cultured on 
a rotary shaker to mid-logarithmic growth phase in liquid medium (Brucella broth, 
supplemented with 10% horse serum) and in a microaerobic atmosphere (10% 
hydrogen, 10% CO2, 80% nitrogen). Bacteria were then centrifuged from the liquid 
medium, and the pellet washed twice with PBS, and sonicated for 5 min in a Branson 
sonfier. The lysate was subsequently stored frozen at -20°C. The lysate dilution of 1: 
2000 represents the minimal dose sufficient to induce cell cycle arrest in 100% of the 
cell population. 
Ionizing radiation. Cells were irradiated (20 Gy), washed once with PBS and 
incubated for indicated time periods in complete medium. 
UV irradiation. Cells were irradiated for 3 min with a short wave UV lamp (model 
UVG-11, 254 nm, 220 V, 0.12 AMPS, 50 Hz, UVP, Upland, USA), washed once with 
PBS and incubated in complete medium for the indicated time periods. 
 
Cell cycle analysis 
Cells were trypsinized, centrifuged and washed once with PBS. The cell pellet was 
resuspended and fixed overnight with 1 ml cold 70% ethanol at 4°C. The cells were 
subsequently centrifuged and resuspended in 0.1 ml propidium iodide (PI) solution 
(0.05 mg ml-1 PI and 0.25 mg ml-1 RNase in PBS) for 30 min at 37°C. Flow 
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cytometry analysis was performed using a FACScan cytometer (Becton Dickinson). 
Data from 104 cells were collected and analyzed using the CellQuest software (Becton 
Dickinson). 
 
Immunofluorescence 
Fifty thousand cells/well, plated on round 13 mm glass coverslips in 24-well plates in 
complete medium, were left untreated or irradiated, and incubated for indicated time 
periods. Cells were fixed with 4% paraformaldehyde, and permeabilized with 0.5% 
Triton X-100 for 30 min at RT. Slides were blocked in PBS with 3% BSA for 30 min 
and incubated for 1 h at RT with a α-Nbs1 mAb antibody (BD Transduction 
Laboratories) diluted 1:50 in PBS. Slides were washed three times for 5 min in PBS, 
and then incubated with fluorescein-conjugated (FITC)-conjugated anti-mouse 
antibody (DAKO); diluted 1:100 in PBS for 30 min at RT. Nuclei were 
counterstained with Hoechst 33258 (Sigma, 0.5 µg ml-1) for 1 min at RT. Slides were 
mounted and viewed by fluorescence microscopy. 
 
Western blot analysis 
Proteins were separated in SDS-polyacrylamide gels, transferred to PVDF membranes 
(Millipore) and probed with the relevant antibodies. The following antibodies were 
used: α-H2AX (Upstate Biotechnology), α-phospho-ATM (Ser1981, Novus 
Biologicals), α-ATM (Genway), α-p53 (Santa Cruz Biotechnology, Inc.), α-actin 
(Sigma), α-phospho-Chk1 (Ser345), α-phospho-(Ser/Thr)-ATM/ATR substrate (Cell 
Signaling) and α-Nbs1 (BD Transduction Laboratories). Blots were developed with 
enhanced chemiluminescence using the appropriate horseradish peroxidase-labeled 
secondary antibody, according to the instructions from the manufacturer (GE 
Healthcare).  
 
Detection of DNA double strand breaks by pulsed-field gel electrophoresis 
Twenty-five thousand cells per well were grown in 12-well plates in complete medium 
containing 4000Bq/ml [methyl-14C]-thymidine for 48 h. The cells were then washed 3 
times with PBS and chased for 2 h in RPMI complete medium. Subsequently, cells 
were treated with IR (20 Gy) and collected at the indicated time points by 
trypsinization in a 150 µl volume. The cell suspension was mixed with 150 µl low 
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gelling-point agarose (InCert) at 37°C to a final agarose concentration of 0.6%, and 
pipetted into plastic moulds for 100-µl plugs. Moulds were incubated at 4°C for 20 
min to solidify the plugs. The solid plugs were transferred into 1ml ice-cold lysis 
buffer (2% sarkosyl, 1mg ml-1 proteinase K, in 0.5M Na3-EDTA, pH 8.0) and 
incubated overnight at 4°C, followed by a second lysis step in high salt solution (1.85 
M NaCl, 0.15 M KCl, 5 mM MgCl2, 2 mM EDTA, 4 mM Tris, 0.5% Triton X-100, pH 
7.5) overnight at 4ºC [28]. Plugs were washed three times for 1 h in 0.1 M EDTA and 
double stranded DNA was separated on an agarose gel (0.8% SeaKem Gold, BMA) in 
a PFGE unit (Gene Navigator, Amersham Bioscience, Uppsala, Sweden) in TBE x 0.5 
as previously described [28]. Following electrophoresis, the gels were sliced at the 
position of the 5.7 Mbp chromosome from S. pombe (BMA), and 14C in the gel 
segments was measured by liquid scintillation. The fraction of radioactivity 
corresponding to DNA smaller than 5.7 Mbp was used to quantify the number of 
double strand breaks [29] assuming an induction of 25 DSB per diploid cell per Gy 
[28]. 
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Results 
 
Myc has been shown to enhance the apoptotic effect of DNA damaging agents, such 
as etoposide and camptothecin, by activation of the pro-apoptotic protein Bax, and the 
downstream caspases 3 and 9 [14, 15]. To identify the Myc-regulated effectors acting 
upstream of the mitochondrial apoptotic pathway, we used the Rat1 fibroblasts TGR-
1 expressing wild type levels of Myc and the isogenic myc null HO15.19 cell line. As 
DNA damaging agent, we chose ionizing radiation since the cellular responses to such 
genotoxic stress are well characterized [20]. Upon irradiation, the Myc expressing 
TGR-1 cells were arrested in the G2 phase of the cell cycle 12 h after treatment. 
Arrest in G2 was followed by cell death, assessed as increase of the sub-G1 
population with fragmented DNA, 24 h and 48 h after irradiation (Figure 1). On the 
contrary, a partial arrest in G2 was observed in the myc null cells HO15.19 24 h to 48 
h after treatment, and signs of cell death occurred only 72 h-96 h post-irradiation 
(Figure 1). 
 
We next tested whether the delay in DNA damage-induced cell death observed in the 
myc null cells was due to a faster kinetics of DNA repair. TGR-1 and HO15.19 cells 
were irradiated and further incubated at 37°C for the indicated time periods. The 14C-
labeled-DNA was subsequently separated by pulsed-field gel electrophoresis (PFGE) 
and visualized by ethidium bromide (Figure 2A). Double-strand breaks were then 
quantified by measuring the 14C-activity for DNA fragments smaller than 5.7 Mbp in 
a liquid scintillator. As shown in Figure 2B, the disappearance of DNA fragments did 
not occur with faster kinetics in the HO15.19 cells compared to the control TGR-1, 
indicating that Myc did not interfere with the rate of DNA repair in these 
experimental settings. 
 
The ATM kinase is a key protein responsible for activation of the cellular responses 
to DNA double strand breaks [20]. Therefore we assessed whether the delayed cell 
death induced by irradiation in the myc null cells was associated with an altered ATM 
response to irradiation. Phosphorylation of ATM on Ser1981 was observed in TGR-1 
cells 30 min after irradiation and was sustained at least up to 8 h post-treatment. In 
this time frame we failed to detect any consistent ATM phosphorylation on Ser1981 
in the HO15.19 cells (Figure 3A and data not shown). This result prompted us to 
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investigate whether Myc was essential also for the activation of ATM effector 
proteins in response to DNA damage. Using an antibody specific for phosphorylated 
ATM/ATR substrates, we detected two phospho-proteins of approximately 35 kDa 
and 110 kDa, respectively in the TGR-1 cells (Figure 3B). Since the levels of 
phosphorylation peaked at 2 h post-treatment, we chose to use shorter time course 
kinetics in the subsequent experiments. Phosphorylation of these two ATM/ATR 
substrates was absent in the HO15.19 cells, at least up to 8 h after irradiation (Figure 
3C and data not shown). As the sizes of these proteins do not correspond to any of the 
known ATM substrates, their identity still remains unknown. 
 
To confirm that the delayed response to genotoxic stress in the HO15.19 cells was due 
to the absence of myc and not an artifact due to clonal selection, we used the HOmyc3 
cell line, where expression of the murine myc gene was reconstituted into the 
HO15.19 background [25]. The HOmyc3 cells responded in a similar way to 
irradiation as did TGR-1, undergoing arrest in the G2 phase of the cell cycle 12 h after 
treatment, followed by cell death, assessed as increase of the sub-G1 population with 
fragmented DNA, 24 h and 48 h after irradiation (Figure 3D). In line with this 
observation, irradiation of the HOmyc3 cells induced ATM phosphorylation similarly 
to that observed in the parental TGR-1 cells (Figure 3E).  
 
To test whether the delayed cell death in the HO15.19 cells was dependent on the type 
of DNA damage, we used two additional genotoxic stresses: the bacterial cytolethal 
distending toxin (CDT), which induces DNA double strand breaks similarly to IR 
[30], and UV irradiation, which causes dipyrimidine photoproducts. CDT intoxication 
induced arrest in the parental TGR-1 cell line and the myc reconstituted HOmyc3 cells 
24 h after treatment. Similarly to irradiation, arrest in G2 was followed by cell death, 
assessed as increase of the sub-G1 population with fragmented DNA 72 h and 96 h 
after intoxication (cp Figure 3D and Figure 4A upper panel). Intoxication of the 
HO15.19 cells induced partial G2 arrest at 24 h, followed by a complete accumulation 
of cells in this phase of the cell cycle by 72 h, while minimal signs of cell death were 
observed as late as 96 h after treatment (Figure 4A upper panel). The delayed 
response of the HO15.19 cells was also confirmed by cell morphology. A massive cell 
detachment was observed in intoxicated TGR-1 and HOmyc3 cells at 48 h post-
intoxication, while this effect was not seen in the HO15.19 cell line up to 96 h (Figure 
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4A, lower panel). As shown in Figure 4B, UV irradiation induced cell death with 
similar kinetics in all the cell lines tested, independently of the myc status, as assessed 
by accumulation of cells with fragmented DNA (upper panel) or by cell morphology 
(lower panel). 
 
ATM autophosphorylation on Ser1981 is dependent on Nbs1, a member of the 
Mre11/Rad50/Nbs1 (MRN) complex, which acts as a sensor for DNA breaks and is 
required for efficient activation of the ATM-dependent response [18, 19]. Therefore, 
we assessed the extent of Nbs1 activation in HOmyc3, TGR-1, and HO15.19 cells in 
response to irradiation and CDT intoxication. As expected, a prevalent perinuclear 
distribution of Nbs1 was detected in the HOmyc3 and TGR-1 cells untreated or 
exposed to the mutant inactive CDT (Figure 5A and data not shown), while exposure 
to IR was associated with formation of distinct nuclear foci in 80% and 90% of the 
cells 30 min and 2 h after irradiation, respectively, in both cell lines (Figures 5A and 
5B). The number of cells presenting Nbs1 nuclear foci started to decrease 4 h after 
exposure to IR (Figure 5B). Similar perinuclear distribution of Nbs1 was observed in 
the myc null cells HO15.19 (Figure 5B). However, irradiation-induced foci formation 
occurred only in approximately 40% of cells 30 min post-treatment, and the number 
of cells presenting nuclear Nbs1 foci further decreased at later time periods (Figure 
5B). A different kinetics of Nbs1 foci formation was observed in TGR-1 and 
HOmyc3 upon CDT intoxication. Up to 70% of the cells presented nuclear Nbs1 foci 
2 h post-intoxication, and this percentage was not significantly decreased 4 h after 
treatment (Figure 5B, lower panel). 
Consistent with a delayed response of the myc null cells HO15.19 to agents causing 
DNA double strand breaks, nuclear re-distribution of Nbs1 was observed in 30% to 
40% of the myc null cells HO15.19, both at 2 h and 4 h after treatment (Figure 5B, 
lower panel). 
 
To further confirm that the ATM response to DNA double strand breaks is delayed in 
absence of myc, we assessed levels of Nbs1 expression and the activation status of 
two other well-charaterized ATM-dependent substrates: the histone H2AX and p53 
[20]. Since the cellular responses to IR and CDT are largely identical, we used IR for 
the next sets of experiments [30]. A two- to three-fold increased expression of Nbs1 
was detected by western-blot analysis in HOmyc3 and TGR-1 cells 2 h after 
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treatment, compared to the untreated controls, while this effect was not observed in 
the myc null cells (Figure 6A). Similarly, HOmyc3 and TGR-1 cells presented a two- 
to three-fold increase of H2AX phosphorylation (γH2AX) 30 min after irradiation. In 
contrast, the increase in the levels of γH2AX was almost completely absent in 
irradiated HO15.19 cells (Figure 6B).  
Irradiation induces ATM-dependent phosphorylation of the p53 protein on Ser15 [31]. 
This prevents its degradation via the uquibitin proteasome system, leading to p53 
stabilization and consequent accumulation of the protein, which can be monitored by 
western-blot analysis. Kinetics experiments showed that accumulation of p53 was a 
late event, detected 24 h after irradiation in TGR-1 and HOmyc3 cell lines (Figure 
6C). This response was further delayed in the myc null cells HO15.19, where 
stabilization of p53 was not detected until 48 h after exposure to IR (Figure 6D). 
Interestingly, the Chk1 kinase, which is a known ATR substrate, was already 
phosphorylated 30 min after irradiation in all the three cell lines (Figure 6E), 
suggesting that Chk1 phosphorylation was independent of cellular Myc levels. 
 
Collectively, these data demonstrated that MYC plays a key role in the regulation of 
the ATM-dependent checkpoint responses to DNA damage. 
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Discussion 
Genomic stability is the main barrier that prevents carcinogenesis. Therefore it is not 
surprising that a number of checkpoint responses are activated to counteract the 
effects of diverse genotoxic stresses [32]. Our data demonstrated that the proto-
oncogene MYC plays an important role in the regulation of the cellular responses to 
gentoxic stress, since myc null cells present impaired recruitment of the MRN 
complex to form nuclear foci and delayed ATM-dependent checkpoint responses to 
agents inducing DNA double strand breaks (IR and CDT) (Figures 3 to 6). In 
essence, this protein may play an important role for maintaining genome stability, 
when expressed at levels observed in non-malignant cells. 
 
ATM may be defined as a bona fide tumor suppressor gene, since Ataxia-
telangiectasia (AT) patients, carrying loss-of-function mutations of ATM, present 
chromosomal abnormality, radiation sensitivity, and increased susceptibility to cancer 
development. In addition, deletion of atm in mice results in development of thymic 
lymphoma [33-36]. Loss-of-function of other key regulators of the DNA damage 
response, such as the Nbs1 protein in patients affected by the Nijmegen breakage 
syndrome, causes clinical and cellular phenotypes similar to those observed in AT 
patients. Based on this evidence and on the data presented in this work it is 
conceivable that MYC may have a similar role, and therefore loss-of-function of MYC 
in association with enhanced survival signals and/or oncogene activation may lead to 
increased tumor development in response to chronic genotoxic stress. 
 
 Interestingly, deletion of myc did not prevent phosphorylation of Chk1 in response to 
IR (Figure 6E). The phospho-specific antibody used in this set of experiments was 
directed against the site known to be phosphorylated by the ATR kinase (Ser 345 in 
human cells) [37]. Therefore, we concluded that Myc regulated the activation of the 
ATM-, but not the ATR-dependent checkpoint pathway induced by irradiation. This is 
consistent with the observation that UV irradiation, a potent stimulus for ATR 
activation [38], elicits cell death with similar kinetics in all the three cell lines tested, 
independently of the myc status (Figure 4B). These data confirm that the delayed 
response to IR and CDT observed in the myc null cells HO15.19 was not an artifact 
due to their slower proliferative capacity [13, 26]. 
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The selective effect on the ATM responses may depend on the fact that Nbs1, one of 
the proteins essential for the full kinase activation [39], is a direct target of MYC. 
Over-expression of MYC under a tetracycline inducible system in Epstein-Barr virus 
transformed B cells is associated with increased levels of Nbs1, while knock down of 
the endogenous levels of MYC by siRNA in 293T cells induced strong down-
regulation of Nbs1 [40]. Furthermore, the Myc/Max complex has been shown to bind 
and enhance transcriptional activation of the Nbs1 promoter [40]. Accordingly, we 
observed an up-regulation of the Nbs1 expression in TGR-1 and HOmyc3, compared 
with the myc null cells HO15.19 2h after irradiation (Figure 6A). Furthermore, we 
observed a strong impairment in irradiation- and intoxication-induced nuclear 
translocation and foci formation of Nbs1 in the HO15.19 cells (Figures 5A and 5B), 
suggesting that Myc exerts an addition level of control, apart from gene regulation, in 
the DNA damage-induced activation of the MRN complex. The different kinetics of 
foci formation observed in irradiated versus intoxicated cells is consistent with the 
fact that CDT is a constantly active enzyme, which induces an increased number of 
lesions over time. 
 
Over-expression of MYC in normal human fibroblasts enhances the basal levels of 
phosphorylation of H2AX and disrupts the repair of DNA DSBs in response to IR. 
This effect leads to enhanced chromosomal breaks and translocations [41]. In 
contrast, we observed a similar kinetics of DNA repair in response to irradiation in 
TGR-1 cells, which express physiological levels of Myc, compared to the myc null 
HO15.19 cells (Figure 2). Interestingly, a 3-fold higher Myc expression in the 
reconstituted HOmyc3 cells [25] was not sufficient to increase the basal levels of 
H2AX phosphorylation compared to those observed in the parental control TGR-1 
(Figure 6B), indicating that there is a threshold after which the levels of MYC 
expression are associated with an abnormal response to DNA damage. 
 
Physiological levels of Myc trigger apoptosis in TGR-1 cells exposed to DNA 
damaging agents, such as etoposide and camptothecin, via activation of the pro-
apoptotic proteins Bax and PKCδ [14, 15]. This response is either absent or delayed 
in HO15.19 cells. In this work, we showed that cell death was delayed in HO15.19 
cells also in response to irradiation and CDT intoxication (Figures 1 and 4). The late 
activation of cell death is in agreement with the late stabilization of the tumor 
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suppressor gene p53, which was not observed until 48 h post-irradiation (Figure 6 
and [42]). Maclean et al recently reported that MYC over-expression via a retroviral 
vector regulates ATM-dependent activation of p53 4 h after irradiation in primary 
human foreskin fibroblasts [43]. However, the involvement of MYC in the regulation 
of upstream activators of ATM, such as Nbs1, was not characterized. 
 
The delayed response of the myc null cells HO15.19 to CDT intoxication is very 
interesting. Epidemiological evidences indicate that chronic infection with the CDT 
producing bacterium Salmonella enterica serovar typhi is associated with increased 
risk of hepatobiliar carcinoma [44], but the exact mechanism(s) by which bacterial 
infections can contribute to carcinogenesis is still poorly characterized. In light of the 
data reported in this work, MYC loss-of-function and consequent delayed cell death 
in chronic infections with CDT-producing bacteria may promote or enhance genomic 
instability, and favour tumor initiation and/or progression. 
 
From the data presented in this work, the sequence of events regulated by Myc in 
response to irradiation or CDT intoxication can be summarized as follows: Myc is 
essential for the rapid nuclear foci formation of Nbs1. This event triggers full 
activation of ATM and subsequent phosphorylation of its down-stream effectors and 
transducer molecules (Figure 7). In the presence of a substantial DNA damage that 
cannot be repaired, activation of the checkpoint response is likely to result in 
mitochondria-dependent apoptosis [14, 15]. 
 
The MYC protein regulates a plethora of cellular responses with outcomes spanning 
from cell proliferation to cell death. Even in the context of genomic stability this dual 
role of MYC holds true. Indeed, over-expression of MYC can induce DNA damage 
both in a ROS-dependent and -independent manner, thus contributing to genome 
instability and chromosomal abnormalities [6, 7]. In contrast, expression of 
physiological levels of MYC is important for the proper activation of the DNA 
damage checkpoint responses. This effect suggests that MYC may exert a tumor 
suppressor-like function, by contributing to the repair of damaged DNA, and 
eventually induce the elimination of cells carrying genomic instability. Our work has 
contributed to the elucidation of this previously poorly characterized role of MYC. 
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Figure legend 
 
Figure 1. Myc deletion delays cell death upon induction of DNA damage 
TGR-1 and the myc null HO15.19 cells were left untreated or irradiated (20 Gy) and 
further incubated in complete medium for the indicated periods of time. Analysis of 
the cell cycle distribution was assessed by PI staining and flow cytometry as 
described in Material and Methods. One out of four experiments is shown. 
 
Figure 2. Myc does not affect the rate of DNA repair 
A) Pulsed-field gel electrophoresis (PFGE). Fifty thousand TGR-1 or HO15.19 cells 
were grown in a 12 well-plate in complete medium containing 4000 Bq [methyl-14C]-
thymidine for 72 h. The cells were then washed twice in PBS, chased for 2 h in 
complete medium before irradiation (20 Gy), and further processed for PFGE analysis 
at the indicated periods of time. One out of two independent experiments is shown. B) 
Quantification of DNA fragmentation at the indicated time periods. 
 
Figure 3. Activation of ATM and ATM-dependent responses upon induction of 
DNA damage is Myc dependent 
A) TGR-1 and HO15.19 cells were left untreated or exposed to IR (20 Gy), and 
further incubated in complete medium for the indicated periods of time. The levels of 
ATM phosphorylation were assessed by western-blot analysis using a α-phospho-
ATM antibody. Actin was used as an internal loading control. One out of four 
independent experiments is shown. B) TGR-1 cells were left untreated or exposed to 
IR (20 Gy), and further incubated in complete medium for the indicated periods of 
time. Phosphorylation of ATM/ATR substrates was assessed by western-blot analysis. 
The arrows indicate two proteins of approximately 35kDa and 110kDa, respectively 
that were phosphorylated in response to irradiation. One out of four independent 
experiments is shown. C) TGR-1 and HO15.19 cells were left untreated or exposed to 
IR (20 Gy), and further incubated in complete medium for the indicated periods of 
time. Phosphorylation of ATM/ATR substrates was assessed as described in Figure 
3B. D) TGR-1, and the myc reconstituted HOmyc3 cells were left untreated or 
irradiated (20 Gy), and were further incubated in complete medium for the indicated 
periods of time. Analysis of the cell cycle distribution was assessed as described in 
Material and Methods. One out of two independent experiments is shown. E) TGR-1, 
HOmyc3, and HO15.19 cells were left untreated or exposed to IR (20 Gy), and further 
incubated in complete medium for 2 h. The levels of ATM phosphorylation were 
assessed as described in Figure 3A. Actin and total ATM were used as internal 
loading controls. 
 
Figure 4. Myc deletion delays cell death in response to CDT intoxication but not 
to UV irradiation 
TGR-1, the myc reconstituted cells HOmyc3, and the myc null HO15.19 cells were 
exposed to bacterial lysates (1:2000) expressing the mutant (CTR) or the wild type 
form (CDT) of H. hepaticus CDT (A), or left untreated or exposed to UV irradiation 
(B), and further incubated in complete medium for the indicated periods of time. 
Analysis of the cell cycle distribution (upper panel) was assessed by PI staining and 
flow cytometry as described in Material and Methods. One out of three experiments is 
shown. The lower panel shows phase contrast micrographs of the cells taken at the 
indicated time points (Magnification 40x). 
 
 19 
 
Figure 5. Myc deletion impairs Nbs1 foci formation in response to DNA damage 
A) TGR-1, the myc reconstituted HOmyc3, and the myc null HO15.19 cells were 
exposed to bacterial lysates (1:2000) expressing the mutant (CTR) or the wild type 
form (CDT) of H. hepaticus CDT, or irradiated (IR, 20 Gy) and further incubated in 
complete medium for the indicated periods of time. The Nbs1 protein was detected by 
indirect immunostaining, as described in Material and Methods. The figure shows the 
sub-cellular distribution of Nbs1 at 2 h post-treatment. C) Quantification of the 
number of cells expressing Nbs1 nuclear foci (one hundred cells were counted for 
each treatment). A cell with more than 5 nuclear foci was scored as positive. Mean ± 
SD of three independent experiments; * statistically significant decreased in Nbs1 foci 
formation. 
 
Figure 6. Myc deletion prevents Nbs1 up-regulation and delays H2AX and p53 
activation in response to DNA damage  
TGR-1, the myc reconstituted HOmyc3, and the myc null HO15.19 cells were left 
untreated or exposed to IR (20 Gy) and further incubated in complete medium for the 
indicated periods of time. The levels of Nbs1 (A), γ-H2AX (B) and phospho-Chk1 
(pChk1) (E) were assessed by western-blot analysis as described in Material and 
Methods. 
C) TGR-1 and the myc reconstituted HOmyc3 cells were left untreated or exposed to 
IR (20 Gy) for the indicated periods of time. The levels of p53 were assessed by 
western-blot analysis. D) TGR-1, the myc reconstituted HOmyc3 and the HO15.19 
cells were left untreated or exposed to IR (20 Gy) for the indicated periods of time. 
The levels of p53 were assessed by western-blot analysis. Actin was used as an 
internal loading control. One out of three independent experiments is shown. 
 
Figure 7. Model for the MYC-dependent responses to irradiation or CDT 
intoxication. In response to IR or CDT, MYC induces up-regulation and nuclear foci 
formation of Nbs1. This event triggers activation (phosphorylation) of ATM, leading 
to phosphorylation of its down-stream effectors and transducer molecules. 
Phosphorylation of the ATR-dependent target kinase Chk1 is independent of MYC 
expression. 
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